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;ote: throughout this thesis statistical probability
values were calculated using two-tailed significance
tests.
Abbreviations: Abbreviations used in this thesis are
mostly those in common scientific usage and the more
unusual are introduced in the text. A list of some of




a/7 ATPase sodium and potassium stimulated, magnes
ium dependant ATPase
Eg ATPase magnesium dependant ATPase
Ca + Ilg ATPase total magnesium dependant and calcium
stimulated, magnesium dependant ATPase
Ca ATPase calcium stimulated, magnesium dependant
ATPase
C.P.M. or c.p.m. counts per minute
IIVA hoinovanillic acid




B.D.H. British Drug Houses Ltd.
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ABSTRACT.
The thesis describes investigations concerning the
effects of lithiura on ATPases and ion transport. Effects
of potassium and lithium on sodium transport from blood to
cerebrospinal fluid and brain were studied using a ventriculo-
cisternal perfusion technique. The fast component of sodium
entry into cerebrospinal fluid was correlated with the cist¬
ernal potassium concentration. This together with results
showing the potassium-dependance of choroid plexus ha./k.
ATPase activity was interpreted as showing choroid plexus
sodium transport to be sensitive to cerebrospinal fluid
potassium concentration and to be due to ha/h ATPase activity
in the apical membranes of the plexuses, effects of lithium
on sodium transport were interpreted as a stimulation of
the sodium-pump when presented to the potassium-sensitive
side and an inhibition when presented to the sodium-sensitive
side.
The effects of chronic lithium administration on
ATPase activities were investigated in subcellular fractions
prepared from rat cerebral cortex. Lithium was found to
have no effect on synaptic plasma membrane ha/k ATPase
activity but Pig ATPase specific activity was increased both
in the membrane fraction and in mitochondria, after 21 ana
7 days administration respectively. The changes in enzyme
specific activity were not due to changes in fraction com¬
position. Lithium administration for 21 days caused an
increase in the concentration of homovanillic acid and
- V -
3,4dihydroxyphenylacetic acid in the striatum. This was
interpreted as showing an increased release and turnover
of dopamine.
ATPase activities were also studied in erythrocyte
membrane preparations. Depressive patients were shown to
have a reduced erythrocyte membrane La/X ATPase specific
activity compared to controls. It is suggested that such
a reduced enzyme activity could explain many of the prev¬
iously observed derangements of sodium metabolism in depress¬
ion. Lithium-treated patients showed increased specific
activities of both Tig ATPase and ha/X ATPase in erythrocyte
membranes. It is suggested that the increase in Na/K ATPase
activity was due to recovery of the patients but that the
increase in Mg ATPase activity was due to lithium itself.
Lithium administration had no effect on erythrocyte menbrane
ATPase activities in the rat. It is concluded that chronic
lithium administration affects the specific activities of
certain Mg ATPases but not the ha/K ATPase. It is speculated
that the changes in membrane Ag ATPase activities reflect
changes in actomyosin-like proteins which could lead to




In recent years lithium carbonate has become an
important drug for the treatment of affective illness.
Within the environs of Edinburgh for example, there are
some 500 people out of a total population of approximately
50C£>00 receiving lithium carbonate treatment. The wide and
increasing use of lithium salts in psychiatry has stimul¬
ated research for two main reasons. Firstly the ingestion
of large quantities of an unnatural inorganic salt over
long periods must be expected to produce marked metabolic
disturbance and therefore research into the toxic effects
of lithium treatment (Vacaflor, 1975) and the mechanisms
involved may be of some value. Secondly, lithium salts
have unique clinical properties and therefore an understand¬
ing of the mode of action of lithium in the treatment of
affective disorders may produce some clues as to factors
in the aetiology of these illnesses.
The first indication of the possible use of lithium
salts in psychiatry is found in the writings of Soranus of
Ephesus, who in the 5th century A.D. advocated alkaline
mineral waters for the treatment of manic excitement
(Johnson and Cade, 1975). Subsequently it has been noticed
that several spa waters have a high lithium content (Johnson
and Cade, 1975). The first medicinal use of lithium salts
themselves was in the treatment of gout in the 19th century
on account of the high solubility of lithium urate. in
retrospect it has been pointed out that in certain cases
of gout-associated depression lithium salts seemed to have
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so ;e "beneficial effect on the mental symptoms (Schou,
1957; Johnson and Cade, 1975). Lithium bromide had a brief
use as an hypnotic and anti-epileptic in the 1920*3 but
this was not sustained, it was not until 1949 that Cade
made the discovery that lithium salts had a tranquilizing-
effect when given to guinea-pigs and were efficacious in
the treatment of mania (Cade, 1949). Cade's original
observation has been followed by a series of clinical
trials using lithium carbonate for the treatment of mania
and depression. It is now generally accepted that lithium
carbonate is an effective treatment for patients suffering
from mania but its effectiveness in the treatment of
depression is still equivocable (Coppen, 1973> Schou, 1973;
.:endels, 1975; Peet, 1975).
The tern affective illness includes both depressive
and manic-depressive illness. The former is also referred
to as unipolar depressive illness and the latter as
bipolar depressive illness since it is characterised by
both manic and depressive episodes, both types of depress¬
ive illness are recurrent in that untreated episodes will
remit spontaneously and then after a period of time the
patient will relapse (Coppen, 1973). There is evidence
(Coppen, 1973) that the interval between episodes decreases
as the patient suffers successive episodes. Clinically,
the most important effect of lithium salts is their
ability, on prolonged administration, to reduce the
morbidity of an affective illness either by reducing the
- 4 -
severity of an episode, by reducing the frequency of
episodes or by abolishing future episodes (Coppen, 1973;
Schou, 1973; Schou and Thomsen, 1373). Such a prophylactic
action is unique in psychiatry.
Research into the mode of action of lithium salts is
hampered by the lack of understanding of the biological
processes leading to mania and depression. Theories of
the aetiology o± the affective disorders have centered on
the involvement of disturbances in either electrolyte
metabolism (Coppen, 1367; Laer, llatman and Fieve, 197oc)
or the metabolism of the catecholamines and indolamines
(Schildkraut, 1965; n.R.C. brain metabolism Unit, 1972).
Studies of potassium, calcium and magnesium metabolism
in affective illness have not provided any consistent
findings (hullin, 1975). However there is considerable
evidence for a disturbance of sodium metabolism in affect¬
ive illness. Using salt loading techniques early workers
found depressed patients to retain more sodium (Klein and
Nunn, 1945; Hlein, 1950). These studies also showed water
and sodium balance to fluctuate with mood. Later studies
showed reduced sodium excretion to be associated with
depression in normal subjects and increased sodium excretion
with manic phases of affective illness (Schottstaedt, brace
and V/olff, 1356a., b; Strom-Olsen and Weil-maherbe, 1953).
Contrary to these reports Russell (i960) found no change
in total sodium balance. Further sophistication of experi¬
mental approach came with the use of tracer and isotope
dilution techniques. Although the interpretation of the
results fro:a such studies is fraught with problems (Shaw,
1971) they provide an approach to the study of electrolyte
distribution in vivo. Using isotopic techniques Gibbons
(i960) found a decreased exchangeable sodium in depressed
patients, although no chaige was found on recovery of the
patients. The lack of effect of recovery was confirmed by
a later study but little can. be deduced from the results
since patients were examined only one day after receiving
electroconvulsive therapy (Coppen, Shaw and Mangoni, 1962).
A Tore extensive study examining patients five weeks after
the beginning of treatment and using isotopic bromide to
estimate extracellular space found recovery to be associated
with an increase in total body water, a decrease in 24-hour
exchangeable sodium and a decrease in the non■■ cxc,hwngeable er
residual sodium (Coppen and Shaw, 1963). Residual sodium
was considered to consist of two components, a component
of slowly exchanging sodium in bone and sodium in the
intracellular compartment of the body. On the basis of
these results Coppen and Shaw suggested that depression was
associated with an abnormality in sodium transport which
resulted in an increase in the intracellular concentration
of sodium. This hypothesis gained support with the finding
that residual sodium was high both in depressed and manic
patients (Coppen, Shaw, 'alienor and Costain, 1966; Cox,
7earson and Speight, 1971). A further study found recovery
to be associated with a decrease in residual sodium but the
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effect did not reach statistical significance (Baer, Burell,
Bunney, Bevy, Murphy, Greenspan and Cardon, 1970a). Results
from studies of exchangeable sodium have failed to find any
consistent pattern (Jenner, Gjessing, Cox, Davies-Jones,
Hullin and Eanna, 1967; Baer et al., 1970a; Cox et al.,
1971). In conclusion balance and isotopic studies, although
not entirely consistent, have shown depression to be assoc¬
iated with a retention of sodium and an increase in the
non-exchangeable or residual sodium. Such results have been
interpreted as showing an abnormality in sodium transport
which causes an increase in intracellular sodium concen¬
tration (Coppen and Shaw, 1963; Coppen, 1967).
Various experimental approaches have been used to
investigate sodium transport in depressed patients and to
test the above hypothesis. Analysis of post-mortem brain
from depressive suicides showed increased water content
and increased sodium concentration compared to control
brain tissue (Shaw, Frizel, Camps and White, 1969). By a
most tentative argument these results were interpreted as
showing an increased intracellular sodium concentration,
however interpretation of such results in terras of intra¬
cellular and extracellular compartments is dubious and the
results therefore do not provide strong evidence to support
the abnormal sodium transport hypothecs. In further attempts
to prove or disprove this hypothesis various workers have
studied the transport of isotopic sodium from blood to
lumbar cerebrospinal fluid. The results of such studies
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have "been contradictory. Coppen (i960) found depressed
patients to have a decreased rate of sodium entry and to
show an increase in transport on recovery. Later studies
failed to repeat these findings (Pother"by, Ashcroft,
Affleck and Forrest, 1963; Carroll, Steven, Pope and
Lavies, 1969) although Potherby et al. did find reduced
sodiu i transport in four cases of severe depression,
".ore recently Laker (1971) found sodium entry into cerebro¬
spinal fluid to be reduced in both manic and depressed
patients compared to scizophrenics and other miscellaneous
controls. Combining results from his own study and fro.:,
all the previous studies on sodium entry into cerebrospinal
fluid Carroll (1972) concluded that sodium entry into
cerebrospinal fluid was significantly reduced in aaric and
depressed patients and that it increased significantly on
recovery. In conclusion, there is considerable evidence
that depression is associated with a decreased sodium
transport into cerebrospinal fluid. Further evidence for
abnormal sodium transport in depression came from a study
of salivary sodium concentration in depressed patients
( ;ien, Onyley and Robinson, I960). These workers found
depressed patients to have an increased sodium activity
in saliva compared to controls and they interpreted these
results as showing a reduced active transport of sodium
from saliva.
In recent years use has been made of the erythrocyte
in order to study intracellular sodium concentration and
sodium transport in depressed patients, however once
again the results have been contradictory. Erythrocyte
sodium concentration was reported to be lower in depressed
patients than in controls (! aylor, ..chamee and ^oody, 1970a;
..endels, Eraser and Secunda, 1972) but other studies have
failed to confirm this (I,aylor, hciiamee and moody, 1971).
1aylor and colleagues found erythrocyte sodium concentration
to decrease as patients recovei,ed fro::: depression (Laylor,
hcbanee and Moody, 1971; aylor, hick, Eic -, Le loidevin
and Whyte, 1973) but this was not confirmed by mendels
(Mendel8, Eraser, Secunda and Stokes, 1971; -ienaels et al.,
1972). Overall there is no consistent evidence for an
abnormal erythrocyte sodium concentration associated with
depression. Studies of active sodium transport in the
erythrocyte showed no difference between depressed patients
and controls (iaylor, cM.av.ee and Moody, 1970b). iMiese
authors did find the passive permeability of the erythro¬
cytes from depressed patients to be lower than that found
in four control subjects. In addition . a,/lor found active
sodium transport to increase as the patients recovered
from depression. Other workers have found reduced active
sodium transport in erythrocytes from manic-depressive
patients during the manic phase of illness (.okin-heaverson,
Spiegel and Lev/is, 1974). Earlier studies showed changes
in sodium metabolism in mania to be similar to those
found in depression (Coppen et al., 1966; Glen et al.. 1968).
It is possible therefore that there is a common electrolyte
abnormality in mania and depression. There are many reports
suggesting that a reduced active transport of sodium nay "be
the abnormality in question but the evidence is far from
unequivo cable.
Since active sodiura transport is considered to be
brought about by the activity of the enzyme sodium plus
Dotassiun activated, magnesium dependant adenosine tri-
; hospTatase (Whittam and Wheeler, 1970) changes in active
sodium transport might be expected to be reflected by
changes in sodium plus potassium activated, magnesium
dependant adenosine triphosphatase (Na/X ATPase) activity.
Such considerations have led to a series of studies of
Na/X ATPase activity in erythrocyte material from depressed
oatients. The results of such studies have shown the ATPase
activity to increase as patients recovered from depression
(iTaylor et al., 1973) as expected if depression is associ¬
ated with reduced sodiura transport which increases on
recovery, '.aylor and colleagues (1973) suggested that
depression was associated with a decrease in Ila/h ATPase
activity, a decrease in active sodium transport and an
increase in intracellular sodium concentration. I owever,
on their own admission, their results did not provide
evidence for such a hypothesis. hokin-Xeaverson et al.,
(1974) suggested that manic-depression was associated
with a genetic Xa/K ATPase abnormality but there is no
evidence for such a view. At present there is no evidence
to suggest whether the putative sodium transport abnormality
-10-
in depression is an event in tlie aetiology of the illness
or a result of hormonal and other metabolic changes occur-
ing in depression.
With the advent of the use of lithium salts in depress¬
ion further evidence has been put forward to support the
concept of a membrane transport defect in depression.
Several investigators have found lithium to be retained to
a greater extent in mania and depression than in recovered
or control states (lioaclc and Trautner, 1955; Greenspan,
Green and Durell, 1968; Hullin, Swans, rlcDonald and brans-
field, 1968). As discussed by Greenspan (1975) this
increased retention may reflect an increased intracellular
concentration of lithium. Some evidence for such a view
has come from erythrocyte studies. lendels and Irazer
(1973) found a high intracellular erythrocyte concentration
to be associated with response to lithium therapy and they
suggested there may be a difference in membrane transport
between patients who respond to lithium and those that do
not. Other studies have found higher and lower erythrocyte
lithium concentrations in manic-depressive patients compared
to controls (Elizur, Shopsin, Gershon and Ehlenberger, 1972;
Lyttlcens, Soderberp and Wetterberg, 1973) so the evidence
concerning lithium distribution in mania and depression is
not unequivocable. In order to study the effects of genet¬
ically-determined electrolyte distribution on lithium
distribution iiendels and colleagues exanined lithium dis¬
tribution in vitro and in vivo in erythrocytes from sheep
- 11 -
known to differ in erythrocyte sodium and potassium dis¬
tribution (Sehless, Frazer, Mendels, Pandey and Theodorides,
1975). Lithium concentration was found to be higher in
the low potassium, high sodium concentration erythrocytes.
These results show that a genetically-determined difference
in membrane properties can produce a difference in lithium
distribution. A monozygotic-dizygotic twin study provided
some evidence that lithium distribution in man was genet¬
ically determined (Dorus, Pandey and Prazer, 1974). On
the basis of such results it has been suggested that some
o.epressives have a genetically determined abnormality in
the cation transport system and the erythrocyte aerubrane
{Mendels and Prazer, 1974; Sehless et al., 1975).
In conclusion there have been many studies suggesting
a leinbrane or cation transport abnormality in depression
but the experimental evidence is not totally in support of
such hypotheses, however these ideas have generated much
research into the effects of lithium on cation distribution
and transport.
Observations on lithium-treated patients showed 24-hour
exchanfeahUe sodium to be increased (Baer et al., 1970a;
Aronoff et al. , 1971) although this was not confirmed by-
earlier studies (Coppen, .all ebon and Shaw, 1965; Coppen and
Chaw, 1967). Animal studies have subsequently showed that
c1 ronic lithium administration leads to a decrease in the
brain sodium concentration (Baer, .assir and Pieve, 1970b;
ho, Gershon and Pinckney., 1970; Birch ana Jenner, 1973).
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These animal and human studies led to suggestions that
lithium mi: ht exert its therapeutic action through effects
on sodium metabolism. In view of the role of the Na/K
ATPase in the active transport of sodium out of the cell
(Whittam and Wheeler, 1970) later hypotheses have centered
around this enzyme. Early physiological and biochemical
experiments used lithium either as a sodium substitute or
as an additional alkali metal with which to study enzyme
specificity. Such studies, although indicating possible
pharmacological actions of lithium salts, used high lithium
concentrations between ten and a hundred fold greater than
t ■ e concentrations found in vivo when lithium is used
therapeutically. These early studies showed lithium to
possess a weak stimulatory effect on the Ka/K ATlase in the
absence of potassium (Bader and Sen, 1962; Whittam and Ager,
1964). Similarly in the absence of potassium lithium
stimulated sodium efflux (Keynes and Swan, 1959; Beauge
and Ortis, 1970). However in the presence of potassium
replacement of sodium by lithium led to decreased sodium
efflux (Keynes and Swan, 1959; Baker, Blaustein, Keynes,
'anil, Shaw and Stein1 lardt, 1969). Willis and Fang (1970)
found lithium (30 - 50 m ) to replace both sodium and pot¬
assium in \a/K ATPase activity in squirrel kidney cortex
slices. In addition they described an ouabain-sensitive
lithium dependant respiration in the absence of potassium,
"r the pharmacology of lithium gained interest lower con¬
centrations of lithium (2-10 ml) were used in a series
of studies of ATBase activity and sodium transport. 3 mm
lithium was shown to stimulate sodium efflux from the
erythrocyte at sub-optimal (2 ink) potassium concentrations
(Glen, Bradbury and Wilson, 1972) and these autuors
suggested such a stimulatory action on sodium transport
■night be involved in the therapeutic actions of lithium.
In support of this suggestion low lithium concentrations
were reported, to stimulate ..a/'.. ATIas e activity at potass¬
ium concentrations below 2 mM (Tobin, Akera, Ban and Brody,
1974). In addition :..loeger (1974a) has shown 10 mil lithium
to : ave a weal: stimulatory action on the sodium-pump (the
active sodium transporting system associated with .ua/h
hi.ase activity) in a rat vagal nerve preparation, ihere
are also some reports of lithiu: , in vitro, having a we a.,
stimulatory effect on brain and kidney .a/.. All ase activity
in the presence of high, saturating, concentrations of
potassium (Gutman, lochman and aid, 1973b; Tobin et al..
1;74). iutman et al. suggested lithium to uncouple the
ATIase, that is to stimulate the enzyme activity whilst
decreasing the transport of sodium and potassium. Overall
these studies provide evidence that lithium can interact
with the potassium-site of the ka/l ATIase and stimulate
the enzyme. owever there is little evidence to support
t e ypotcesis that cue: an effect occurs in vivo, at
therapeutic plasma concentrations of lithium (0.6 - 1.6 mM),
or at physiological potassium concentrations.
loeger (1974a, b) has suggested t at lit. iu . :iay
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exert its therapeutic effects through an inhibitory action
on the sodium-pump at both the potassium and sodium sites,
his evidence for such a hypothesis is however not convincing.
The inhibitory effect at the potassium site was deduced from
experiments in which pre-treatment of a rat vagal nerve
preparation with lithium in the absence of potassium
caused an inhibition of a subsequent potassium activated
response. It is difficult to extrapolate such an effect to
suggest an inhibition of the -a/1 ATIase at the potassium
site under physiological potassium concentrations. Apply¬
ing lit iurn externally loe;,er claims to find an inhibition
of the sodium-pump at the internal sodiuia site on the basis
of lithium-sodium competition, it is difficult to be
certain such ar effect is occuring inside the cell. Stronger
evidence for an inhibitory effect of lithium cane from exper¬
iments in which Ploeger found superfusion with lithium to
inhibit ha/. ATIase activity in a stimulated nerve. On
the basis of these results Ploeger suggested lithium to
reduce the reserve capacity of the sodium-pump. In further
experiments he found chronic lithium treatment to reduce
a/ ATFase activity in rat vagal nerve homogenates. Sue!
an inhibitory effect of chronic lithium treatment has also
een reported by Reading and colleagues (Reading, Kinloch
and Loose, 1975) in t, e rat cortex synaptic ..e. .brane.
utman and colleagues found chronic lithium treatment to
increase microsomal ha/K ATPase activity in the salivary
, "
not in the brain (C~utman, Lochman and. Strachman, 1973a;
futman et al., 1973b). cbulty, l'bonovan and Leonard
(1975) found La/> ATPase activity in brain to be reduced
after a single injection of lithium chloride. Although
these studies are not all in agreement they provide some
evidence for an inhibitory effect of lithium on the sodium-
pump .
In interpreting and carrying out studies of the effects
of lithium on a/ ATPase it is important to consider two
moints. Firstly, effects of chronic treatment may be
different from those of an acute application. Secondly, the
a/ ATPase is specifically orientated in the membrane in
such a way that the internal and external enzyme sites
. ave different properties ('Whittaru and Wheeler, 1370). The
enzyme is activated externally by potassium and internally
by sodium (Whittam, 1962; Whittam and Ager, 1964). in view
of the differing cation specificity of the two opposing
enzyme sites it is possible that lithium could exert
different effects at the two sites. It is well established
that lithium can stimulate the enzyme at the external site
but its action at the internal site is unknown. As mentioned
above Ploeger (1374b) has suggested lithium to inhibit the
sodium-pump at the internal site and such an effect is
feasible in view of the several reports that lithium is not
actively transported out of the cell by the sodium-pump
( eynes and Swan, 1959; hodgkin and heynes, 1965; .aizelc,
1'6•; Smith, 1974). The "sidedness" of the ha/• ATPase
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and different effects of lithium on the two opposing enzyme
sites have teen suggested to he important in the therapeutic
action of lithium (Glen and Heading, 1973). These authors
suggested that in the depressive phase of a manic-depressive
illness intracellular sodium concentration was high and
lithium was predominantly extracellular. In this situation
they suggested lithium to stimulate the a a/ ATPase at
the potassium, external site. On the other hand they
suggested that in mania intracellular sodium concentration
was low and more lithium moved into the intracellular
compartment where it had an inhibitory effect on the ha/
ATPase at the sodium site. The action of lithium in both
cases was proposed to bring the intracellular sodium con¬
centration back to within the normal range.
Whatever hypothesis is forwarded to describe the
effects of lithium on the ha/i ATPase and sodium transport
it must explain the observation that high concentrations of
lithium inhibits sodium transport across the isolated frog
skin epithelium (Zerahn, 1939; Leblanc, 1372; liber and
Curran 1970).
There is evidence that in 1 eLa cells cultured in the
presence of lithium there is an increased Pa/K ATPase
activity and an increase in the number of ouabain-bindin<_
sites (Boardman, Hume, Lamb and Poison, 1975). These
results suggest that in addition to activation effects on
the enzyme lithium may also affect ha/K ATPase at the level
of'protein synthesis.
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-ecently it has been shown that lithium-treatment of
patients leads to an increase in Ha/h ATPase activity in
erythrocyte membranes (Naylor, lick, Dick and ..oody, 1974;
Dick, Naylor, Dick and oody, 1974). it was not possible
from these results to distinguish whether the effect was
due to recovery of the patients or to lithium itself. it
is possible however that lithium treatment affects ha/k
ATPase activity in man.
Magnesium-dependant adenosine triphosphatase activity
{'Mg ATPase) l as also been implicated in the therapeutic
action of lithium (Glen and Heading, 1973). Termination
of lithium administration to animals has been found to
cause an increase in synaptic plasma membrane mg ATPase
activity (Reading, Dewar and iinloch, 1374). These results
were interpreted as suggesting lithium to cause a fusion
between vesicles and the synaptic plasma membrane (Glen
and Reading, 1973; Heading et al., 1974). hater results
have shown lithium administration itself to increase syn¬
aptic .membrane Mg ATPase activity (Heading et al.. 1973).
Considering the possible presence of an actornyo sin-like
ATPase in synaptosomal material ana its proposed role in
neurotransmitter release (Lerl, Puszkin and uicklas, 1373)
it is possible that the kg ATIase activity affected by
lithium treatment could be associated with the actoiayosin-
like protein and neurotransmitter release. The advantage
of such a hypothesis is that it would provide a connection
between electrolyte ana amine theories of affective illness.
Previous suggestions to connect these fields have involved
interaction between sodium metabolism and amine re-uptake
from the synaptic cleft (Singh, 1970; Hendels et al., 1971;
Glen et al. , 1972; Haas, 1972). There is some evidence
for chronic lithium treatment of rats causing an increase
in noradrenaline uptake by synaptosomes (Colburn, Goodwin,
Eunney and Davis, 1967; Baldessarini and Yorke, 1970) and
increased intraneuronal metabolism of noradrenaline
(Schildkraut, Schanberg and Kopin, 1966). Overall however
the effects of lithium on amine metabolism which have been
described in the literature are very varied (Shaw, 1979).
Besides its effects on Mg ATPase, lithium has been
reported to affect other magnesium dependant enzymes and
magnesium distribution within the body. There is no
consistent pattern in the reports of the effects of lithium
on magnesium distribution in man (hullin, 1975) but animal
studies have shown an increase in plasma magnesium follow¬
ing lithium (hullin, 1975; Andreoli, Villani and Erambilla,
1972; Mellerup, Plenge and Kafaelson, 1973; haavaldson and
Ingvaldson, 1973). Changes in magnesium distribution have
been suggested to be important in the therapeutic action of
lithium (Glen and Reading, 1973). It has also been suggested
that lithium's ability to compete with magnesium in biolog¬
ical situations could explain its therapeutic actions
(Birch, 1973; 1974). In support of this hypothesis Birch
referred to lithium's chemical similarity to magnesium
(hellerup and Jorgenson, 1975) and the inhibition of the
- 1
magnesium dependant enzymes hexokinase, alkaline phosphatase
ana pyruvate kinase by lithium in vitro (Birch, Hullin,
Inie and Leaf, 1974). However this hypothesis has been
challenged because high lithium concentrations were needed
for inhibition in some cases and because other workers
have failed to find inhibition of these and other magnesium
dependant enzymes (Agar, Gruca, Gupta and liar-ley, 1975;
Gupta and Crollini, 1975; Ischeidt and heltzer, 1975). Of
some relevance to this thesis is the suggestion by birch
(1974) that lithium's therapeutic actions may be due to
the formation and special properties of a lithium-ATP
complex.
The previous pages have described the experimental
results and hypotheses concerning the role of electrolytes
and ATPases in affective illness and in the therapeutic
action of lithium and have set out the experimental and
theoretical basis of this thesis. Besides the literature
discussed there are many other studies concerning the many
pharmacological effects of lithium and there are several
reviews which cover the various aspects which have not been
considered in detail (Jenner, 1973; Schou, 1973; Steinberg,
1973; Johnson, 1975; Schou, 1976).
It is not possible to study the biochemistry of
affective illness and the pharmacology of lithium by invest¬
igating human brain tissue except for the occasional post¬
mortem material. The most useful available human material
is cerebrospinal fluid and blood but studies of these
- 20 -
materials suffer from giving only indirect information on
train function. As an alternative to human work one can
study the effects of drugs on animal brain biochemistry.
However this approach also has its limitation, primarily
tne lack of an adequate animal model for manic-depressive
illness. Since lithium is reported to have little effect
on the brain functions of normals (Schou, 1976) it is
possible that effects of lithium on animal brain function
are not at all related to its therapeutic action, further¬
more lithium is unique in that it has a prophylactic action.
It is therefore important to study the effects of chronic
lithium administration. V.hen given therapeutically lithium
is found in concentrations in the range 0.6 - 1.6 mh in
plasma (Schou and baastrup, 1967; Schou, 1976). Therefore
in chronic administration experiments one should attempt
to achieve such concentrations. It is also necessary to
try to avoid toxic effects since these might affect the
results obtained from the experiment. Plasma concentrations
of 0.6 - 1,6 mm are accompanied by brain concentrations
of the order of 0.5 m ■ ./kg (Schou, 1976) and it is important
therefore to use lithium at concentrations between 0.5 and
1.0 mm when doing acute in vivo or in vitro experiments.
Only effects found with such a range of concentrations can
be said to be of any possible therapeutic significance. In
the work to be described acute in vitro and in vivo admin¬
istration, chronic administration and lithium-treated
patients have all been used in order to attempt to answer
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certain questions. Throughout the work it was attempted
to use lithium concentrations, in vitro and in vivo, com¬
parable to those found in the therapeutic situation.
Schou (1973) has stated that 'ho comprehensive and
experimentally testable hypothesis has been advanced for
the biochemical mechanism undei'lying the mood-normalizing
effects of lithium salts" and it is true that deex^ite the
wealth of experimental observations there is a dearth of
specific, testable hypotheses, however where possible the
work to be described was designed to answer certain
specific questions raised by previous work described in
this introduction. Several experimental approaches were
used to study the effects of lithium on ATPase systems and
ion transport and these approaches together with the
experimental results are described in the following four
sections.
Section II describes experiments designed to determine
whether 1 ithiuin (0 .6 - 1,2 mil) could stimulate sodium
transport when applied to the potassium-sensitive side of
a sodium-transporting system and inhibit it when applied
to the sodium-sensitive side. This was approached experi¬
mentally using tie ventriculo-cisternal perfusion technique
to study sodium transport from blood to cerebrospinal fluid.
This system allowed study of the effects of lithium when
presented to opposing sides of the sodium transporting
system and so allowed testing of a premise basic to the
hypothesis forwarded by Glen and heading (1973). In the
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process of this work experiments were carried out to
examine whether sodium entry across the choroid plexus was
sensitive to cerebrospinal fluid potassium concentration.
This provided a basis for the lithium experiments and also
contributed evidence for the implication of a sodium-
pump in choroid plexus sodium transport, finally, section
II describes a study of lithium transport from cerebro¬
spinal fluid.
Section III describes experiments which examined the
effects of chronic lithium administration on A'liase activ¬
ities in subcellular fraction prepared from rat brain in
order to determine: (a) whether lithium affected ilg Aim ase
in all fractions or in synaptic plasma membranes alone,
(b) whether changes in membrane ng ATPase activity after
lithium treatment could be due to vesicle-membrane fusion
as suggested by Glen and Reading (1973) and (c) whether
chronic lithium administration had any effect on synaptic
plasma membrane ba/h ATPase activity, in addition an
experiment is described in which lithium distribution in
the brain was stiidiec.
Section IV describes experiments designed to attempt
to relate changes in hg ATPase after lithium administration
to changes in striatal dopamine metabolism.
Section i describes experiments on various Ai'Pase
activities in erythrocyte membranes from depressive patients.
The aim of the experiments was to determine: (a) whether
depression was associated with a decreased .,a/h ATPase
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activity since such an abnormality would explain a large
number of previous observations, (b) the effects of lithium
treatment on membrane Aliases in humans since in animals
lithium was shown to affect Mg ATIase activity, (c)
whether the changes observed were due to in vivo activation,
in vitro activation, or effects via protein synthesis, and
(d) whether ATPase changes were related to electrolyte
changes. In addition an experiment is described in which
the effect of chronic lithium administration on rat
erythrocyte membrane ATPase activities was investigated.
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SECTION II
INVESTIGATIONS OF SODIUM TRANSPORT
FROM LLQOI) TO BRAIN AND CEREBROSPINAL FLU IB,
THE EFFECTS OF LITHIUM ON SUCH SODIUM TRANSPORT AID
THE TRANSPORT OF LITHIUM FROM CEREBROSPINAL FLUID.
I:-:TkOLUgTIQj .
In respect to its fluid-containing spaces the central
nervous system is unique in that in addition to intra¬
cellular and extracellular fluid there is also the cerebro¬
spinal fluid (C.S.F.) which provides a separate fluid
compartment in and around the brain. C.S.F. is thougnt to
resemble brain extracellular fluid in co iposition, the two
fluids being in close contact with little or no restraint
on the passage of substances between them (JDavson, 1967,
1976). The close proximity of C.S.F. to nervous tissue
and its ease of sampling both in man and animals has led
to much experimental study. One approach has been to per¬
fuse the C.S.F.-containing spaces with artificial fluid.
In the case of the ventricle-cisternal perfusion technique
fluid is introduced into the lateral ventricles and with¬
drawn from the cisterna magna so allowing perfusion of the
lateral, third and fourth ventricles. This section describes
experiments in which the ventriculo-cisternal perfusion
technique has been used to study the potassium dependance
of sodium transport from blood to C.S.F. and the effects of
lithium on sodium transport from blood to brain and C.S.F.
and upon C.S.F. secretion rate.
C.S.F. is thought to be primarily secreted by the
choroid plexuses (Davson, 1967). handy and Blackfan (1914)
found that if the Aqueduct of Sylvius was plugged acutely
a hydrocephalus developed, so showing that the ventricles
were the source of C.S.F. Welch (1963) provided the first
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strong; evidence for the choroid plexuses as the source of
fluid. e measured the iiae, latocrit in the arterial and
venous blood enter in.- and leaving the rabbit choroid
plexuses and concluded there was a loss of water fro.a the
blood during: its passa; e through the choroid plexuses.
From the amount of water lost he was able to calculate a
theoretical C.S.F. secretion rate of 8/ul/minute. Davson
and ..is colleagues also using the rabbit measured C.S.F.
secretion by gravimetric methods and by inulin and flextran
8lue dilution. Their values were 10.4, (Davson and Tollay,
1963), 10.6, 11.6 (Davson and Bradbury 1964) and 12.0 and 8.1
(Davson and SegiaJJ1970) comparing favourably with Welch's
estimate and thus suggesting that most if not all C.S.F.
may be produced by the choroid plexuses. Further evidence
for C.S.F. secretion by the choroid plexuses came from the
work of /mes and his colleagues (De Rougemont, Ames, r.esbett
and. I'ofnann, I960; Ames, Sakanoue and Endo, 1964) who coll¬
ected, undei- oil, freshly secreted fluid from the choroid
plexus of the lateral ventricles of the cat. The ionic
composition of this fluid resembled that of cisternal C.S.I.
and this suggested that C.S.F. is not altered to any great
extent during its passage through the ventricles. There is
still argument however over whether C.S.F. is produced
exclusively by the choroid plexuses (Davson, 1967; Cserr,
1971).
As pointed out by Davson and Segal (1970) the turnover
p p
of Fa in C.S.F. (0.48. renewed per minute) is comparable
to the rate of fluid secretion (a secretion rate of 8.8^ul/
minute and a total C.S.F. volume of 1.8 :nl would five a
renewal rate of 0.48"-'' per minute) and this suggests that
the major route for the transfer of isotopic sodium from
blood to C.S.F. is via newly secreted fluid at the choroid
plexuses. Faveon and Pollay (1963) studied the transfer of
isotopic sodium from blood to C.S.F. using the ventriculo-
cisternal perfusion technique in the rabbit. They inter¬
preted their results in terms of two components, a fast
component due to transport across the choroid plexuses and
a slow component due to transport from blood to brain and
thence to C.S.F. The slow component is obvious in these
experiments because perfusion at a high rate does not allow
equilibration between C.S.F. and brain extracellular fluid
and this results in diffusion of isotopic sodium from extra¬
cellular fluid into the perfusing fluid. Favson and
Bradbury (1964), assuming isotopic sodium entered C.S.F.
in secreted fluid at the same concentration as it was in
plasma, calculated a theoretical curve for the entry of
sodium into the perfusing fluid. Comparing this with the
experimental curve they concluded, as did Favson and Pollay
(1963), that isotopic sodium entry into C.S.F. was primarily
in freshly secreted fluid.
It is now- well established that both C.S.F. secretion
and the entry of isotopic sodium into C.S.F. are inhibited
by ouabain (Welch, 1963; Fates, Font in and Oppelt, 1964;
Ames, Higashi and Fesbett, .1965; lavson and Segal, 1970)
and several workers nave therefore suggested that a fca/K
ATI as e is involved in the transport of sodium across the
choroid plexuses and in the secretion of C.S.F. (Yates ejt
al., 1964; Lavson and Segal, 1970; Wright, 1972; Johansen,
need and Woodbury, 1974). The choroid plexus ha/K ATFase
has also been implicated in the removal of potassium from
C.S.h. and in the control of C.S.F. potassium concentration
(^radbury and Stuclova, 1970; \usted and heed, 1976).
4 2
_radbury and Stuclova perfused K through the ventricles
at various potassium concentrations and measured the loss
of isotope from the perfusion fluid and the amount of isotope
in the brain at the end of perfusion. It was then possible
to calculate the "barrier-clearance" of potassium - that is
the amount of isotope transported from C.S.F. into blood.
The barrier-clearSnce was found to be sensitive to the C.S.F.
potassium concentration and Bradbury and Stuclova interpreted
this in terms of the choroid plexus iia/K A'iTase being
involved in the removal of potassium from C.S.F. Such a
potassium-transporting system should occur at the apical
(C.S.F.-facing) membrane of the choroid plexus epithelium
(Bradbury and kleeman, 1967) and so it was suggested that
tie i.a/K ATFase was situated in the apical membrane and
orientated so as to be sensitive to C.S.F. potassium (Brad¬
bury and Stuclova, 1970; Johansen et al., 1974). In contrast,
other workers (Pollay, 1 apian and nelson, 1975) have suggested
that transport of potassium from C.S.F. to blood across the
sheep choroid plexus v/as due to passive diffusion and that
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the Na/X ATPase was situated so as to be involved in the
active transport of potassium from blood to C.S.P. however
ouabain-binding studies (Quinton, Wright and Tormey, 1973)
showed that in the frog ouabain-binding is predominant at
the apical membrane of the choroid plexus epithelium so
providing evidence for the apical siting of the Na/X ATPase.
Furthermore Wright (1972) using isolated frog choroid
plexus found ouabain to only inhibit net sodium flux if
applied to the ventricular side.
In summary, the transport of sodium across the choroid
plexuses is thought to be associated with C.S.I1, secretion
and to be due to Ha/'. ATPase activity. This Ka/X ATPase is
generally thought to be situated in the apical membrane and
to be involved in the transport of potassiu i from C.S.i'.
On such a nodel the sodium transport into C.S.P. should be
sensitive to the potassium concentration in C.S.P. In this
section experiments are described in which ventriculo-
cisternal perfusion was used to study the effect of reduced
C.S.F. potassium concentration on sodium entry into C.S.P.
and brain. Experiments are also described in which the
effects of low concentrations of lithium on sodium entry
into C.S.F. and brain were investigated.
Previous work lias shown lithium at high concentrations
(3-30 mh) to have a stimulatory action both on the efflux
of sodium and on the a/X ATPase. Thus lithium when pre¬
sented extracellularly to the erythrocyte will stimulate
both the Ma/K ATPase (V/hittan, 1362) and sodium efflux
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(Glen et al., 1972). Similarly lithium will stimulate
sodium efflux from muscle (Beauge and Ortis, 1970) and
stimulate Na/K ATPase activity in a rat vagus nerve pre¬
paration (ELoeger, 1974a), in rat kidney (Gutman et al. ,
1973a) and in rat "brain preparation (Tobin et al. , 1974).
Amongst others Keynes and Swan (1959) have suggested
lithium intracellularily might compete with sodium for the
sodium-pump and Ploeger (1974b) although he applied lithium
extracellularly interpreted his results in terms of lithium,
intracellularly, inhibiting the sodium-pump. Glen and
Reading (1973) suggested that an important aspect of
lithium's therapeutic action might be its ability to stim¬
ulate the sodium-pump at the potassium sensitive side and
inhibit it at the sodium sensitive side. It thus seemeu
important to studyr the effects of lithium on sodium trans¬
port when it was presented to two opposing sides of a
membrane system actively transporting sodium. The ventriculo-
cisternal perfusion technique was therefore used to study
the effects of lithium in vivo on choroid plexus sodium
transport. Guabain-binding studies (Quinton et al., 1973)
found no evidence for sodium-pumps present at the lateral
membrane of the choroid plexus epithelium and it is probable
that tae transport of sodium and lithium from blood into
the choroid plexus epithelium is by passive diffusion
(bright, 1972). Infusion of lithium into the blood should
thus result in diffusion of lithium into the choroid plexus
epithelium where it could interact with the apical .aembrane
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La/K ATPase from the intracellular side. As pointed out
by do": ansen o t al. , (1974) if the la/K ATbase is orientated
e.s described above then it should be sensitive to intra¬
cellular sodium. Thus presentation of lithium via the blood
should allow lithium to interact with the sodium-pump at
the sodium sensitive side. On the other hand perfusion of
the vent/i cles with a lithium containing solution allows
presentation of lithium to the opposite side of the apical
me hrane - the side which, as results to be presented will
s ov, represents the potassium sensitive side of the sodium
transporting system. In this section experiments will be
described ir. vkic: lit" iu . was presented via the ventricles
2 A
and via the bloodstream and tie entry of ' a into C.S.I.
a id hi-ai; studied. As mentioned in Section 1 of this
thesis when lithium is used clinically its concentration
in las ;a is of the order of 0.6 - 1.6 'hi. Thus in the
evperi ents to be described it was decided to use concent¬
rations of lithium of the order of 1 id.
huriny passa.se of a lithium-containing perfusion
fluid thrpugh the ventricles lithium is lost from that fluid
(i roc :o and larcuc, 1972). The work of Pro chop and . iarcus
was the only previous stud;/ of the transport of lithium
between blood, brain and 0.3.7. aid it was therefore of
interest to look at some features of lithium transport
usin vertriculo-cisternal perfusion. In addition to the
"act t" at C.3.F. and extracellular fluid are in close prox-
i '.it;/, the blood-brain and blood-C.S.F. barriers possess
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certain features in common: the rate of transport of many
substances (2^,a, for example) into brain and C.S.P. are
ver; similar (Davson, 1967) and furthermore iodide, bromide
and tuiocyanate are all actively transported from C.S.P.
across the choroid plexuses and also from extracellular
fluid across the blood-brain barrier (Davson, 1976). ihus
the transport of lithium into and out of C.S.F. nay well
reflect similar transport at the blood-brain barrier.
bATO.fUALS AuD ■ iDThOLC .
1. Chemicals.
All chemicals were British Drug Houses (B.D.h.) Analar
,'rade except where otherwise specified.
a was purchased as ^BaCl in sterile isotonic
saline from the Radiochemical Centre, Amersham, U.K. 100 juCi
aliquots were made up to 10 ml with sterile isotonic saline.
Approximately 30 - 40yuCi were used for each experiment.
Sterile, artificial C.S.P. , pi* 7.6, was made up by the
Pharmacy, Royal Infirmary, Edinburgh. The co position was
as follows: ba+ 152 mM, B+ 2.98 mil, Hg++ 1.0 mil, Ca++ 2.1 mil,
Cl~ 131 mh, 25.6 m- , 0^~ 0.76 mil and dextrose 1 nig/
ml. In addition, 100 mg/ml Dextran Blue 2000 (from Pharmacia
Ltd., Sweden) was added immediately before the experiment.
In certain experiments there was no potassium present in
the perfusion fluid and in other specific experiments lithium
chloride was added at a concentration of 1 mm. These alter¬
ations in composition would have changed the osmolarity and
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r loT-ide concentration by less tbr CL
2. Ventrlculo-cisternal perfusion.
The perfusion technique used in this work was based on
the technique developed by Davson and Pollay (1963) and used
by Davson and his colleagues (Bradbury and Davson, 1964, 1965;
Davson and Segal, 1970). All experiments involved bilateral
perfusion of the ventricles as was used by Davson and Segal
(1970). In the perfusion systems used by Davson and colleagues
and by other workers (e.p. Pappenheiner, Beisey, Jordan and
Downer, 1962) flow through the system was produced by a
single pump situated on the inflow side of the system and
the cisternal effluent drained away under hydrostatic
pressure. In the present work, a second pump, matched to
the inflow pump, was introduced into the outflow system
betv/een the cisterna magna and the fraction collector.
Such a system has been used previously in the dog (Halliday
and Moir, 1974). The inclusion of the outflow pump should
result in perfusion with a C.S.F. pressure of zero assuming
exact balancing of the inflow and outflow pumps, A zero
pressure in the system should be sufficiently low to pre¬
vent any appreciable loss of material by bulk: drainage.
The experimental arrangement is shown diagrammatically
in Figure 1. On the inflow side of the system fluid passed
through a T-piece manometer situated between the pump and
the ventricles and the level of the fluid in the T-piece
gave an indication of the fluid pressure in the inflow











Figure 1. A diagrammatic representation of the experimental
arrangement used in the ventriculo-cisternal perfusion
experiments.
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the animal, fluid was pumped out of the cisterna magna to
a fraction collector.
Adult, male hew Zealand V.'hite rabbits (weignt 3 - 3.3
kg) were used throughout. All the experiments performed
were of an acute nature and so no sterile procedures or
conditions were used. The animals were anaesthetised with
intravenous sodium thiopentone (40 rng/kg initially With
subsequent doses as necessary) and were allowed to breathe
naturally, no artificial respiration being used. Prior to
surgery the top of the head was shaved and the subcutaneous
tissue of the scalp and base of the neck infiltrated witn
1 ml lignocaine solution (2r ) as local anaesthetic. A
midline incision was made from the front of the skull to
the base of the neck and the periosteum and te oral nuscles
reflected laterally to expose the skull. The next stage was
to drill two holes in the skull in order to place the inflow
cannulae. These holes were located 10 mm behind the coronal
suture and 10 mm lateral from the midline. After the r. iles
had been bored using a hand twist-drill (2 ... 0, they were
threaded using a hik tap and the two guide-tubes screwed
firmly into position. The guide-tubes consisted of small
screws with a cavity in the centre through which the inflow
cannulae could pass ( "oir and low, 1370). he firm position-
ins of the guide-tubes gave support to the cannula.® and
helped to prevent them moving during the experiment. 25G
Yale Oicrolance needier were used as the inflow cannulae
and they were connected with silicone rubber tui.Lr to the
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manometer and the reservoir of artificial C.S.F. Correct
positioning of the inflow cannulae in the ventricles was
achieved using the manometer present in the inflow system.
The tubing leading to one of the cannulae was clamped so as
to prevent flow of fluid and the other cannula then inserted
through one of the guide-tubes into the brain. The fluid
in the inflow system was pumped past the manometer to the
cannula and so when flow out of tne cannula was prevented
there was a rise in pressure and the fluid level in the
manometer rose. On inserting the cannula into the brain
there was a rise in the level of fluid in the manometer.
The cannula was slowly lowered further through the brain
until a slow fall in the level of fluid in the manometer
was seen. This fall in pressure indicated that the tip of
the cannula was in the lateral ventricle. Once the cannula
was positioned correctly it was clamped off and the proced¬
ure repeated for the second cannula. After the successful
positioning of both cannulas articicial C.S.P. was infused
into the ventricles for 15 minutes. During this infusion
period the skin of the base of the neck was reflected
laterally prior to cisternal cannulation. A 30 mm needle,
bevelled, and with 2 holes drilled behind the bevel was
used as the cisternal cannula. After the ventricles had
been infused for 15 minutes the cisternal cannula was
inserted through the nuchal musculature and between the
axis vertebra and the base of the skull, into the cisterna
magna. The animal's head was flexed slightly forward to
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facilitate this operation. Successful placement of the
cannula was evident from the rapid flow of the blue-coloured
fluid through the outflow tubing connected to the cannula.
The effluent fluid was pumped to an 1KB automatic fraction
collector. Inflow and outflow fluids were pumped using
separate channels of a Watson-marl ow 1000 03 IRE H.R. flow
inducer which was calibrated so that inflow and outflow
rates were equal. The speed selector on the flow inducer
was not entirely satisfactory and this resulted in variation
of pump rate between experiments. It was necessary there¬
fore to measure the rate of perfusion at the end of each
experiment. This was done by weighing the water pumped in
a measured time period.
The perfusion system was allowed to equilibrate for
10 minutes after cisternal cannulation. After this time
had elapsed the dead-space in the outflow system had filled
with fluid and t>ie perfusion system was then complete -
fluid was being pumped into the ventricles, out of the
cisterna and could be collected at the fraction collector.
Fluid was perfused through the system at between 55 and 75
^ul/minute.
Once the perfusion system was complete and there was
a continuous flow of fluid, isotope was introduced into the
bloodstream. ^Na (as ^NaCl in 0.9% saline) was infused
into an ear vein using a Braun micro-injection pump with
the following infusion schedule:
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Cuch a schedule gave a constant (-5/■) level of l a in the
plasma.
The time at which isotope infusion started was noted
and this was used as the reference time to which isotope
Q A
results were referred. Na was infused for a period of
one hour during which tine 10 minute collections of the
cisternal effluent were collected. There was a considerable
dead-space in the outflow system and the time taken fox-
fluid to flow from the cisternal cannula to the fraction
collector was determined as 10 minutes, it was necessary
therefore to correct all the effluent isotope results by
subtracting 10 minutes from their noted collection time in
order to obtain a true value of the time (with reference
24 \
to the start of l.'a infusion) at which the fluid left the
cisterna.
luring the infusion period arterial blood samples
(1 ml) were taken every 15 minutes from the central ear
artery. These were centrifuged at 1000 g for 5 minutes
24
and aliquots of plasma taken for estimation of Na. In a
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few experiments arterial "blood samples were a]so taken for
blood gas analysis.
After infusion for one hour the venous infusion cannula
was removed, the animal killed by thiopentone overdose and
the brain excised. The lateral ventricle choroid plexus,
which usually contained a considerable amount of blood, was
dissected out and discarded. The brain was then blotted to
remove residual traces of blood and homogenised by hand.
The cisternal effluent collections and the brain tissue
were used for the following analyses:
a) 0.1 ml aliquots of cisternal effluent were taken for
24
determination of ha.
b) 0.1 ml aliquots of cisternal effluent together with
samples of original perfusion fluid, were taken for
determination of Dextran Blue concentrations.
c) The remaining cisternal effluent was stored at -2G°C
and laler aliq.uots were taken for potassium and lith¬
ium determinations.
d) Weighed aliquots of brain (approximately 1 g) were
24
taken for determination of Na. In certain experi¬
ments an aliquot of brain was also taken for lithium
determination.
3. ea.surement of radioactivity.
24
Na is a strong y-emitter wit! a short half-life of
15 hours. It was estimated using a Tracerlab U-Guard 150
X-ray spectrometer which had been calibrated specifically
24
for the estimation of ha. Aliquots (0.1 ml) of cisternal
effluent and plasma were diluted to a standard Volume of
1 al before counting. Approximately 1 g aliquots of brain
were analysed. All samples were counted for 10 minutes and
all results were corrected for background radiation. As
there was only a small number of samples per experiment it
was not necessary to correct the aeasured counts for isotope
decay.
4. leasurement of jotassin.i and lithium concentrations.
Potassium and lithium were measured in some of the
cisternal effluent samples and in a few experiments lithium
o
was also measured in brain. Samples wei*e stored at -20 Cf
in plastic tubes, before analysis.
All potassium estimations were done by flame emission
spectrophotometry using a Pye-Unicam £090 atomic absorptio-
r^eter with an air-acetylene flame. An absorption filter
was fitted between the flame and the monochromator in order
to reduce interference from sodium and using this there was
no interference from artificial C.S.P. As previously
reported (Amideen, 1967), there was no interference by
lithium in the estimation of potassium. In view of the
fact there was no interference from sample constituents,
samples were compared with standards of .mown amounts oi
potassium chloride dissolved in distilled water. Samples
and standards were diluted 1:70 with deionized water for
anal;, is.
There are several reports concerning the effects of
sodium, potassium and other ions or the estimation of
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lithium. A mid sen (1967) reported lithium determination "by
flame emission spectrophotometry to be affected by the
sodium concentration, however, the effect did vary between
different machines. Other workers have found little or no
consistent effects of sodium, potassium of other ions on
lithium determination by flame emission spectrophotometry
or atomic absorption spectrophotometry (Levy and Kate, 1970;
Pybus and lowers, 1970). Interference of artificial C.S.F.
i
with lithium estimation was therefore investigated prior
to the present study and standards were aade up in deionized
water or artificial C.S.F. as appropriate.
Initially lithium concentrations in the cisternal effluent
were determined by flame emission spectrophotometry using a
Pye-Unicam SP90 atomic absorptionmeter. Artificial C.S.F.
was found to cause an enhancement of the signal. This enhance¬
ment was a constant percentage of the signal. Cisternal
effluent- samples were therefore compared to standards of
lithium carbonate dissolved in artificial C.S.F. loth
standards and sanples were diluted 1:20 with deionized water
for analysis.
Curing the course of the work presented in this thesis
a Perkin-Elmer 360 at.5 -lie absorptiometer became available,
"'his new machine allowed estimation of lithium by atomic
absorption which was ".ore satisfactory than uoirq flame
emission spectrophotometry techniques. Thus, thereafter
lithium was measured by atonic absorption spectrophotometry.
■
o interference by -odium, potassium or artificial C.S.F.
was found anci therefore samples were compared with standards
of lithium carbonate dissolved in deionized water.
In order to assay lithium in brain tissue the extract¬
ion procedure of Bradbury et al. was ado, ted (Bradbury,
hleeman, Bagdoyan and Jerberian, 1966). The aliquot of
brain (500-1000 :ag) was placed in a weighed glass vial and
the vial reweighed. The tissue was dried at 105°C for 48
hours and reweighed. After grinding the tissues to a fine
powder with a glass rod, 0.75 b nitric acid (1 inl/nig wet
tissue, hristar grade) was added. The vials were then
nixed with inversion for 24 hours and then stored at -20 G.
After subsequently being thawed, they were centrifugecl at
1500 g for 10 minutes and aliquots of the supernatant dil¬
uted 1:20 with deionized water for analysis. Recovery of
lithium using this procedure was 905 .
5. measurement of 0.3.P. Secretion Kate.
The dilution of a non-diffusable substance on its
passage through the ventricles during ventriculo-cisternal
perfusion as been used by several workers to calculate
C.S.l. secretion rate; , (rappenheimer et al., 1962; Lavson
and Segal, 1970). Early studies used inulin as the non-
diffusable narker substance but work by all et al. (1982)
shower! that inulin diffused out of the perfusing fluid into
the brain during ventriculo-cisternal perfusion. Such loss
of inulin could give a spuriously high value for C.S.B.
secretion and so later workers used Dextran I lue as the non-
diffusable marker and this was found to ive a lower value
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for C.h.h. secretion t.-.an inulin (Lavson end Le.al, 1970).
jthe present work Lextran Blue 2000 was used. Its con¬
centration in both the perfusion fluid and the cisternal
effluent samples was estimated spectrophotometrically by
its absorption at 625 nin. 0.1 ml aliquots of samples were
diluted to 1 ral before estimation.
The derivation of the relationship between Lextran
Blue concentrations aid C.S.F. secretion rate is given
below. it differs fro,a that described by Lavson (1567)
since the latter applied to a situation where fluid was
only pumped into the ventricular system whereas in the
present experiments fluid was pumped both into and out of
the ventricular system, however the final equation des¬
cribing C.S.F. secretion in terms of Lextran Blue concen¬
trations is the sane as that derived by Davson.
Let ; = rate of perfusion (^xl/min)
Let j
£ = rate of C.S.F. secretion (^ul/nin)
Let C., C be the concentrations of Lextran Blue inl' o
the inflowing and outflowing fluid respectively.
he rate at which Lextran Blue enters the ventricles =
.c,.p i
Lextran Blue entering the ventricles is diluted by-
nascent C.S.F. Assuming that the system is in the steady-
state and that the ventricles contain only nascent C.: .F.
and perfusion fluid, the dilution of inflowing perfusion







and tr e rate of removal of Lextran Hue equals
( o)2 rt— . C i
n + ' fir- X
The rieasured rate of appearance of Dextran Llue in
trie cisternal effluent equals I , . C .n
P o
Assuming no lextran llue is lost from the perfusion
fluid during passage through the ventricular- system, the
rate of removal derived above must equal the rate of
appearance in the cisternal effluent.
Therefore, .C =» (! . )*"
P ° 2 • Q .
Xn + KfP x
Dividing both sides of the equation by i t,,
C = Y
0 iL_ •
i _p + K£ p
rearranging the equation,
_ p _ n
— * K (1)
C p
o
Thus by measuring C., C' and it is possible toJ l' u P
calculate 7 the rate of C.S.i. secretion. As shown in
figure 10 the concentration of lextran. llue in the cisternal
effluent increased durin the early stages of perfusion but
remained constant during the later stages when the system
ah reached a steady-state. An average value of CQ was
calculated fro \ the stead;-state concentrations and this
value was used in the calculation of C»S*P« secretion rates.
- 45 -
6. "easurement of Transfer constant, ., and clearanceout
into train.
Transport of a substance out of the ventricles during
ventriculo-cisternal perfusion results in lower CQ/C. ratio
than that for the non-diffusable markers inulin or Lextran
( oil<av and Lavson, 1963; ~radbury and Davson, 1964, 1965).
A transfer constant, K ., can be calculated in order to' out'
rive a numerical value to the rate of loss of a substance
fro.p. the perfusing fluid. in addition- it is possible to
calculate the total clearance of a substance from the per¬
fusion fluid and the clearance into brain. The calculations
outlined below follow those of Bradbury and Bavson (1964).
Let K , , 0. and C denote rate of perfusion, rate
p f* l o '
of C.S.F. secretion and Eextran Llue concentrations as
described above.
Let CC * be the concentrations of the substance
i ' o
under study in the inflowing and outflowing fluids respect¬
ively.
Let F equal the flux of substance under study fro i
tre perfusion fluid.
Let 0. be the concentration of substance under study
in plasma.
Let T be the total period of perfusion (min).
Let To be the period for which each cisternal seople
is collected (iiin).
In the steady state,
7 = K . (C.* - C *) - K . C *
p i 0 X o
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Substituting for K„ from equation (1),1 G.
F = K . 0 * - C„* . -sip 1 ° c0
The transfer constant, K .j., equals the flux, F,
divided by the mean concentration difference between per¬
fusion fluid and plasma for the substance under study. The
mean concentration of the perfusion fluid is uncertain but
C.* - C *
assuming it is the arithmetic mean ——-—— ,
F
K
out =C.*-C* - „
-i — " °pl*
2
in the present studies the concentration of the sub¬
stance under study in plasma is approximately zero. There-
F
fore, K . = G. * - G * in units of ml/min. (2)' out 10
The total amount of substance to enter the ventricles
during perfusion equals C^* . K . T^
The total amount to be removed in the cisternal effluent
equals the sum of Cq* . . To for all cisternal samples
collected.
The total clearance of the substance under study is the
difference between the amount infused and the amount removed
divided by the weighted mean of the concentration of the
substance in the perfusion fluid. The clearance of the
substance into brain is the total amount of substance in the
brain at the end of perfusion divided by the weighted mean
of the concentration of substance in the perfusion fluid.
Expressing the brain clearance as a percentage of the total
clearance the weighted means cancel out and
- 47 -




7. Measurement of Blood pC0o, p0 and pH
c. c. •
For certain experiments 1 ml arterial blood samples
were taken from the central ear artery prior to and during
perfusion. Samples were immediately sealed using parafilm
and measurement of blood paraneters was carried out within
minutes using a Radiometer Blood Micro system.
8. -easurement of Choroid Plexus ATBase activity.
Adult, male New Zealand white rabbits were killed by
cervical fracture and the brains removed. Lateral ventricle
choroid plexuses were dissected out and homogenised in water
(5 ml/plexus).
ATPase activity was measured in aliquots of the horno-
genate by measuring the liberation of inorganic phosphate
from disodium ATP. Homogenate was incubated with 3 mM
disodium ATP, 100 jnM NaCl, 6 mil MgCl _, 30 mM Tris buffer,
i c~
pH 7.4, 0.1 mM EDTA and various concentrations of KC1.
Inorganic phosphate was determined by the method of ,iartin
and Doty as described by Lindberg and Ernster (1936).
RESULTS.
OA
1• Analysis of ha entry into the perfusing fluid.
In the majority of experiments carried out the time
course of appearance of isotonic sodium in the cisternal
effluent was qualitatively similar. The results for control
experiments (in which the perfusion fluid had a potassium
concentration of 2.98 mm) are shown in Figure 2. The curve
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^Na entry into CSF
C.PM /ml. C.S.F
CP M./ml. plasma
Time after start of isotope infusion. (MINI)
24
Figure 2. The entry of Na from blood into ventriculo-
cisternal perfusion fluid during perfusion with artificial
C.S.F. containing normal ionic constituents. The points
represent mean values from 11 experiments and the bars
represent twice the standard errors of the means.
24
showing Na entry into the perfusing: fluid is comparable
to the results of Davson and lollay (1963) ana Davson and
Segal (1970). Davson and Pollay interpreted such a curve of
entry in terms of two exponential components. As shown in
figure 3 plotting the results semilogarithmically allowed
separation of the curve into two components. Graphical
extrapolation of the slow component back to zero time allowed
its estimation over the early period of entry, for each set
of experiments the mean values of the slow component of
entry were subtracted from the individual, experimental
values of sodium entry to give values for the early fast
component of sodium entry. The mean calculated values of
the fast component for control experiments are shown in
Figure 3. It can be seen that the fast component increases
over the first twenty-five minutes after which it is con¬
stant and this was also true for potassium-free and lithium
24
perfusions. The corrected value of the ratio of ha in
Ac*— the. soov\|?(e_
the perfusate to that in plasma after 20 - 30 rainute»Awas
therefore taken as an estimate of the sodium entry due to
the fast component of entry. The slow component of entry
was estimated graphically from semilogarithmic plots of
data from each experiment.
24
2. Effects of potassium-free perfusion on i\a entry into
the perfusiri/ fluid and brain and upon C.S.F. secretion rate.
24
The entry of Na into perfusing fluid during potassium-
free perfusion is shown in Figure 4. It is qualitatively
similar to the curve of entry in control experiments but
- 50-




Time after start of isotope infusion(MIN)
24
Figure 3. A semilogarithmic plot of the entry of Na
from "blood into ventriculo-cisternal perfusion fluid during
perfusion with an artificial C.S.F. containing normal ionic
constituents. -X- represents the experimental data and
shows extrapolation of the slow component of entry to zero
time. The histograms represent values of the fast component
obtained by subtraction of the slow component from the
observed data.
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there is a noticeable reduction in the sodium entry over
the first 30 minutes. The results after analysis into fast
and slow components of entry together with values for
sodium entry into brain and C.S.F. secretion rate are shown
in Table 1. Potassium-free perfusion had no effect on tne
slow component of sodium entry into C.S.F. or sodium entry
into brain. There was however a small, but not significant,
reduction in the mean values of the fact component of
sodium entry and C.S.F. secretion rate.
Analysis of the cisternal effluent from potassium-free
perfusions showed an appreciable concentration of potassium
present (Figure 5). Potassium-free perfusion caused a
rapid and variable influx of potassium into the perfusing
fluid. It ic lihely, therefore, that there was a consider¬
able concentration of potassium within the ventricles
during these experiments and this may explain the small
effect of potassium-free perfusion on sodium entry and C.S.F.
secretion.
The cisternal effluent potassium concentration varied
a great deal in these experiments and it was possible there¬
fore to examine whether there was any relationship between
the cisternal effluent potassium concentration and the
sodium entry into C.S.F. and brain. As shown in Figure 6
t - e fast component of sodium entr^ into C.S.F. during
potassium-free perfusion was significantly correlated
(r - .. Cr < . .02) with the near potassium concentration
in the cisternal effluent collected ami the first 30
- 52 -
24
Na ENTRY INTO C.S.F.
24
Figure 4. The entry of Na into ventriculo-cisternal
perfusion fluid during perfusion with artificial C.S.F.
containing no potassium (-•-), 1 mM lithium and no
potassium (-o-) and normal constituents (-x-).
Points represent mean values from 14 experiments in the case
of potassium-free perfusions, from 10 experiments in the
case of lithium perfusions and from 11 experiments in the
case of control experiments. Bars represent the standard
errors of the means.























Figure 5. Potassium concentration in the cisternal effluent
during perfusion with a potassium-free artificial C.S.F. (X)
or a potassium-free artificial C.S.F. with 1 mM lithium
added (•). Points represent mean values from 6 (lithium per¬
fusions) and 11 (potassium-free perfusions) experiments.
Bars represent the standard errors of the means. The bars
for points 35 and 45 minutes represent the standard errors
of the means for the potassium-free perfusion. It was not
possible to show the small standard error for the lithium
experiments as the bars co-incided with the other features
of the diagram. Comparison of each pair of points using a
Student's ' t' test showed no significant difference between







































Cisternal potassium concentration (mM)
Figure 6. The relationship between the fast component of
2^Na entry into C.S.F. and the mean potassium concentration
in the cisternal effluent collected during the first 30
minutes after ^Na was introduced into the plasma. (X)
represents results from potassium-free perfusions, (o)
potassium-free + lithium perfusions. In the potassium-free
perfusions the fast component of 2^Na entry is significantly
correlated (r=0.668, p<0.02) with the cisternal potassium




linutes of a infusion, Here was no correlation of
C.S.I1', secretion, of slow component of sodium entry or of
sodiu 1 entry into brain with the cisternal effluent pot¬
assium concentration.
The results of these experiments suggest that the
fast component of sodium entry into C.S.F. is sensitive to
the C.S.F. potassium concentration.
3. The effect of potassium concentration on choroid plexus
ATTase activity.
Tie sensitivity of the fast component of sodium entry
to C.S.I1, potassium concentration suggests that such sodium
entry is due to Na/K ATPase activity. To further test this
hypothesis experiments were carried out to investigate if
choroid plexus Na/K ATPase activity was sensitive to potassium
cor-centrations comparable to those in the perfusion experiments.
ATPase activity was measured in homogenised lateral ventricle
choroid plexuses at various potassium concentrations in the
incubation medium. The results, expressed as a percentage of
the activity in the absence of potassium, are shown in Figure 7.
The activity was sensitive to potassium concentrations up
to 3 mil. Such results show that the perfusion results could
be explained in terms of a potassium-sensitive sodium pump.
4. The effects of lithium, presented via the ventricles, on
24
ma entry into the perfusin; fluid and brain and upon
C.S.I1, secretion rate.
In order to present lithium to the potassium sensitive
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Potassium concentration (mM)
Figure 7. The potassium dependance of choroid plexus
ATPase activity in vitro. The results are expressed as
a % of the activity in the absence of potassium. Figures
represent means of four experiments, bars represent twice
the standard errors of the means.
chloride (1 i.) was added to the perfusing fluid in two
series of experiments. The first series consisted of
experiments in which lithium was perfused through the
ventricles in a potassium-free artificial C.5.P. line
24
entry of Na into the perfusing fluid during these experi¬
ments is shown in Figure 4 and when compared with results
from potassium-free perfusions there is increased early
entry of in the lithium experiments.' Further analysis
of lithium experiments showed an increased fast component
of sodium entry into C.S.I. (Figure 6, Table 1. p<0.003)
while there was no effect on the slow component of sodium
entry into C.S.F. or sodium entry into brain (Table 1).
As shown in j'able 1 perfusion with lithium also caused an
increase in C.S.F. secretion rate compared to potassium-
free perfusions (p<0.05).
Inclusion of lithium in artificial C.S.F. during
potassium-free perfusion had little effect on the cisternal
pot ssiurn concentrations (Figure 3) ana it is unlikely
therefore that the effects of lithium perfusion on sodium
entry and C.S.F. secretion could be due to lithium causing
an increase in the ventricular potassium concentration.
The second set of experiments involved perfusion with
artificial C.S.F. containing 1 mm lithium chloride in add¬
ition to the normal concentration of potassium (2.30 mil).
The entry of sodium into perfusing fluid during these
experiments is shown in Figure . Further analysis of the
results (Table 2) shows lithium perfusion to cause a
- 59 -
Na ENTRY INTO C.S.F.
Figure 8. The effect of ImM lithium chloride present in
perfusion fluid of otherwise normal ionic constitution on
24
the entry of Na into ventriculo-cisternal perfusion
fluid. Results are shown for control (-X-) and lithium
(-•-) experiments. Points represent mean values from 11
control experiments and from 7 lithium experiments. Bars
represent standard errors of the means.
24

















+1in-jlithium3.9-2.1*0 58.031 *0350. 280413 inperfusionfluid (7)(
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significant increase in the fast component of sodium entry
(p<0.05) and a barely significant (p<0.1) increase in C.S.J,
secretion rate, There was no effect on the slow component
of sodium entry into perfusing fluid or the sodium entry
into brain.
In both series of experiments the lithium concentration
in the cisternal effluent was measured and in both cases
found to be in the range 0.6-0.8 rail. Lithium was found to
be barely detectable in plasma during these experiments, the
concentration being approximately 10~^ h. It is most likely
therefore that the effects on sodium transport and C.8.F.
secretion described above were due to lithium present within
the ventricular fluid and at concentrations in the range
0.6-1.0 h".
5. The effects of intravenous infusion of lithium chloride
24
on iia entry into perfusing fluid and brain and upon C.S.P.
secretion rate.
infusion of 1 M lithium chloride following the schedule
outlined for ^Ua gave plasma lithium concentrations in the
range 0.6-1.2 hi. The lithium concentration in plasma
during infusion was not constant, there being a steady
decline over an hour. V'ith plasma concentrations of lithium
of 0.6-1.2 mil, the cisternal effluent was found to contain
lithium concentrations of between 0.04 and 0.1 oh.
Two series of experiments were performed. In the
24
first series, lithium and ha infusions were started
24
together. Toe curve of a entry into the perfusing fluid
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is shown in figure 9. In contrast to the results from pre¬
vious experiments there was a flattening off in the curve
over the final 30 :iinutes of perfusion. This is reflected
in a reduced slow component of sodium entry "but there was
no effect on the fast component of sodium entry or upon sodium
entry into brain (Table 3.). Lithium infusion also caused a
marked decrease in C.S.F. secretion rate.
One explanation of these results was that lithium
infusion caused a redaction in sodium transport across
the choroid plexus and a reduction in C.S.F. secretion
rate but that these effects were not immediate. Therefore
e second series of experiments were performed in which
lithium chloride was infused for 30 minutes prior to and
?4
also during a infusion. The results for t ese experiments
are shown in Figure 9 and Table 3. There was again a
marked reduction in C.S.F. secretion rate. The curve of
p/
entry of la into the perfusing fluid was qualitatively
similar to controls showing no flattening off at latex*
time periods. Further analysis showed a significant (p 0.03)
reduction in the fast component of sodium entry but no
effect on the slow component of sodium entry into the
perfusing fluid.
6. The effect of various experimental procedures on blood
pCO^t ph and pG^.
The concentration of some ions in C.S.F. is Known to
affect respiration (Leusen, 1J72) and blood pCO^ and ph are
.nown to ai'Cect C.G. . secretion rate (Lavson, 1967). it
- 63 -
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4 0 6 0
time (min )
Figure 9. The effects of intravenous infusion of lithium
24
chloride on the entry of Na into ventriculo-cisternal
perfusion fluid. Results are shown for control experiments
(-X-), experiments in which lithium was infused concommit-
antly with ^Na (-0-) and experiments in which lithium was
24
infused 30 minutes prior to and during Na infusion (-•-).
Points represent mean values from 11 control experiments,
3 pre-infusion experiments and 4 concommitant infusion
experiments. Bars represent the standard errors of the
means.
Table3.



























Combiningtheresultsfroma ltlithi mnfusionexperiments,heC.S.F.secretionrawas6 51.7****(8).
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was important therefore to eliminate changes in respiration
as being indirectly responsible for the effects observed in
the experiments described previously. In some of the experi¬
ments already described arterial blood pCO^, ph and pO^ were
measured before and during perfusion with the various arti¬
ficial cerebrospinal fluids and before and after intravenous
infusion of lithium chloride. The results are shown in
Table 4 and they show no evidence for the various experi¬
mental procedures changing blood pCCy, pi or p0o.
7. A study of the loss of lithium from the inflowing
-•^rf^sion fluid.
When artificial C.S.F. containing 1.0 ml lithium was
perfused through the ventricles there was a loss of lithium
from the perfusion fluid. The results for a typical experi¬
ment are shown in Pi are 10. The results are expressed as
ratios of the inflowing to outflowing concentrations for
Dextran Blue and lithium. The ratio for Bextran blue
-eoresents dilution of the perfusion fluid with nascent
C.S.F. Additional dilution of lithium is evident from the
value of the C /C. ratio being smaller than that of Lextran
0 1
Blue and this represents transport of lithium from the
- erfusing fluid. Table f shows mean steady state values
of C /C. ratios for a series of experiments together with
calculated values of the transfer constant, K ,. describin .out
loss of lithium from the
, erfusing fluid and the percentage
of lithium lost to brain.
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Table 4. Arterial pCU^, pK and p^2 before and during various
experimental procedures. Control values are those
for sanples taken prior to any experimental pro¬
cedure. Values given are means of 2 or 3 estimation
Potassium 1 mil Lithium lithium
Expt. free in perfusion infusion
Ho. Control perfusion fluid into blood
1 7.48 7.46 _
2 7.31 7.31 - -
pH 7J 7.42 - 7.45 -
4 7.40 - 7.39 -
5 7.44 - - 7.43
6 7.46 — — 7.42
1 30 32.5 - -
2 36 38 - -
pC02 3 27.5 - 25.5 -
(mm Hg) 4 35 - 29.5 --
5 - 20.5 - ~ 26.5
b 28 — — 26
1 34 65 - -
r
C. 76 69 - -
po? 3 81 - 79 -
(mm Hg) 4 60 - 67 -
5 70 - - 67





Figure 10. The ratios of lithium and Dextran Blue concen¬
trations in inflowing fluid to those in cisternal effluent
during ventriculo-cisternal perfusion. Results shown are
from one experiment.
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Table 5. Parameters describing the transport of lithium
is
from perfusion fluid during ventriculo-cisternal
perfusion. Figures given are mean values ^
standard deviation with the number of estimations
in parentheses. C, and C represent inflowing
and outflowing concentrations respectively.
Steady-state Steady-state Transfer Clearance of
C C
value of rr value of constant Kn..^ lithium into
for for for brain as a % of
Dextran Blue lithium lithium total clearance
(yul/rain)
0.83 - 0.048 0.71 - 0.073 10.2 - 4.2 15.8 - 1.7
(0) (7) (7) (4)
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PiSCUSSIOr.
The purpose of these experiments was twofold, Firstly
to investigate if sodium transport from blood to C.S.F. was
sensitive to C.S.F. potassium concentration and secondly to
investigate the effects of low concentrations of lithium on
such sodium transport. In addition a brief study of the
transport of lithium from the perfusing fluid was also
carried out.
24
The analysis of ha entry during ventriculo-cisternal
perfusion in terras of two components follows the work of
Pavson and Pollay (1963). In the present work graphical
analysis of the results allowed estimation of both the fast
and slow components of entry. Davson and Pollay (1963) and
Pavson and Segal (1970) suggested that the fast component
of sodium entry was due to the transport of sodium directly
from blood to C.S.F. across the choroid plexuses and that
the slow component was due to transport of sodium from
blood to brain and thence to C.S.F. Assuming that all the
2 A
Na entered the perfusing fluid in nascent C.S.F. as a
result of transport across the choroid plexuses, Pavson
PA
(1967) calculated the steady-state ratio of ha in the
perfusing fluid to that in plasma to be 0.133. Using the
method of analysis described in this section calculation
of the steady-state value of the fast component of sodium
entry for control experiments gave a value of 'J. 122. The
good agreement between txese two values supports t:,e view
that the fast component, as measured in this work represents
- 70 -
the transport of sodium across the choroid plexuses.
Perfusion with a potassium-free fluid caused a rapid
and variable compensation for potassium which resulted in
a high (2-3 mh) concentration of potassium in the cisternal
effluent. Previous work (Bradbury and Bavson, 1965; Bronsted,
1970) has shown similar effects of potassium-free perfusion
and Bradbury and Davson (1965) interpreted their resists in
terms of a homeostatic mechanism controlling 0.0.7. potassium
concentration. The considerable potassium concentration in
the cisternal effluent during potassium-free perfusion
implies that ventricular fluid may contain potassium at
concentrations of the sane order in these experiments. Such
a large compensation for potassium would explain why
potassium-free perfusion had only a small effect on sodium
entry into C.S.F. and C.S.F. secretion. Bronsted (1370)
using an aqueductal perfusion technique found potassium-
free perfsion to reduce net flux of sodium into C.S.F. but
it was not possible to distinguish between sodium entering
C.S.F. from blood and sodium entering fro; brain. The
nesent experiments were able to show a correlation between
C.S.F. cisternal potassium concentration and the fast com¬
ponent of sodium entering into C.S.F. Such a correlation
could have been due to (a) sodium entry being a process
sensitive to C.S.F. potassium (b) C.S.F. potassium affecting
sodium entry indirectly or (c) the potassium homeostatic
mechanism being dependant on sodium entry. Botasr • ;• i-
free erfusion had no effect on blood gases and so the
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correlation is unlikel to be due to an indirect effect
on respiration. When lithium was present during potassium-
free perfusion there was an increase in the fast coeoonent
of sodium entry but the cisternal potassium concentrations
were unchanged from those in potassium-free perfusion
experiments. This suggests that sodium entry did not
affect potassium homeostasis. The most likely explanation
of t' e correlation is that the sodium entry was directly
sensitive to ventricular potassium concentration.
The fast component of sodium entry is considered to
be due to a sodium-pump in the choroid plexus epithelium
(favson and Segal, 1970; Wright, 1972; Johansen et al.,
1174). Bradbury and Stuclova (1970) suggested that the
choroid plexus sodium-pump was situated at the apical
(C.S.P. facing) membrane and this hypothesis was substanti¬
ated by the demonstration of ouabain-hinding to the apical
membrane of the frog choroid plexus epithelium (Quinton
et al., 1973). On this hypothesis one would expect sodium
entry into C.S.F. to be sensitive to C.S.F. potassium
concentration. The resent experiments have shown this to
he the case. The in vitro studies on choroid plexus ATPase
activity showed that the Ma/Y ATPase activity was sensitive
to potassium concentrations comparable to those which
affected sodium entry in the perfusion experiments. This
su ortr the view V at the potassium sensitive system seen
in the perfusion experiments is the sodium-pump. Overall
the experiments provide further evidence for trie : lication
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of the choroid plexus sodium-pump in sodium transport across
that tissue and they suggest the sodium-pump is orientated
so as to be sensitive to C.S.F. potassium concentrations.
Despite the observations that both C.S.F. secretion
and Ha entry into C.S.F. are inhibited by ouabain (Welch,
1963; Oppelt, Patlak and Kail, 1962; Vates et al., 1964;
Davson and Segal, 1970) it cannot be categorically stated
that all the sodium transport across the choroid plexuses
is due to sodium-pump activity because the inhibitory
effects of ouabain in vivo on ^Ha entry are not total
and the effects of ouabain on C.S.F. secretion are variable,
there only being a 559 inhibition by 10~^ m ouabain in the
rabbit (Davson and Segal, 1970). The finding that 6.7 x
-5
10 . ouabain, in vitro, totally abolished sodium flux
across the choroid plexus (Wright, 1972) provides some
evidence that the sodium-pump may be the sole mechanism
for active sodium transport across the choroid plexus
epithelium. owever it is equivocable how great a proport¬
ion of choroid plexus sodium transport into C.S.F. is due
to the activity of the sodium-pump and therefore the
observed effects of lithium on sodium transport in tne
^resent experiments cannot be unequivocably attributed to
effects on the sodium-pump.
Lithium chloride administered via the ventricles or
by intravenous infusion did not affect the blood pCo^, ph
or pOg and it is unlikely therefore that the observed
effects of lithium on sodium transport were due to indirect
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effects of lithium on respiration.
If, as suggested, the choroid plexus ua/K ATbase is
orientated so as to he sensitive to C.S.F. potassium con¬
centration perfusion of the ventricles with a solution
containing lithium will present lithium to the potassium
sensitive side of the choroid plexus sodium-pump. Perfusion
experiments of this nature showed a very low concentration
of lithium in plasma (approximately 10~"° m) which suggests
that the observed effects of such experiments were due to
lithium acting at the potassium sensitive, ventricular side
of the choroid plexus epithelium, it is unlikely the effects
were due to changes in C.S.I, chloride concentration. The
action of lithium presented in this manner was to cause
an increase in C.G."'. secretion and the fast component of
sodixira entry both at reduced and normal C.S.P. potassium
concentrations. In order to show that the effect of
lithium was due to action on the sodium-pump, experiments
were attempted which involved perfusion with an ouabain-
containin; solution. erfusion with such a fluid caused
aeatr due to respiratory failure and so it was not possible
to study the effects of ouabain in the present series of
experiments, however it is most likely that lithium was
affect inr trie sodium-pump in these experi .ents. The results
of these experiments provide evidence for a stimulation of
the sodium-pump by low concentration (0.6 - 1.0 ,) of
lithium when presented to the potassium sensitive side of
the system.
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On the other hand results from experiments in which
lithium was infused into the bloodstreamjsuggest that
lithium can also inhibit choroid plexus sodium transport.
The low concentration of lithium in the cisternal effluent
(0.04-0.1 mm) indicates that the effects observed during
these experiments were due to lithium presented from the
blood side rather than effects of lithium present on the
24
ventricular side. Infusion of lithium and Na concomittant-
ly resulted in a large decrease in C.S.F. secretion rate
Q A
together with an unusual curve of entry of Ka into the
perfusing fluid which appeared to show an almost total
abolition of the slow component of sodium entry. There were
two inconsistencies in these results. Firstly the large
decrease in C.5.F. secretion rate was not accompanied by a
reduction in the fast component of sodium entry into C.3.F.
2 A
Secondly the ha entry into brain in tnese experiments was
similar to that in controls. This, together with an almost
non-existent slow component of sodium entry into C.S.F.
24
would suggest that the ha in brain had been unable to
diffuse into the perfusing fluid. Such a barrier to diffusion
is most unlikely. One explanation of both these inconsist¬
encies is that lithium infusion caused a reduction in both
C.S.F. secretion rate and the fast component of sodium entry
b t that these effects too? some tiue to develop. If this
was the case then there would be a delay before lithium
1 ibibited the fast component of sodium entry and. this could
er lain the unusual curve of entry without any change in
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O A
entry of a into C.S.F. from brain occuriny. The ^resent
method of analysis would not have detected a delayed effect
on the fast component, however C.S.P. secretion rate was
calculated from steady-state values for samples collected
some 40 minutes after the start of lithium infusion ro that
a delayed effect on C.S.P. secretion would be noticed.
That a delayed inhibition of the fast component of sodium
entry and C.S.P. secretion rate was the explanation of
these results was substantiated by a second series of experi¬
ments in which lithium was infused 30 minutes before and
during ^"a infusion. The results of these experiments
showed a marked decrease in C.S.P. secretion rate together
with a normal curve of entry of ^.'a into C.S.P. and a
significant decrease in the fast component of sodiu entry.
Taken together the results of these two experiments
show lithium presented via the bloodstream to cause a
decrease in C.S.P. secretion and the transport of sodium
across the choroid plexuses. Lithium infusion in the dog
has been reported to have a positive inotropic action on
the heart tending to raise blood oressure (: organ, Procter,
Ford, Velandia and Vasserman, 1974). If this had ar effect
on C.S.P. secretion it would tend to increase it. Changes
in blood pressure have been reported to affect the entry of
Na into brain (Go and Pratt, 1975) and so the lack of
effect of lithium infusion on sodium entry into brain
rugnests that any blood oressure char er ir the resent
expert ertr were not sufficiently -reat to cause an effects
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on sodiu: entry into C.S.b. or train. it is unlikely
therefore that the eifects of lithium infusion were due
to indirect effects of lithium on "blood pressure.
The results of these experiments suggest therefore
that lithium presented to the choroid plexuses from the
blood causes an inhibition of sodium transport across the
tissue. Transport of sodium from blood into the choroid
plexus epithelium is thought to be due to diffusion g.'rigut,
1972) and it is unlikely that lithium would affect this
step in the transport of sodium across the tissue. Thus
the inhibitory effect of lithium must be on the transport
of sodium out of the choroid plexus epithelium into O.S.i'1.,
a process which is thought to be due to the activity of tl e
sodium-pump (Davson and Segal, 1970; Wright, 1972; Johansen
et al., 1974). As pointed out by Johansen et al. (1974)
such a sodium-pump should be sensitive to the concentration
of sodium within the choroid plexus.epithelium. The most
likely explanation of the results of the lithium infusion
experiments is therefore that lithium at low concentrations
inhibits the sodium-pump when presented to the sodiu?;
sensitive side.
Amidsen and Schou (1968) showed lithium to have no
pA
effect on the transfer of ha from blood to brain in tue
rat and the work described here in the rabbit also failed
to find an effect of lithium on sodium entry into brain
despite effects on the entry of sodium into C.g.i. in
both studies the entry of sodium into brain was measured
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pA
as a ratio of Na in "brain to that in plasma. Such a
ratio will depend on the equilibrium of several processes
and so an effect of lithium on any one process could be
hidden.
As shown in Figure 10 the dilution of lithium in the
perfusing fluid during its passage through the ventricles
was greater than the dilution of Dextran Blue and this
shows that some lithium was lost from the perfusion fluid.
The loss of lithium can be expressed mathematically by a
transfer constant, ^ The value of the transfer const¬
ant for lithium was similar to the published values for
42
sodium, urea and creatinine but less than that for K
(Bradbury and Davson, 1964, 1965). The constant K .j.
depends on several factors including the permeability
of the ependyma, whether or not the substance is actively
transported and the ability of the brain cells to act as
a sink for the substance in question((Bradbury and Davson,
1965; Cserr, 1965). The ability of brain cells to act as
42
a sink for K has been suggested as the reason for the
large value of 4 ^ for potassium and the fact that
approximately 559' of potassium lost during perfusion is
recovered from the brain whereas only 20% of sodium is
recovered and 59' of calcium (Graziani, Escriva and Xatzman,
1964; Bradbury and Davson, 1965; Cserr, 1965). The
permeability of the ependyma to substances such as creat¬
inine and inulin suggests that the permeability of the
ependyma is not a limiting factor in the loss of small
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molecules and ions from the perfsuing fluid.
The value of 1 , for lithium is less than that for
out
sugar's which are removed by facilitated diffusion and it
is similar to values for sodium, urea and creatinine which
are thought to be lost by passive diffusion (Bradbury and
Davson, 1964). It is likely therefore that the loss of
lithium from the perfusing fluid is due to passive diffusion
and suggests that lithium is free to diffuse between C.S.I',
and brain extracellular fluid ana therefore that C.S.F.
concentrations of lithium will reflect the concentrations
in extracellular fluid. Previous results have shown that
in the dog lithium is also lost from perfusion fluid by
passive diffusion (Prockop and Marcus, 1972). In contrast
it has been suggested that rubidium is actively transported
from C.S.F. in the rabbit (Bradbury, 1970). The present
experiments found only 160 of the lithium lost during
perfusion was recovered in the brain and this is comparable
to results with sodium and calcium (Graziani et al., 1964;
Cserr, 1965) but lower than that for potassium (nradbury
and Davson, 1965; Cserr, 1965). This together with the
small value of R
.j. compared to potassium suggests that
lithium is slow to penetrate brain intracellular space.
The conclusions from the experiments described in
this section are that:
a) Lithium diffuses out of the perfusing fluid into brain
but is slow to enter brain cells.
b) The fast component of sodium entry into C.S.F. is
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sensitive to the potassium concentration in C.S.F. and this
is compatible with choroid plexus sodium transport being
due to a sodium-pump situated in the apical membrane,
c) Lithium, presented to the potassium sensitive side of
the choroid plexus sodium-pump, caused a stimulation of
sodium transport whereas if presented to the sodium
sensitive side of the system lithium caused an inhibition
of sodium transport.
SECTION III
AN INVESTIGATION OF THE EFFECTS OF LITHIUM
ON ATFase ACTIVITIES IN SUBCELLULAR FRACTION
PREPARED FROM RAT CEREBRAL CORTEX.
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Changes in membrane ATPase activities have heen
suggested as important in the therapeutic action of lithium
(Glen and Reading, 1973). Chronic lithium treatment was
postulated to affect synaptic plasma membrane Mg ATPase
activity, possibly due to fusion of the synaptic membrane
and the synaptic vesicles. This section describes an
investigation of the effects of chronic lithium treatment
on ATPase activities in synaptosomal and mitochondrial
fractions from rat brain.
Early studies of the distribution of ATPase activity
in subcellular fractions derived from brain were difficult
to interpret since the fractions were heterogeneous and
not well defined in terms of morphology (Whittaker, 1965).
Ra/K ATPase activity was mainly associated with microsomal
fractions but there was also considerable activity in the
crude mitochondrial pellet (Schwartz, Bachelard and iicllwain,
1962; Albers, Rodriguez be Lores Arnaiz and be hobertis,
1965; Whittaker, 1965). Further analysis of ATPase dis¬
tribution was possible with the advent of methods for sub-
fractionation of the crude mitochondrial pellet and for
the production of synaptosomes, synaptic vesicles, synaptic
plasma membranes and synaptic mitochondria (Whittaker,
Michaelson and Kirkland, 1964; Albers et al., 1965;
Whittaker, 1965). Subsequent studies showed ha/K ATPase
activity to be primarily associated with pinched-off nerve
endings (synaptosomes) and synaptic plasma membranes
rather than microsomes (Hosie, 1965; Alters et al., 1965;
Kurokawa, Sakamoto and Kato, 1965; Lradford, x rownlow and
Gammack, 1966). Na/K ATPase activity has also been shown
to be associated with neuronal plasma membranes by micro¬
dissection techniques (Cummins and Hyden, 1962). The
occurrence of la/V ATPase in synaptic plasma membranes is
consistent with its proposed function in the active trans¬
port of sodium and potassium (Skou, 1965; Whittam and
Wheeler, 1970; Abdel-Latif, 1973).
The distribution of kg ATPase activity in sub-
synaptosornal fractions showed two distinct enzymes, a hp
ATPase activity stimulated by 2,4 dinitrophenol and a Mg
ATPase activity insensitive to the phenol. The insensitive
activity was associated with vesicular and synaptic mem¬
brane fractions while the mitochondrial Mg ATPase activity
was stimulated by 2,4 dinitophenol (Hosie, 1965). Hosie
found the Na/K ATPase activity to be located in the mem¬
brane fractions with none occurring in the vesicle fraction.
She concluded that synaptic vesicles possessed an inherent
Mg ATPase activity. Other workers have since confirmed
the occurrence of ilg ATPase activity in synaptic vesicles
but in addition they have reported a very low Na/K ATPase
activity in vesicle fractions and they have attributed
this to contamination with membranous material (Germain
and Proulx, 1965; Kadota, Mori and Imaizumi, 1967; .iorgan,
Vincendon and Gombos, 1973). Mg ATPase activity has also
been reported in catecholamine-containing granules in the
adrenal medulla and blood platelets (banks, 1965; Poisner
and Trifaro, 1967; Heinrich, Da Prada and Pletscher, 1972;
Agostini and Taugner, 1973). The occurrence of Mg ATP as e
activity in synaptic plasma membrane fractions has been
confirmed (Kurokawa et al., 1965; Reading, Dewar and
Kinloch, 1974) but its function remains unknown. The
function of the synaptic vesicle Mg ATPase is also obscure
but it has been suggested to be involved in the release
and storage of acetylcholine and catecholamines (Germain
and Proulx, 1965; Kadota et al., 1967; Poisner and Taugner,
1973; Pletscher, Da Prada, Steffen, Lutold and Berneis,
1973). Recently evidence has started to accumulate
suggesting the occurrence of actomyosin-like Mg ATPase
in mammalian brain which might be involved in the exocytotic
release of neurotransmitter (Berl, Puszkin and Kicklas,
1973).
Bowler and Duncan (1966) reported ATP-induced absorb-
ancy changes in a supernatant fraction from crayfish nerve
and they interpreted this as showing the presence of
actomvosin-like protein in the nerve membrane. They
suggested the Mg ATPase activity of this protein to control
passive permeability. More recently, proteins with various
properties similar to muscle actomyosin have been isolated
from rat, cat and bovine brain (Puszkin, Berl, Puszkin
and Clarke, 1968; Berl and Puszkin, 1970). These properties
included superprecicitation by ATP, ATPase activity stimul¬
ated by both .lagnesium and calcium seperately, solubility
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properties in potassium iodide (Puszkin et al.t 1968),
polyethylenesulphonate inhibition of Ag ATPase activity
and Kg ATPase kinetics with respect to ATP and magnesium
(Berl and Puszkin, 1970). Further studies have shown the
presence of actin-like and myosin-like proteins in brain
(Berl and Puszkin, 1970; Fine and Bray, 1971; Puszkin and
Eerl, 1972). The properties of these proteins resembled
their muscle counterparts; the brain myosin-like protein
(stenin) showed a much "neater ATPase activity with
calcium than magnesium but this situation was reversed b;y
the addition of actin-like protein from brain (neurin).
In addition neurin stimulated muscle myosin Mg ATPase
activity, possessed 3-methylhistidine as does actin,
polymerised in 0#1 1 CI in the presence of magnesium and
imderwent viscosity changes after interaction with muscle
myosin. Overall, there is considerable evidence for the
presence of a contractile protein in brain wiich possesses
Mg ATPase activity.
More recent work has shown this contractile protein
to occur in the synaptosomal fraction of rat and bovine
brain (Puszkin, Nicklas, Berl, 1972). The protein was not
found in any other subcellular fraction of brain and
accounted for 8-10' of synaptosomal protein. This protein
extracted from synaptosomal material showed properties
similar to the protein extracted from whole brain. In a
further study (Eerl et al., 1973) synaptic vesicle and
synaptic plasma membrane fractions were examined for
actin-like and myosin-like proteins. Vesicles were found
to contain mostly stenin (myosin-like) and only a little
neurin (actin-like). In contrast plasma membrane fractions
contained mostly neurin with only a. little stenin. Vesicular
stenin possessed no Mg ATPase activity unless actin or neurin
were added. Interpretation of these results is equivocable
in view of the heterogeneity of the fractions concerned but
the results suggest myosin-like protein to be associated
with synaptic vesicles and actin with synaptic membranes.
On the basis of these results Berl and his colleagues
suggested that .neurin and stenin are involved in the mech¬
anism of exocytosis in a manner comparable to the contractile
events in muscle; when calcium enters the cell it causes an
interaction between neurin and stenin so causing a contract¬
ile event to occur which gives rise to release of neuro¬
transmitter. Burridge and Philips (1975) have shown actin
and myosin to interact with chromaffin granule membranes.
Further evidence for a muscle-like contractile system in
brain has come from the extraction of tropomyosin!ike
comnlexes from brain, from neurones in culture and from
synaptic plasma membranes (Pine, Blitz, Hitchcock and
Paminer, 1973; Mahendran, Nicklas and Berl, 1974; Puszkin
and Kochwa, 1974).
In summary, Na/K ATPase activity has been shown to be
primarily associated with external membrane fractions such
as synaptosomes and synaptic plasma membranes. Vesicles
possess an inherent kg ATPase activity as do synaptic plasma
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membranes. The relationship between these two activities
and their function is obscure. However in view of the
reports of actomyosin-like hg ATPase in synaptosomal fract¬
ions one must entertain the possibility that either
synaptic plasma membrane or synaptic vesicle kg ATI as e
activity is associated with actomyosin-like protein. The
:ig ATPase activity in mitochondria is distinct from vesic¬
ular and membrane activity in that it is stimulated by
2,4 dinitophenol.
Despite the problem of possible glial conta lination
of synaptosomal fractions ( organ, Wolfe, . andel and Combos,
1371; Henn, Anderson and Rustad, 1376), preparation of such
fractions from lithium-treated animals is a useful approach
to the study of the effects of chronic lithium treatment
on ATPase activities associated with synaptic vesicles and
membranes. The experiments to be described in this section
examined the effects of chronic lithium treatment on synaptic
lembrane, synaptic vesicle and brain mitochondrial ATPase
activities. It was suggested in the previous section that
the distribution of lithium would determine the chronic
effect of the drug on the Ka/h ATPase activity associated
with the stodium-pump« Using synajjtic membrane material it
was possible to investigate the effect of chronic lithium
treatment on ha/'C ATPase activity. Previous work on the
effects of chronic lithium administration on Ka/k ATPase
activity in nervous tissue has been contradictory. Floeger
(1374a) found chronic lithium administration to decrease
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i.a/ . ATPase activity in rat vagal nerve homogenate. using
the same dose and administration time Gutman and colleagues
were unable to show any effect of lithium administration
on rat brain microsomal Na/K ATIase activity although Na/K
ase activity was increased in parotid gland and kidney
medulla * icrosomes and decreased in microsomes prepared
from colonic mucosa (Gutman et al.t 1973a; 1973b). In
agreement with the findings of Ploeger, Reading and his
colleagues have reported chronic lithium administration to
decrease rat synaptic plasma membrane Na/K ATPase activity
(Reading, Kinloch and Loose, 1975). Furthermore Na/K ATPase
activity was found to increase 1 week after the termination
of lithium administration (Reading et al., 1974).
In view of these contradctory results it was of interest
to study the effect of chronic diet administration of lithium
on rat brain Na/ ATPase activity and this was done in the
present experiments using rat cerebral cortex synaptic
plasma membranes. Chronic lithium administration has been
reported to increase rat synaptic plasma membrane ,.g ATPase
activity (Reading et al., 1975). However previous work
had shown rat synaptic plasma membrane Kg ATPase activity
to increase 3 weeks after termination of lithium administr¬
ation (Reading et al., 1974). In view of this confusion
experiments were carried out to further examine the effects
of chronic lithium administration on rat synaptic plasma
.'.embrane Ig ATPase. The work was extended to examine the
ossikle effects of lithium on Kg ATPase activities in
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litochondrial and synaptic vesicle fractions in order to
determine whether the effect of lithium on i-ig ATPase
activity was restricted to plasma membrane fractions.
Previous work has failed to show an effect of chronic
lithium administration on rat brain microsomal iig ATPase
activity (Gutman et al., 1973a). Changes in subcellular
fraction specific enzyme activities are open to equivocal
interpretation in that they can be explained either in
terms of changes in enzyme specific activities associated
with a distinct subcellular structure or in terms of changes
in the quantitative composition of the fraction. In an
attempt to test whether changes in enzyme activities were
due to changes in fraction composition, enzyme markers for
membranes and mitochondria were also measured in the present
experiments.
Christensen (1974) has reported that lithium is
associated with the particulate fraction of rat brain
following the long-term administration of lithium to rats
although it is not possible from his results to determine
the structures with which lithium could be associated. If
lithium was strongy bound to subcellular structures it
could be resent in subcellular preparations. It was
important therefore to determine whether lithium, added in
vitro, had any effects on AT] ase activity in the various
fractions studied. In addition a preliminary attempt to
measure lithium in subcellular fractions was made.
Finally, lithium distribution between various brain
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areas was studied following chronic lithium administration
in order to examine whether in future experiments it would
"be useful to study any particular area of the brain in
relation to effects of lithium. At the time of carrying
out these experiments there were three contradictory reports
concerning lithium distribution, ho et al. (1970) reported
no regional variation in lithium concentration whereas both
bdelfors and Gothgen (1971) and Ebadi, Simmons, 1 endrickson
and Lacy (1974) reported regional differences. Following
the present work, other reports have come to press (fond,
Brooks and. Judd, 1975; Edelfors, 1975).
materials ail methods.
All chemicals used were l.D.I . Analar grade except
where otherwise stated.
1• Animals and Lithium administration.
Male, Wistar rats (200-250g) were used throughout.
They were purchased from Edinburgh University Animal
breeding Station, Bush Farm, Edinburgh and housed three
animals per cage under a regular, normal cycle of 12 hours
light and 12 hours dark. All animals used for experiments
were killed between 9.30 and 10.30 a.m.
Reading et al. (1974, 1975) used intraperitoneal
injection (injection at 4-5 p.m., daily) to administer
lithium chloride (30 mg/rat/day) to rats over periods of
three to six weeks. however such treatment of the animals
ave rise to a massive diuresis necessitating a dail^ change
of cage. In addition the animals were irritable and in a
- 90 -
general unhealthy condition. This situation was partially
improved "by offering the animals a salt-lick in their cage.
Although the animals' general condition improved, lithium
administration still caused diuresis. As shown by Morrison
et al. (Morrison, Pritchard, liraude and D'Aguanno, 1971)
intraperitoneal administration of lithium produces a high
and short-lived peak of lithium concentiation in plasma
followed by a rapid fall to almost zero after 24 hours.
Chronic administration of lithium by intraperitoneal
injection would be expected therefore to give rise to wide
variation in plasma lithium concentration. The high
concentrations attained may exascerbate the problem of
toxicity (Thomsen and Oleson, 1974). It was decided there¬
fore to attempt administration of lithium chlorde to rats
by giving animals ground food to which lithium chloride
had been added. Animals v/ere also offered 0.99 saline and
water to drink as this had. been previously shown to reduce
toxic effects of lithium (Thomsen and uleson, 1974).
Initially lithium chloride was given in the food at
a concentration of 100 mmol/kg food but this regimen
caused the animals to lose weight. Subsequently a dose of
60 rnrnol lithium chloride/kg food was used together with
saline and water to drink. This lower dose was similar
to that used by other workers (Thomsen and Oleson, 1974;
• °nd. et al., 1975) and was found satisfactory from the
-oint of view of animal health; the animals maintained
weight, appeared healthy and had little or no diuresis.
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Although the animals receiving lithium in the diet did not
gain as much weight as those receiving intraperitoneal
injection (Figure 11) their general health was much
superior. The lower weight gain in the diet-administered
group may be due to the animals eating less.
Results shown in Figui-es 12 and 13 give a comparison
of plasma and brain concentrations of lithium following
diet and intraperitoneal injection administration of lithium
chloride. They show considerably higher (p<0.001) plasma
and brain concentrations of lithium following diet admin¬
istration (100 mM/kg food). Using the lower diet dosage
of lithium, plasma lithium concentrations were also con¬
siderably higher than those achieved by injection admin¬
istration. Comparison of lithium concentrations between
injected and diet administered groups is difficult since
animals were killed 16 hours after injection and an
unknown but probably much shorter time after eating food
containing lithium. Morrison et a.1. (1971) showed oral
administration of lithium to produce stable lithium con¬
centrations in both plasma and brain but there was no
peak value as found after injection administration. It
is probable that in the present experiments intrapez'itoneal
injection gave periodically higher brain lithium concen¬
trations than diet administration but that diet admin¬
istration produced more stable concentrations. It was
decided that diet administration was superior to injection
administration since it probably produced pharmacokinetics
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Figure 11. Change in body weight following administration
of lithium chloride to rats. Results are shown from experi¬
ments in which lithium chloride was given by diet admin¬
istration and by intraperitoneal infection: -A- intraperit¬
oneal injection (30 mg LiCl/rat/day), -•- intraperitoneal
injection (30 mg LiCl/rat/day) together with a salt-lick as
supplementation, -x- diet administration (60 mmol LiCl/kg
food) and -St- diet administration (100 mmol LiCl/kg food).
Animals receiving lithium chloride in the diet were offered
a choice of water and 0.9% saline to drink. Results are
also shown from control animals (-o-) which received ground
food, a salt-lick and a choice of 0.9% saline and water to
drink. Values given represent the change in mean body
































Figure 12. Plasma lithium concentration following diet
and intraperitoneal injection (i.p.) administration of
lithium chloride to rats for 1, 2 and 3 weeks. Results
are shown from animals which received lithium chloride
by daily intraperitoneal injection (30 mg LiCl/rat/day),
with and without salt-supplementation in the form of a
salt-lick, and by diet administration with a choice of
water and 0.9% saline to drink. Diet administration was
given at two doses, Diet A (60 mmol LiCl/kg food) and
Diet B (100 mmol LiCl/kg food). Values represent means -
standard deviations from 6 (Diet B and i.p. groups) and
14 (Diet A group) animals. Groups were compared using a
Students 't* test, both diet groups different from i.p.
groups (p<0.00l) at each week, i.p. group significantly




























Figure 13. Brain lithium concentration following diet and
intraperitoneal injection (i.p.) administration of lithium
chloride to rats for 1, 2 and 3 weeks. Results are shown
from animals which received lithium chloride by diet
administration (100 mmol LiCl/kg food) and by daily intra¬
peritoneal injection (30 mg liCl/rat/day) with and without
salt supplementation in the form of a salt-lick. Animals
given lithium chloride in the food had a choice of water
and 0.9% saline to drink. Values represent means - standard
deviations from six animals. Groups were compared using a
Students 't* test, diet group significantly different
(p^O.OOl) from i.p. groups at each week. There was no
significant difference between i.p. and i.p. + salt groups.
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which were closer to those found in the clinical situation
(Schou, 1976). Use of 60 mmol LiCl/icg food produced plasma
lithium concentrations comparable to those achieved clin¬
ically. Thus in all experiments to be described lithium
was administered in the diet using ground food containing
60 ramol lithium chloride/kg food. Control animals received
ground food (standard rat diet, Oxoia modified 43-B) and a
choice of 0.9: saline and water to drink.
As shown in figures 12 and 13 access of the animals to
a salt-lick reduced their plasma lithium concentrations when
lithium was administered by intraperitoneal injection
(significantly reduced at 1 and 2 weeks treatment, p 0.09
and p 0.003). This may represent a difference in the
excretion of lithium since a sodium-enriched diet has been
shown to increase lithium excretion in humans (Thomson and
Schou, 1968).
2. Preparation of subcellular fractions from rat cerebral
cortex.
Mitochondrial, synaptic membrane and synaptic vesicle
fractions were prepared from rat cerebral cortex using
methods described by Vhittaker and Barker (1972). A
summary of the preparation of membrane and vesicle fractions
is shown in Figure 14. All procedures were carried out at
0 - 4°C.
Animals were killed by cervical fracture and decap¬
itated. After removing the top o the skull, a slice of
cortical tissue (approximately 0.3g per animal) was taken
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PREPARATION OF SYNAPTIC MEMBRANES AND VESICLES
All operations at 0° - 4°C.
Make 10^c homogenate of cortex in 0.32M sucrose (+lmM Mg++)
Spin 1000g/15 mins
Residue - Nuclei etc.
1
Supernatant
I Spin 12,000g/20 mins.
Residue = Pg pellet Supernatant
Wash once in equal volume





Suspend in ice-cold water
(2. 5ml/g original tissue wt.)
Leave 30 mins. at 0°C.
Spin at 10,000g/15 mins.
Cloudy supernatant (Ws fraction)
Put on sucrose gradient
NB = sucrose gradient











Figure 14. Preparation of synaptic vesicle and synapti
plasma membrane fractions from rat cerebral cortex.
and kept on ice. 7 issue froui two animals was pooled and
homogenised in 10 volumes of 0.32 sucrose v+i a.i .igClp).
Iioiaogenisation was at a speed of lodi revolutions/minute
for two periods of one minute with a 30 second interval
between. The mortar was kept in ice the whole time. A
glass mortar with a fitted teflon pestle (clearance 7
thousands of an inch) v/as used throughout. The homogenate
was centrifuged at 1000 g for 15 minutes to remove nuclei
and cell debris and the resulting supernatant centrifu&ed
at 12,000 g for 20 minutes to remove microsomes, so pro¬
ducing Pg the crude mitochondrial pellet. This pellet was
washed once in sucrose by resuspension and centril'ugation
at 12,000 g for 20 minutes. The crude mitochondrial pellet
consists mostly of synaptoeomee and mitochondria. The
synaptosomes were lysed in ice-cold water (2.5 rnl/g
original tissue) and left at G-4WC for 30 minutes. The
suspension was then centrifugea at 10,000 g for 15 minutes
and the resulting supernatant {\ ) layered on to a sucrose
gradient, 0.4-0.6 :T continuous, 1.2 . discontinuous. After
centrifugation at 100,000 g for 75 minutes two layers of
material could be seen. A faint band of material was
visible some 1-2 cm below the fluid meniscus. 2 ml of this
material were taken and this is described as the vesicle
fraction. The synaptic membrane fraction consisted of 2 ml
of white, fluffy membranous material taken from just above
the 0.6 M:1.2 M sucrose interface. These fractions were
stored, at 4°C before assay.
The residue from the post-lysis centrifugation of the
crude mitochondrial pellet was discarded in early experi¬
ments. Latterly however it was used for the preparation
of a mitochondrial fraction. The pellet was resuspended
in 0.32 h sucrose and layered on to a 0.8 11:1.2 M discon¬
tinuous sucrose gradient and centrifuged at 53»000 g for
2 hours. . itochondria appeared as a pellet at the bottom
of the tube with the synaptosomal fraction at the 0.8 A:
1.2 sucrose interface. The mitochondrial pellet was
yellow or brown in colour and there was a white la;yer of
synaptosomal material just above it. This white layer was
removed by gentle agitation in 0.32 . sucrose (two washings
required). The mitochondrial pellet was then resuspended
in 3 ml water and stored at 4°C.
In order to achieve good separation of synaptosomes
and mitochondria and thus to produce reasonably pure
mitochondrial fractions it was necessary to omit magnesium
from the sucrose used for the discontinuous gradient.
Other workers have often used 1 m.. EBTA in media used for
mitochondrial preparation (Piesold, 1974) but this was not
found necessary in the present work.
Subcellular fraction0 produced by the above procedures
were characterised using both electron microscopy and
enzyme markers. both electron microscopy and enzyme
content showed the fractions to be of satisfactory purity.
3. easurement of A.TPase activity.
ATPa.se activity was measured by estimation of the
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inorganic phosphate liberated during incubation with
disodium-ATi (L.L.h., Poole). Incubation v.as at 37.5°C
for various periods of time: 30 minutes for synaptic
plasma membranes, 1 hour for synaptic vesicles and 15
minutes for mitochondria. ATPase activity was linear with
respect to length of incubation. The incubation conditions
for the estimation of ATTase activities in synaptic plasma
membranes are shown in Table 6. and were based on those
used by ..onting: arc Caravaggio (1963)» kurokawa et al
(1/65) and heading et al. (1974). ATi-ase activities were
defined in terms of cation activation, kg ATPase activity
was defined as the activity found in the presence of aag-
nesium as the only cation and a/k ATPase was defined as
the additional activity in the presence of sodium and pot¬
assium. Por the assay of vesicular ha/" ATPase it was
found necessary to use Tris buffer, not water, to aake up
the volume of the incubation medium and this gave a final
concentration of 90 .n Tris. Tris was used to make up
volume for all assays of vesicle and litochondrial fractions.
All assays were done in triplicate and run with enzyme and
reaction blanks. The reaction was stopped with 1 ml 245
trichloracetic acid and inorganic phosphate estimated by
the method of . .artin and boty as described by Lindberg and
hrnster (1956). Samples were compared for phosphate content
with standards of J '-JO.. Specific activities were calcul-
ated as yunol k. liberated /hr/mg; protein.
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Table 6. Incubation conditions for assay of ATPase
activities in synaptic plasma membranes. The
table shows final concentrations (nr.) of chemicals
included in the incubation medium. The total
volume of the incubation medium v/as 2.5 ml.
Na/r ATPase activity was defined as the difference
between total and magnesium dependant activity.
Total ATPase i-lagnesium dependant
activity ATPase activity









4. 'ieasurement of Succinic deir/drogenase activity.
Succinic dehydrogenase activity was measured spectro-
pMotometrically by following the succinate dependant
reduction of potassium ferricyanide. The procedure
followed that described by Singer (1974) and is given
below.
Reagents: 0.3 .1 buffer, pH 7.5
0.01 KCK
0.01 "I KFeCNg
0.2 sodium succinate, pli 7.5
Procedure: Phosphate buffer (0.5 ml), cyanide (0.3 ml)
and succinate (0.3 ml) together with enzyme and water (com¬
bined volume 1.4 ml) was pipetted into a cuvette and left
at 3P°C for 7 minutes. The reaction was started by adding
0.5 ml ferricyanide and the optical density at 420 n:n was
followed for 5-15 minutes, the cuvette being kept at 38°C.
The blank consisted of all the above constituents except
enzyme. In the absence of succinate there was no measurable
reduction of ferricyanide. Results are expressed as change
in optical density/10 minutes/mg protein.
5. "measurement of p-nitrophenylphosphatase activity.
p-nitrophenylphosphatase activity was measured using
previously described methods (Lowry, Roberts, Vu, Kixon
and Crawford, 1954; Albers et al. , .1965) as modified by
Bewar (1972). The method measures the —nitrophenol liber¬
ated by its optical density in alkaline solution.
: eagents: a) 0.1 glycine in 1 ink /;gClp and 85 RaOH
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1) 0.4/' p-nitr;,g)henyl phosphate (Sigma Chemical Co. Ltd.)
in 1 m? HC1, p! 6.5 - 8
c) t: Mixture of reagent a) and b) in equal proportions.
d) 0.02 M NaOH
Procedure: 0.03 ml sample was added to 0.3 rnl of reagent
c)> and incubated at 38°C for 30 minutes. The reaction was
stopped by cooling to 0°C and 3 ml of 0.02 0 FaOh added.
The optical density at 420 no was measured and measured
again after additon of 2 drops concentrated hydrochloric
acid. rr,he difference in optical densities was a measure
of the p-nitrophenol present. Results are expressed as
change in optical density/20 minutes/.0,; protein.
6. Electron microscopy.
The morphological characteristics of various subcell¬
ular fractions were studied by electron microscopy using
thin section techniques. Fractions were prepared as described
earlier and then resuspended in 5 rnl 0.32 0 sucrose. The
suspensions were then centrifuged at 60,000 g for 15 minutes
to pellet the subcellular material and the supernatant fluid
aspirated off. The pellet was fixed in 1 ml 5!"' glutaraldehyde
in 0.5 ; sodium cacodylate buffer, rH 7.3. The material was
left in fixative for 18 hours at 0-4°C and then washed twice
in 10" sucrose in cacodylate buffer (each wash was for ten
minutes). Tissue was 00st-fixed in osmium tetroxide, 1
in cacodylate buffer, for 1 hour. After dehydrating the
tissue in alcohol ( 4 ten minute washes in 10', ethanol then
4 ten minute washes in absolute alcohol) the tissue was
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cleared in epoxypropane (2 ten minute washes) and embedded
in araldite. Tissue was left in araldite for 3 days before
o
cutting. 500 A tnlck sections were cut through the embedded
material using a 1KB III ultra nicrotome and the sections
stained in saturated uranyl acetate (15 minutes) and lead
citrate (10 minutes). The sections were finally rinsed in
5 mm I.aOK and then distilled water. Sections were examined
on an A.E.I. Eii6M electron microscope using copper grids.
7. Protein was estimated by the method of Lowry et al.
(1951) as given in Appendix 2.
8. measurement of lithium in whole brain and plasma.
All estimations of lithium in plasma and in digests of
whole brain were done by flame atomic absorption spectro¬
photometry at 670 nm using a Perkin-Elmer 360 atomic
absorptiorneter.
Blood was taken from the severed cervical blood vessels
at the time of death and centrifuged at 1000 g for 5 minutes
to separate plasma and erythrocytes. Plasma was stored at
-20°C before analysis. Samples and standards were diluted
1:10 for analysis. Brain was digested using the procedure
of Bradbury et al. (1968) as described in section II. The
digest was diluted 1:10 for analysis. All standards used
consisted of known amounts of lithium chloride dissolved in
distilled water (Baker Chemical Co. Ltd., hew Jersey).
9. . .easure.;,ent of lithium in discrete areas of "brain and
in subcellular fractions.
ieasurement of lithium in small amounts of various
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kinds of tissue was carried out using a flaneless method
of ato :ic absorption spectrophotoraetric analysis. This
tethod war i ore sensitive and used less .material than the
usual flame oethods of atonic absorption analysis and there¬
fore allowed analysis of very low concentrations of lithium
in small amounts of tissue. It was first applied to the
measurement of lithium distribution in the brain and later
to the measurement of lithium in rat brain subcellular
fractions and human erythrocyte membranes (see section V).
a) Digestion of brain tissue: Weighed aliquots (10 -
100 mg) of fresh brain were dried at 105°C for 48 hours
and reweighed. The dried samples were then ground to a
powder and a weighed aliquot transferred to a plastic tube
(kpoendorf) using a Calm electrobalance fitted with a
tantalum boat. The weighed powder was digested in 1.5
nitric acid (500 jxl) at 80°C for 48 hours. The contents
were evaporated to dryness and the residue redissolved in
0.75 0 nitric acid. Nitric acid did not interfere with the
subsenuent analysis.
b) Measurement of lithium in subcellular fractions:
It was difficult to measure lithium directly in subcellular
fractions since sucrose ^resent in the fractions charred in
the furnace and interfered with the estimation. One sol¬
ution to this problem was to add ammonium hydroxide to the
fraction so reducing the interference. However this also
reduced the sensitivity of the estimation.
c) Flameless atomic absorption spectrophotometric
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analysis: Lithium analysis was carried out at 70 run
using a Terkin-hlrner hGA-74 heated graphite furnace.
Blanks consisted of relevant material (brain di; ests or
brain subcellular fractions) prepared from rats which had
not received lithium treatment and standards consisted of
similar material with known amounts of lithium chloride
(Baker Chemical Co. Ltd.,) added. Standards, samples and
blanks were diluted 1:5 with deionized water for analysis
of lithium in brain areas whereas subcellular fractions
were analysed both without dilution and at 1:5 dilution.
50 jul of solution was pipetted into the graphite furnace
and the analysis carried out using the workiny programme
summarised in Figure 15. After a short pre-drying period
to reduce spraying, the sample was dried at 240°C, thermally
destroyed by steadily increasing' the temperature to lp60oC
and atomised rapidly at 2500°C. The furnace was operated
using uninterrupted gas flow (200 al/nin) with Argon as
the inert gas.
The sensitivity of the analysis was 8 jug/litre for
1" absorption. Using 50 Jul samples it was possible to
detect amounts of lithium in the order of 1 ny . Absorpt¬
ion was linear over a ranye of lithium concentrations u_..
to 700j Li/litre (o.l n ).
10. Dissection of brain areas.
The brain was removed, washed in chilled saline and
dissected over ice as quickl; as possible. "The following
areas were taken for lithium analysis: cerebellu: ,
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TEMPERATURE! t)
Figure 15. A diagrammatic representation of the working
programme used for analysis of lithium "by flameless atomic
absorption spectrophotometry. Analysis was carried out as
described in the text using a Perkin Elmer HGA-74 graphite
furnace. The figure shows the temperature and duration of
the predrying (l), drying (2), thermal destruction (3) and
atomization (4) stages of the analysis.
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hypothalamus, striatum, lower frontal cortex, cortex and
brain stem. The procedure for separating the various areas
is described below.
The cerebellum was removed by cutting the cerebellar
peduncles and the remaining tissue sectioned into three
by a series of three complete coronal knife-cuts - one at
V
the level of the optic chiasma, another behind the mamillary
bodies and a third behind the superior colliculi. The
tissue anterior to the optical chiasraa section will be
referred to as anterior tissue, that tissue posterior to
the optic chiasma section but anterior to the section behind
the mamillary bodies will be referred to as central tissue
ana finally the tissue posterior to the section benind the
mamillary bodies but anterior to the section behind the
superior colliculi was brain stem. A horizontal cut was
made along the line of the anterior commissure through the
anterior and central tissue. The central tissue ventral
to the horizontal cut with the cortical tissue on either
side removed was hypothalamus. Lower frontal cortex was
the anterior tissue which was ventral to the horizontal
cut. Striata were removed from the dorsal anterior tissue
with curved forceps. Cortical tissue was peeled off from
the dorsal anterior tissue and pooled with the cortical
parts of the central tissue block and was termed cortex.
RESULTS.
1. Composition of subcellular fraction.
A series of experiments was performed in order to
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study the morphology and "biochemical characteristics of
mitochondrial, synaptic vesicle and synaptic plasma mem¬
brane fractions produced by the procedure used for later
experiments, fractions prepared from control animals were
examined biochemically by studying enzymes which are con¬
sidered to be markers for certain subcellular structures
and by electron microscopy. Succinic dehydrogenase was
used as a marker for mitochondria (Rodriguez he Lores
Arnaiz et al., 1967; Morgan et al., 1973; Curd, Jones,
Mahler and Moore, 1974; Marchbanks, 1974), Ka/K ATPase as
a marker for plasma membranes (Whittaker and Barker, 1972)
and p-nitrophenylphosphatase as a marker for membrane mat¬
erial (Rodriguez De Lores Arnaiz et al., 1967; Reading et al.,
1974). Mg ATPase was also studied as this enzyme is assoc¬
iated with synaptic vesicles (hosie, 1969; Kurokawa et al.,
1963). Assuming that a marker enzyme is specific to a
particular structure, then by comparison of specific enzyme
activities in the fractions to those in the supposed spec¬
ific locus of that marker it was possible to calculate an
estimation of the contamination of one fraction with another.
Contamination therefore can be defined as the percentage of
protein in a fraction which is due to a specific contamin¬
ating structure.
Electron micrographs of the various fractions are
shown in Figures 16 - 18. The tnree fractions examined
had distinct morphological characteristics. The distinct
nature of the fractions was also shown by their enzyme
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content as is shown in Figure 19. lorpholo?; ically the
synaptic vesicle fraction comprised, mostly of small
synaptic vesicle structures together with a little membrane
contamination. There was no evidence for the presence of
mitochondria. The membrane contamination of the vesicle
fraction was also reflected in the biochemical studies
which showed some Na/K ATPase and p-nitrophenylphosphatase
activity in the vesicle fraction. However the activities
of such markers were very low, especially in the case of
iia/K ATPase which in many instances was not detectable.
Estimates of the membrane contaaination in the vesicle
fraction were 10/ (using Na/K ATPase) and 2 % using
p-nitrophenylphosphatase. The synaptic vesicle fraction
showed considerable enrichment in Mg ATPase activity
relative to Na/K ATPase compared to the synaptic membrane
fraction. The ratio of the specific activity of Mg ATPase
to Na/K ATPase was 3.5 in the vesicle fraction compared to
0.57 in the membranes.
The electron micrographs of the mitochondrial fraction
showed typical mitochondrial" structure such as cristae
together with many ill-defined membranous structures. In
some cases the latter showed the remains of cristal struct¬
ure suggesting that much of ill-defined membranous structure
was lysed mitochondrial material, biochemically the mito¬
chondrial fraction showed characteristically high Mg 51'Pase
and succinic dehydrogenase activities together with some
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Figure 16. Electron micrographs of synaptic vesicle fractions
prepared from cerebral cortex of control rats. Both pictures
show predominantly synaptic vesicle structures with a small
amount of larger .membranous material. Magnification:
PgS^40,-)00,4b) X 100,000 ;;w||
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Succinic Dehydrogenase p-nitrophenyl phosphatase
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UZA
Figure 19. Biochemical characteristics of subcellular
fractions prepared from cerebral cortex of control rats.
ATPase activities are expressed as ^umol P^ liberated /hr/
mg protein, succinic dehydrogenase as change in optical
density/10 min/mg protein and p-nitrophenylphosphatase
activity as change in optical density/20 min/mg protein.
Values given are means - standard deviations with the
number of preparations studied in parentheses.
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these membrane marker enzymes, membrane contamination of
the mitochondrial fraction was estimated at between 10
(p-nitrophenylphosphatase) and 30; (Na/K ATPase).
Measurement of succinic dehydrogenase activity in
the synaptic plasma lembrane fraction showed little (13)
mitochondrial contaaination. This was supported by the
electron microscopy which failed to show any considerable
mitochondrial contamination. The plasma membrane fraction
had characteristically high Xa/X ATPase and p-nitrophenyl-
phosphatase activities. Morphologically the fraction
consisted mostly of membranous material, 'ghost'-like
structures which were most probably intact synaptosomes
and broken-up, l.ysed membrane structures. So .i e myelin
contamination was evident together with some densely
staining bodies, possibly lysosomes. Possible post syn¬
aptic thickenings and synaptic junctions can be seen in
Figure 18.
In conclusion, both the biochemical and morphological
studies suggest that the fractions produced were clearly
distinct and of considerable purity with only limited
contamination. In the e perime its to be described ATPase
activities were compared between control and drug-treated
preparations and in such a situation it was essential not
simply to assume certain contamination of fractions, but
to measure marker enzymes to investigate whether changes
in contamination did occur.
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2. The effect of chronic lithium administration on ATPase
activities in various subcellular fractions.
Rats were given lithium chloride in their diet (60 mrnol/
kg food) for periods of 1, 2 and 5 weeks. Plasma lithium con¬
centrations were in the range 0.5-1.0 mil. Following lithium
treatment, animals were killed and subcellular fractions pre¬
pared from the cerebral cortices. Three control and three
drug-treated preparations were attempted on each occasion.
The results presented in the following paragraphs represent
data from two or three chronic lithium treatment experiments.
In order to combine the results from all the experiments the
data were expressed as percentages of the mean control enzyme
activity for each batch of preparations. Statistical analysis
of results expressed as percentages of mean control enzyme
activity was carried out using a Wilcoxon ranking test.
The results shown in Table 7. show the effect of lithium
administration on rat cerebral cortex synaptic plasma membrane
ATPase activities. Lithium treatment had no significant
effect on Na/K ATPase activity but after three weeks of lith¬
ium treatment there was a significant increase (p 0.01) in
synaptic plasma membrane Mg ATPase specific activity.
Mitochondrial contamination of the fractions was monitored
by measuring succinic dehydrogenase activity. As shown
in Table 7. there was no effect of lithium treatment on tie
specific activity of synaptic plasma membrane succinic
dehydrogenase so suggesting no changes in the mitochondrial
contamination of the fraction. The increased Mg ATPase
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Table 7. The effect of chronic lithium chloride admin¬
istration on the specific activity of ha/Y, A'i'Pase,
i-ig ATPase and succinic dehydrogenase in synaptic
plasma membrane fractions. Synaptic plasma mem¬
branes were prepared from rats given lithium
chloride in the diet (60 rrnnol LiCl/kg food) and
control animals. Results are expressed as per¬
centages of the mean control value of each batch
of preparations. Values are means - standard
deviations with the number of preparations in
parentheses. Groups were compared using a







iig ATI ase dehydrogenase
controls 100 - 24 100 - 13 100 - 21
(19) (19) (19)
lithium- 1 117 ±17 91 - 21 113 ± 41
treated (6) (6) (6)
84 - 17 94 ±23 113 ± 67
(7) (3) (6)
94 - 21 123 - 16* 102 - 33
(3) (6) (8)
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activity after 3 weeks was not paralleled "by a change in
mitochondrial contamination or membrane fraction purity
as judged by La/K ATPase activity and so it is unlikely
that changes in fraction composition could account for the
increased specific activity of the Mg ATPase.
In view of this increased Mg ATPase in the membrane
fraction further experiments were carried out to examine
the effects of lithium on mitochondrial and synaptic
vesicle kg ATPase activity. As shown in Table 8. lithium
treatment, although tending to increase vesicle Mg ATPase
activity, failed to produce a significant effect. There
was however a marked increase (p<0.01) in vesicle fraction
ka/li ATPase activity after 3 weeks of lithium treatment.
This indicates increased membrane contamination of the
fraction. Further experiments are needed to establish
whether this is a true effect of lithium changing the
fraction characteristics so that there is a redistribution
of material during fractionation.
Lithium treatment of animals for one week caused a
significant increase (p(0.01) in the specific activity of
mitochondrial Mg AIM ase (Table 9.). This was not accompan¬
ied by any change in succinic dehydrogenase or ..a/.. Al. ase
activity thus showing that accompanying changes in fraction
composition could not explain the ciiange in Mg ATPase
activity, longer treatment with lithium (3 weeks) was
associated with a return of the mitochondrial Mg ATPase
activity to control levels. There was a trend for lithium
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Table 8. The effect of chronic lithium chloride admin¬
istration on the specific activity of ba/K
ATPase and Mg ATFase in synaptic vesicle fractions.
Synaptic vesicles were prepared from rats given
lithium chloride in the diet (60 mmol LiCl/hog food)
and control animals, hesults are expressed as
percentages of the mean control value of each
batch of preparations. Values are means - stand¬
ard deviations with the number of preparations
in parentheses. Groups were compared using a
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Table 9. The effect of chronic lithium chloride admin¬
istration on the specific activity of ha/
ATPase, Mg ATPase and succinic dehydrogenase in
mitochondrial fractions. Mitochondria were pre¬
pared from rats given lithium chloride in the
diet (60 mmol/kg food) and control animals.
Results are expressed as percentages of the
mean control value of each batch of preparations.
Values are given as means - standard deviations
with the number of preparations in parentheses.
Groups were compared using a Wilcoxon ranking



































treatment to reduce mitochondrial succinic dehydrogenase
activity hut the effect was not of statistical significance.
3. 1'he lithium concentration in subcellular fractions,
mitochondrial, synaptic plasma membrane and synaptic
vesicle fractions were analysed for their lithium content.
ho lithium was detectable in the fractions using flame atomic
absorption spectrophotometry analysis, however, using
flamelees atomic absorption methods with a graphite furnace
it was possible to detect very low levels of lithium in
the fractions, x'he amount of lithium present was so small
that it could not be accurately determined but the approx¬
imate lithium concentration in all three types of fraction
was 2 a.. Such a concentration of lithium could result in
a concentration of u.l - 0.2 u. in the Ailas e incubation
medium.
4. ihe effect of lithium, in vitro, on subcellular- fraction
AIT ase activities.
Experiments were carried out to investigate the effect of
lithium, in vitro, on v a/K AITas e and lug All ase activities in
the sane types of subcellular fraction as were studied in the
chronic treatment experiments. Lithium concentrations used
were chosen to span the range from the low concentrations
expected when subcellular fractions from lithium-treated
rats were assayed to the higher concentrations found in
the plasma of both animals ana humans treated with lithium
salts. Subcellular fractions were incubated with litnium
for 10 minutes prior to Ailase assay. Lithium was added
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to the Incubation medium as lithium chloride. The results
are shown in Table 10. They show no evidence of any effect
of lithium, at any concentration, on iia/K ATPase or Mg
ATPase activity in any of the fractions studied.
5. The distribution of lithium in various areas of rat brain.
Rats were given lithium in the diet (60 mmol/kg diet)
for three weeks. Such a drug regimen produced plasma
lithium concentrations of 0.5 - 1.0 mil. After 3 weeks
treatment the animals were killed by cervical fracture and
the brain removed. Various brain areas were dissected out
and their lithium content measured. The results are shown
in Table 11. An analysis of variance showed there were
significant differences in the lithium content of the
various areas (p 0.05). Comparisons of the individual
groups showed the striatum to have a significantly higher
lithium content than the cerebellum (p 0.025). The lithium
content of the other areas studied was not significantly
different from that of cerebellum.
DISCUSSION.
The subcelliilar fractions produced in the present work
had not only to be of high purity but also to be reproducable
in order to allow comparison between control and drug-
treated preparations. Previous workers have used a variety
of techniques to produce pure fractions of synaptosomal
material; extensive washing of the crude mitochondrial
pellet to remove microsomes (Morgan et al., 1971; Gurd
et al., 1974), lysis of synaptosomes rather than lysis of
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Table 10. The effect of lithium chloride, in vitro, on
ATPase activities in synaptic plasma membrane,
synaptic vesicle and mitochondrial fractions
prepared from cerebral cortex of control rats.
Preparations were pre-incubated with lithium
chloride for 10 minutes prior to assay. Results
are expressed as ^umol P^/hr/ml fraction. Values
-f.
are means - standard deviations with tne number

































































Table 11. Lithium concentration in various areas of rat
brain following chronic lithium chloride
administration. Rats were given lithium chloride
in the diet (60 mmol LiCl/kg food) for 3 weeks.
Results are expressed as mmol/kg wet tissue.
Values given are means - standard deviations
from five animals. An analysis of variance
showed the groups to be significantly different,
p 0.05. Comparison of areas with the cerebellum
using a students •t' test showed the striatum
to be significantly different (p 0.025) from
cerebellum.
Brain area Lithium concentration
(mmol/kg)
cerebellum 0.35

















the crude dtochondrial pellet (Cotiaan and attliews, 1971;
Gurd et a.1. , 1974) and filtration of vesicular :aaterial to
remove aembranes (Morgan et al., 1973). All these pro¬
cedures extend both the preparation tine and the number of
operative procedures involved and are thus not well suited
to comparative enzyraological studies. Therefore a fraction¬
ation procedure was chosen which had a short preparation
time and a minimum of operative procedures. An additional
washing of the crude mitochondrial pellet was introduced
to minimise :icrosomal contamination of the synaptic
fractions.
The procedure adopted produced fractions which were
distinct in their morphological and biochemical properties,
"or/biologically the fractions appeared to be of considerable
purity and were of similar appearance to those presented in
the literature (Lapetina, Soto and De Robertis, 1967;
Rodri, ues Be lores Arnaiz et al., 1967; Morgan et al. , 1971;
1973). Both morphologically and biochemically the synaptic
vesicle fraction seemed to possess little contamination.
Estimates of nembrane contamination as judged by ha/h ATIase
and p-nitrophenylphosphate activity were 10 - 25'"'. Such
values compare favourably with those reported in the
literature (V/hittaker et al. , 1964; morgan et al., 1973).
mitochondrial contamination of the synaptic membrane
fraction war very low (13") and comparable to that achieved
by similar and more complex preparative procedures (V'hittaker
et al., 1364; Cotman and ' 'atthews, 1971; or an et ml., 1971;
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Gurd et al., 1974). When examined electron microscopically
the synaptic membrane fractions appeared to consist of
intact synaptosomal 'ghosts' and broken-up lysed membranous
material. Membranes were also present in the mitochondrial
fraction and were estimated to give rise to some 15 - 30.
contamination.
The characteristics of t^e various fractions were such
that it was possible to consider the fractions as being
distinct in their bioche .ical and structural contents.
Tie separation of material achieved allows one to allot,
with some confidence, changes in fractions to particular
subcellular structures.
The distribution of ATiase activities between the
various fractions studied was similar to that reported by
earlier workers (Kosie, 1965; Kurokawa et al.. 1965; Reading
et al., 1974) in that kg ATPase activity was associated with
all fractions but particularly vesicles and mitochondria
whereas ha/ ATPase was found predominantly in the synaptic
plasma membrane fraction.
Lithium treatment for three weeks was found to
significantly increase the specific activity of synaptic
plasma membrane ig hi, ace. This result confirms the earlier
finding of (eading et al. (1975) that synaptic plasma
le.fbrane kg ATPase activity is increased during lithium
administration. There are three possible explanations of
the observed rise in specific enzyme activity. Firstly,
lithium present in the fractions could have activated the
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enzyme In vitro. This, however, can be discounted since
lithium over a wide concentration range showed no effect
in vitro on synaptic plasma membrane Mg ATPase activity.
Secondly, the change in Mg ATPase activity could have
arisen as a result of a change in the composition of the
membrane fraction. Reading et al. (1974) have interpreted
changes in subcellular fraction ATPases in terms of a
redistribution of synaptosomal material during preparation,
'bwever, such an explanation of the present results is
untenable in view of the unchanged mitochondrial contam¬
ination and the unchanged membrane content of the fraction
as judged by enzyme markers. Glen and Reading (1973)
suggested that changes in Mg ATPase activity in synaptic
membrane fractions might reflect effects of lithium on
vesicle-membrane fusion and neurotransmitter release. The
present results provide no evidence for such a hypothesis.
The most probable explanation of the observed increase
in synaptic membrane Mg ATPase activity is that it is due
to a real increase in the specific activity of the enzyme
present in the synaptic membrane material. In view of the
possible glial contamination of synaptosomal material
(Morgan et al., 1971; Eenn et al., 1976) it cannot be
unequivocally stated whether the increase in Mg ATPase
activity occurred in neuronal or glial cells. There is
immunohistochemical evidence (Katus, 1976)'for synaptic
membrane fraction containing material present in the
synaptic membrane itself. It is possible therefore that
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tie increased kg ATPase observed in synaptic membrane
fractions is a lithium-induced change in a synaptic compon¬
ent.
In contrast to the earlier work of Reading et al.
(l >75) the present work failed to show an effect of lithium
treatment on synaptic plasma membrane fta/k ATPase. Tile
observed increase in kg ATPase activity (25 } in the present
studies was also less than the 50 - 150. increase observed
by Reading. The reason for the difference in the two sets
of results is unknown but it may lie in the different mode
of lithium administration used in the two studies. Oral
administration of lithium does not produce the short-lived,
high lithium concentrations found after intraperitoneal
injection (...orrison et al.t 1571). It may be that sua
short-lived, high concentrations of lithium are effective
in changing ATPase activity and in particular it is possible
that only high, toxic lithium concentrations are effective
in altering I.a/1 ATPase activity. Reading et al. (1975)
showed that animals offered a salt-lick in addition to
lithium showed less change in ATPase activity than animals
with no salt supplementation. Results presented here showed
the salt supplementation to decrease the plasma lithium
concentration. It would seem therefore tnat the cj.anyes
in synaptic membrane ATPases observed during lithium treat¬
ment are sensitive to tie lithium levels achieved and that
/•ode of administration is important in determining the
effects of lithiu .. Ti e
_ resent experiments, in v'.ici
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plasma lithium concentrations of 0.5 - 1.0 mH were achieved
and in which the levels of drug were probably stable
(Schou, 1976) provided no evidence that chronic lithium
treatment affects brain Na/K ATPase activity.
The specific activity of mitochondrial Hg ATPase was
increased after 1 week of lithium treatment. The succinic
dehydrogenase and Na/K ATPase activities were unchanged
suggesting that changes in fraction composition could not
explain the increased g ATPase specific activity. Lithium,
in vitro, had no effect on mitochondrial 14g ATPase activity.
It is most likely that the increase in Hg ATPase activity
reflects an increase in enzyme specific activity in the
mitochondria. The return of mitochondrial Hg ATPase spec¬
ific activity to control level after further lithium treat¬
ment (3 weeks) is a similar effect to that described for
synaptic membrane :ig ATPase (Reading et al. , 1975). It is
evident therefore that the increases in both mitochondrial
and membrane enzymes are only transient. Further experi¬
mental evidence is required to be able to state whether
such changes represent an in vivo activation of the enzymes
or the presence of more catalytic protein. The functional
significance of the changes is unclear. The function and
nature of the membrane Hg ATPase is unknown so the signifi¬
cance of changes in its activity are particularly obscure.
It is unlikely that the Hg ATPase activity affected by
lithium treatment is due to the activity of adenyl cyclase
since chronic lithium treatment has been shown to decrease
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rat brain synaptic plasma membrane adenyl cyclase activity
( .eadin. et al«, 1979). It is possible that the change
may reflect an alteration in synaptosomal contractile
protein Kg ATPase activity functioning in neurotransmitter
release. The mitochondrial ATPase is associated with ion
transport and ATI synthesis (hacker, 1979) and its increased
activity may be reflected in increased ATP synthesis in the
mitochondria.
There was no evidence of lithium affecting vesicle g
A base at the treatment times studied. It is possible that
such a change was missed since the changes in the other
fractions were only transient. I revious workers have
studied .microsomal fractions with contradictory results,
'.sin.- chronic treat..ient lutuan et al. (1973a) found no
effect of lithium on microsomal Aliases in brain but
C: ulty et al. (1975) found a single dose of lithium to
decrease hp ATPase activity in rat brain subcellular
fractions which although not defined were probably micro¬
somal. Iloeger (1974a) reported chronic lithium treatment
to decrease rat vagal nerve homogenate hg ATPase. It is
not possible to give a rationale for these varying effects
of lit' iun on Ig ATPases in different tissues and different
subcellular fractions. Differences in lithiu. administration,
lithium distribution and the possibility of different enzymes
in different physiological systems are some of the possible
e:s lariat ions.
The r-ccults of anal.. sir of subcellular fractions
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prepared froia lithium-treated animals showed very little
lithium present in mitochondria, synaptic membrane of
synaptic vesicle fractions. This would su, est that
lithium is not tightly "bound to these particular sub¬
cellular structures. Chronic treatment of rats with
lithium gave rise to an uneven distribution of lithium in
tne brain. Results showed a particular concentration of
lithiua in the striatu ; with little difference in distrib¬
ution in the other areas studied although hypothalamus and
cortex tended to have a higher lithium content than brain
stem and cerebellum. Previous work on lithium distribution
has given varied results, ho et al. (1970) failed to show
differences in lithium content between different brain
areas, however later workers did find differences after
both acute and chronic administration. The striatum was
reported to have a high lithium content by some workers
(hbadi et al., 1974; Bond et al., 1975) and hypothalamus
by others (Edelfors, 1975). Possible explanations of the
uneven distribution of lithium include differences in cell
type, cell size, cell number and the size of extracellular
space in the various regions of the brain. Although tiie
significance of the regional distribution of lithium is
unclear it is evident from the present work and that of
others that the effects of lithium may not be uniform
throughout the brain.
The work described in this section bar led to the
following; conclusions:
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1. lithium, in vitro, does not affect Ag ATPase or -a/'
ATIase activity in mitochondrial, synaptic plasma membrane
or vesicle fractions.
2. Chronic lithium administration in the diet leads to a
transient increase in the specific activity of Ag ATiase
in synaptic plasma membrane and in mitochondrial fractions
prepared from rat cerebral cortex. The effect of lithium
treatment on Mg ATPase activity is not restricted to
synaptic plasma membranes.
3. Chronic lithium treatment has no effect on the specific
activity of synaptic vesicle Mg ATPase.
4. Chronic lithium treatment, usint diet administration,
has no effect on synaptic membrane ha/iC ATPase.
r;. The results provided no evidence for chronic lithium
treatment leading to a change in composition of the syn¬
aptic membrane fraction. The lithium-induced changes in
Mg ATiase activity were not related to vesicle-membrane
fusion.
6. The effects of chronic lithium treatment on synaptic
membrane Mg ATPase and y.a/K ATPase activities may depend
on the mode of administration of the drug.
7. lithium is not evenly distributed throughout the brain.




AN INVESTIGATION 01 THE EFPECTS
OP CHRONIC LITHIUM TREATMENT ON DOPAMINE HETAEOLISK
IN THE RAT STRIATUM.
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INTRODUCTION.
Results presented in the previous section showed
chronic lithium treatment to increase the specific activity
of synaptic plasma membrane Mg ATPase. The functional sig¬
nificance of such a change is uncertain. However, if the
ilg ATPase activity is associated with an actomyosin-like
protein involved in neurotransmitter release (Berl et al.,
1973) then changes in Mg ATPase would be expected to be
associated with changes in the release and the metabolism
of neurotransmitters. The aim of the work to be described
in this section was to establish whether or not the regimen
of lithium treatment which produced changes in synaptic
plasma membrane Mg ATPase also produced changes in neuro¬
transmitter metabolism. Neurotransmitter metabolism was
studied in animals chronically treated with lithium, using
the same dose of lithium and the same length of treatment
as was found to cause changes in Mg ATPase activity. The
approach used was to measure the concentration of dopamine
and its metabolites, homovanillic acid (KVA) and 3,4 dihydroxy
phenylacetic acid (DOPAC) in striatal material from lithium-
treated rats. Although this approach suffered from the dis¬
advantage that neurotransmitter metabolism was being studied
in a different brain area to that in which ATPase changes
had been found, there were advantages gained from studying
the striatum: the striatum has been shown to have a high
concentration of lithium (Ebadi et al., 1974; Bond et al.,
1973; this thesis) and in addition it is associated with a
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well-characterised dopaminergic neuronal system which has
its nerve terminals in the striatum (Kornykiewicz, 1573).
Previous studies of the effects of lithium on catechol¬
amine metabolism in the brain have provided few consistent
results. The variation in the effects found may be due
to the differences in length of treatment, mode of adiain-
istration and dose of lithium used in the various experiments
(Shaw, 1975). Such differences in drug treatment make it
difficult to compare results from the various experiments.
In the case of noradrenaline metabolism, in general lithium
seems to cause an increase in intraneuronal metabolism
together with increased re-uptake and possibly decreased
release of noradrenaline (Shaw, 1975). Less work has been
done on the effects of lithium on dopamine metabolism.
However, the available evidence suggests lithium treatment
causes a decrease in dopamine turnover. Using chronic diet
administration for 3 weeks, lithium treatment was found to
have no effect on whole brain dopamine concentrations
although it did cause a reduction in dopamine turnover as
."judged by the depletion of brain dopamine after inhibition
of tyrosine hydroxylase (Corrodi, Fuxe and Schou, 1963).
Using histochemical techniques, these workers demonstrated
increased dopamine depletion in the tubero-infundibular
system and decreased depletion in the mesotencephalic area
of the brain. Later workers showed intraperitoneal injection
of lithium chloride for 14 or 19 days to cause decreases in
both striatal and whole brain dopamine synthesis (Friedman
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and Gershon, 1973; Poitou arid Loiiuon, 1973), findings
consistent with decreased dopamine turnover. A further
report however failed to observe any significant effects
of lithium on dopamine turnover in various areas of rat
brain (!o, Loh, Graves, liitzemann and Gershon, 1970).
Generally lithium treatment has been found to have no
effect on steady-state dopamine concentrations (Corrodi
et al., 1969; ho et al., 1970; Friedman and Gershon, 1973)
although Leonard (1979) showed a decrease in whole brain
dopamine content following a single lithiua injection.
Studies of striatal HVA content following chronic lithium
administration have failed to show any effect of lithium
on dopamine turnover or catabolism (lerez-Cruet, Tagliamonte
Taglia onte and Geesa, 1971; Schubert, 1973).
The present work used a different approach from the
previous studies in that rather than measure dopamine turn¬
over and synthesis by using metabolic inhibitors and radio¬
active substrates, metabolism has been studied by measuring
striatal concentrations of dopamine and its major metabolite
HVA and DO!AC (Sharnan, 1973). The reason for using metabol
ite studies was in order to try and distinguish between
release and re-uptake processes. The hypothesis that DOPAC
is the product of intraneuronal metabolism and MYA the
product of extraneuronal metabolism (Roffler-Tarlov, Sharnan
and Tegerdine, 1971; V/ilk, Watson and Travis, 1973; Roth,
urrin and halters, 1976) allows analysis of changes in
metabolite concentrations in terms of intraneuronal and
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extraneuronal compartmeritation and release and re-uptake
of neurotransmitter. Measurement of dopamine concentrations
allows distinction between effects on turnover of the amine
and effects on release alone.
j.A1ahi-jiijib API) ^Jjs.
1. General.
All chemicals were of Analar Grade from British Drug
louses Co. Ltd. unless otherwise stated. S-Adenosyl-
(me thy1- L) methionine and (side chain-2,3- H) tyrosine were
purchased from The Radiochemical Centre, Amersh&m, U.K.
Male, Wistar rats (200 - 230 0) were given lithium
chloride in the diet (60 mmol LiCl/kg food) for a period
of up to 3 weeks. In experiments involving DOT AC, i.YA and
dopamine estimations animals were anaesthetised with Nembutal
(70 mg/kg, intraperitoneally) and blood taken by cardiac
puncture. Animals were then killed by decapitation and the
brain removed. In experiments involving tyrosine hydroxylase
estimations animals were not anaesthetised end \vere killed
by cervical fracture. Striata were dissected out as described
in the previous section and stored in liquid nitrogen until
analysis. Plasma lithium analysis was carried, out as des¬
cribed in the previous section.
2. hstimation of homovanillic acid (hVA) and 3«4dihydrox;Y-
phen;,lacetic acid (DPIAC).
. VI. and DO. AC were measured in striata by gas-liquid
chromatography using; an electron capture detector (Pearson
and Sharman, 1973 modified by Likolaou). The procedure for
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assay is outlined below.
Tissue (20 - 40 rug) was homogenised in 0.1 L perchloric
acid (300 juI/IC mg tissue) and centrifuged at 10,000 g i'or
13 minutes. 673 /LL of supernatant was transferred to a
plastic (Eppendorf) tube and 0.3 ml toluene added, hollow¬
ing vortexing for 30 seconds the mixture was centrifugeu
at 1000 g for 2 minutes. The aqueous layer was then extracted
with 0.3 ml ethyl acetate (Reeve Angel scientific Ltd.) for
1 minute. following vortexing, the tube was centrifuged
(1000 g, 2 minutes) and the ethyl acetate layer transferred
to a reaction vial. The aqueous layer was extracted twice
lore with ethyl acetate and the organic extracts combined
and evaporated to dryness under a stream of nitrogen. The
dried extracts were then reacted with 0.2 ml twice redistilled
trifluoroacetic anhydride (Aldricl: Chemical Co. ltd.) and
0.1 ml redistilled hexafluoroisopropanol containing 3, v/v
freshly prepared boron trifluoride etherate. The reaction
was earned out at 100°C for 1 hour. After cooling, the vial
contents were evaporated to small volume at room temperature
under a strea:, of nitrogen. The oily residue was dissolved
in 1 ml of dry ethyl acetate containing 100 ng/ml penta-
fluorophenylbenzoate as internal standard. 2 jxl of this
solution was injected into the gas chromatogram. Standards
of EVA and 101 AC were run with all assays.
las-liquid chromatography of the trixluoroacetyl-
; exaf1uoroisopropy1 derivatives was carried out using a
6^
Hewlett-Packard 3710 Gas Chromatograph fitted with <hi
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electron capture detectors maintained at 250°C. Carrier
pas was argon with 5.: methane and this was delivered at a
flow rate of 50 ml/rainute (corresponding to a gas pressure
of 40 p.s.i.). The col\imn used was a 2% SE52 liquid phase
coated on Chromosorb 2 (Hewlett-Packard ltd.) and the work¬
ing temperature v/as 115°C.
Retention times of the HVA and DOPAC derivatives
compared to the internal standard were 0.35 and 0.52
respectively. Areas of sample peaks were calculated and
the metabolite contents calculated from comparison with
areas of peaks derived from known standards of HVA and
POPAC. Recoveries of HVA and DOPAC were 90H and 87
respectively. Results were not corrected for recoveries.
3. Estimation of dopamine.
The estimation of striatal dopamine was done using a
radiometric assay employing methylation of dopamine with
-Z
S-Adenosyl-(methyl- H)methionine followed by extraction and
measurement of the labelled raethoxytyraraine formed. The
method used was derived from those described by Coyle
and Hendry (1973) and Palkovits, Brownstein, Saavedra and
Axelrod (1974). The assay procedure is outlined below:
Striata (20 rag) were homogenised in 0.1 N perchloric acid
(300yul/10 mg tissue). The homogenate was centrifuged at
10,000 g for 15 minutes and 300yul of the supernatant fluid
used for the subsequent assay. 300yul aliquots of 0.1 h
perchloric acid were used as blanks and standards of dop¬
amine added to brain extracts were run with all assays.
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standards, samples and blanks were reacted with
labelled S-Adenosyl methionine in the presence of catechol-
o-methyl transferase. 300jx\ of samples were added to a
mixture containing 300 /ug of dithiothreitol, 0.3 yuraol
. ,.;Glp, 140ytuaol Tris-kCl buffer, ph 9.6, 2.3yul of rat
liver catechol-o-aethyl transferase (prepared as described
by Axelrod and Tamchick, 193S) and 2.9 ;uCi of S-Adenosyl-
/ *5 \ o
( aethyl-"h )methionine. After incubation at 37.3 C for
1 i.our the reaction was stopped by the addition of 5oO ,/ul/
...9 h borate buffer, pit 10. After addition of non-radio¬
active carrier (7yUg methoxytyramine) and 1 mg EDTA in a
total volume of 30 /nl, the o-methylated leaction products
were extracted into 3 ml of water saturated ethyl acetate-
He tnanol (10:1 v/v) by shaking for 30 seconds. The phases
were separated by centrifugation (luOO g, 3 minutes) and
.5 ml of the organic layer transferred to another tube
containing 0.5 ml 0.5 M borate buffer, ph 10. 8 ml of the
%
subsequent organic phase was mixed for 30 seconds witi
0.5 ml 0.1 h nydrochloric acid. After separation of the
two phases by centrifugation the organic phase was discarded.
The acid aqueous phase was washed in 6 ml water-saturated
ethyl acetate by nixing and centrifugation.
The procedure so far described results in the 'iethyl-
ation of both noradrenaline and dopamine and tne extraction
of their methylated derivatives. In order to separate
normetanephrine (noradrenaline derivative) fro.-, nethoxy-
tyramine (dopamine derivative) the aormeta.sep .rine side-chain
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is cleaved by periodate to form vanillin which is then
separated from methoxytyramine. The acid aqueous phase
described above was reacted with 50 yul of 3> (w/v) sodium
metaperiodate and 0.5 ml 0.5 M sodium phosphate buffer,
pH 7.5 for 5 minutes at 0°C. The reaction was stopped by
the addition of 50 ^ul 10% (v/v) glycerol and 10 ml toluene
added. After mixing and separation of the two phases, tne
toluene layer could be used for noradrenaline estimation as
it contained the labelled vanillin. The aqueous phase con¬
tained labelled methoxytyramine and was used for dopamine
estimation. 5 ml toluene was added to the aqueous layer
and the mixture shaken and centrifuged to separate the two
phases. 0.5 ml 1 ft borate buffer, ph 11 and 6 ml toluene-
isoamyl alcohol (3:2) was added to the aqueous layer. After
mixing and separation of the two phases 5 ml of the organic
layer was taken and added to 10 ml NE260 liquid scintillant
(Nuclear Enterprises Ltd.).
4. Measurement of tyrosine hydroxylase activity.
Tyrosine hydroxylase was measured in striatal material
by measuring the labelled dopa produced by incubation with
'Z
(side chain-2,3- H)tyrosine exactly as described by Hendry
and Iverson (1971). Results are expressed as nmol dopa
formed/hr/g wet tissue.
5. Efficiency of radioactive counting.
Efficiency of the counting of the tritiated products
of both dopamine and tyrosine hydroxylase assays was 30/ .
All samples were corrected for quenching by the external
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standard channels ratio method. All samples were counted
for 10 minutes.
RESULTS.
1. The effect of chronic lithium treatment on striatal
HVA, DOPAC and dopamine concentrations.
Rats were treated with lithium chloride in the diet
(60 mmol/kg food) for 3 weeks. Plasma lithium concentrations
in samples taken prior to decaptation were 0.48 - 0.63 mivl.
Analyses of HVA, DOPAC and dopamine in the striata from
lithium-treated and from control rats are shown in Table 12.
The results show the lithium-treated animals to have sig¬
nificantly increased HVA (52%) and DOPAC (31%) concentrations
in the striatum, lithium treatment had no significant effect
on the dopamine concentration in striatum.
2. The effect of chronic lithium treatment on striatal
tyrosine hydroxylase activity.
An experiment was carried out to investigate whether
the increased HVA and DOPAC concentrations found in lithium-
treated animals were associated with changes in tyrosine
hydroxylase activity. Rats were given lithium chloride
in the diet, for 1, 2 and 3 weeks. Plasma lithium concen¬
trations in these animals were in the range 0.5 - 1.0 mM.
Striatal tyrosine hydroxylase activity was measured in
lithium-treated animals and controls. The results (Table
13.) show no effect of lithium treatment on the enzyme
activity.
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Table 12. The effect of chronic lithium administration
on concentrations of horaovanillic acid (HVA),
3,4dihydroxyphenylacetic acid (DOPAC) and
dopamine in the striatum. Results are shown
from rats given lithium chloride in the diet
(60 mmol/kg food) for 3 weeks and control animals.
Values given are means - standard deviations with
number of animals in parentheses. Groups were
compared using a Students 't' test, *p<0.025,





















Table 13. The effect of chronic lithium administration on
striatal tyrosine hydroxylase activity. Results
are shown from rats given lithium chloride in
the diet (60 oimol/kg food) for 1, 2 and 3 weeks
and control animals. Enzyme activity is
expressed as nmol dopa formed/hr/g wet tissue.
Values given are means - standard deviation
with the number of animals in parentheses.
Tyrosine hydroxylase
Duration of lithium activity
treatment (weeks) (nmol dopa/hr/g)
controls 22.32 - 4.79
(3)
1ithium-treated 1 23.85 - 10.57
(6)
2 27.40 - 12.08
(4)




Tie concentrations of HVA and DOPAC in striata from
control rats are in the range of values reported by other
workers (Wilk et al., 1975; Roth et al., 1976; Korf,
Zieleman and Westernik, 1976) although the ratio of HVA:
DOPAC is greater than that previously reported (Pearson
and Tharnan, 1975; Wilk et al., 1975; Korf et al., 1976).
Chronic lithium chloride administration for 3 weeks caused
a significant increase in rat striatal IVA and SOPAC con-
Uw«{-
centrations while the dopamine concentration^romaincd un-
changed by lithium administration.
Changes in HVA and DOPAC concentrations could be caused
by interference with transport of the metabolites from the
brain, interference with release of neurotransmitter or
interference with neurotransmitter re-uptake. Administration
of probenecid has been shown to reduce transport of HVA from
the brain and this is reflected in increased striatal HVA
concentrations (Guldberg and Brock, 1971; Roffler-Tarlov
et al., 1971; Wilk et al., 1975). However, probenecid
administration was not accompanied by increased DOPAC con¬
centrations. Considering these findings, the increase in
both DOPAC and HVA in the present experiments suggests that
the effects of lithium are not due to interference with
transport processes for removal of dopamine metabolites
from the brain. Analysis of metabolite concentrations in
terras of release and re-uptake can be made assuming DOPAC
reflects intraneuronal metabolism and HVA extraneuronal
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metabolic;;. (Roffler-Tarlov et al.t 1971; 5 barman, 1973;
Roth et al., 1976). however such interpretation is
equivocable since the above hypothesis concerning the
compartmentation of dopamine metabolites has recentlj' teen
challenged on the evidence that a putative dopamine uptake
blocker, nomifensine, does not affect DOPAC metabolism in
the striatum (Korf et al., 1976). However, assuming LX3PAC
concentrations do reflect intraneuronal dopamine metabolism,
the increase in striatal DOFAC following lithium admin¬
istration suggests that lithium is not affecting dopamine
metabolite concentrations through an inhibition of dopamine
re-uptake. If the increased KVA and DOPAC concentrations
are not due to interference with re-uptake or transport
from the brain, then they must reflect increased release of
dopamine and increased biochemical activity of the striatal
dopaminergic neurons. Since the present evidence favours
the hypothesis that DOFAC reflects intraneuronal metabolism,
the most likely interpretation of the present results is
that lithium treatment causes an increased release of
dopamine from striatal nerve terminals. However such an
increase in release war not associated with a change in
steady-state dopamine concentration and this would suggest
that there was an increased turnover of dopamine in the
lithium-treated striata. It cannot be decided from the
resent evidence by what mechanism lithium treatment causes
increased dopamine turnover.
."ince lithium-treatment caused an increase in dopamine
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turnover and since both changes in dopamine turnover and
nerve activity are thought to "be associated with changes
in tyrosine hydroxylase activity (Roth, Walters, Murrin
and orgenroth, 1976) it was of interest to investigate
whether lithium treatment caused any change in striatal
tyrosine hydroxylase activity. However lithium treatment
for 1, 2 and 3 weeks was found to have no effect on tyrosine
hydroxylase activity in rat striatum. Since assay condit¬
ions were optimal for enzyme activity it is possible that
activation effects were missed. The results show that there
was no induction of enzyme associated with the increased
dopamine turnover.
The finding that lithium treatment increased dopamine turn¬
over is in conflict with previous reports. Lithium admin¬
istration by intraperitoneal injection for 14 days was
shown to reduce striatal dopamine synthesis (Friedman and
Oershon, 1973) and other studies have shown 2-3 weeks of
lithium treatment to reduce dopamine turnover and synthesis
in whole brain (Corrodi et al., 1369; Foitou and nohuon,
1975). However the picture is not entirely clear since
Corrodi et al., showed the effects of lithium treatment on
dopamine turnover to vary with the area of the brain studied.
'Furthermore other workers have failed to find any changes
in dopamine turnover following chronic lithium treatment
( To et al., 1970; Bliss and Ailion, 1970). Diet administration
of lithium has been reported to both have no effect and to
decrease dopamine turnover (Corrodi et al., 1969; bliss and
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.Ailion, 1:70). hi iilar discrepancy was found with intra¬
peritoneal administration (1 o et al. , 1970; iriea.aan and
Gershon, 1973; i:oitou and Bohuon, 1973). The differences
in various results reported cannot therefore t>e readily
explained by different modes of drug administration, iiie
present results also differ from previoxis reports of
striatal IiVA concentration following lithium administration
( ersson, 1970; Terez-Cruet et al. , 19-71). owever the
earlier studies involved acute and short-term (9 day)
lithium administration and this might explain the differ¬
ence between those results and the present ones. Whether
differences in the stress to which the animals were subject
could account for the variation in results is purely spec¬
ulative. The different effect of lithium treatment on
dopamine metabolism to that described by earlier workers
cannot be at present explained.
The object of the experiment examining the effects of
lithium on dopamine metabolism was to investigate whether
changes in amine metabolism and release occurred after t..e
sa e drip treatment, which caused the changes observed in
synaptic plasma membrane kg Ali ase activity. In conclusion
it can be said that 3 weeks of diet administration of
lithium both increased synaptic plasma membrane -ig AT.i ase
activity and affects dopamine metabolism. The mechanism
by which lithium affects dopamine metabolism is not clear
from the experiments but there is probably an increase in
dopaaine release and turnover in the striatum, i'urtner
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studies, perhaps using synaptosomal preparations, are
needed to test further whether this effect of lithium
on amine metabolism is due to it affecting the release of
neurotransmitter. The results although not showing a link
between the effects of lithium on Mg ATPase activity and
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AN INVESTIGATION OF ERYTHROCYTE MEMBRANE ATPase
ACTIVITIES IN DEPRESSIVE PATIENTS
AND THE EFFECTS OF LITHIUM TREATMENT ON SUCH ACTIVITIES.
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INTRODUCTION.
Erythrocytes provide material which is readily
available from human subjects and from which membrane
preparations can be made in order to measure enzyme
activities. Erythrocyte membranes can be prepared rel¬
atively easily, in large yield and without contamination
from subcellular organelles. In the present studies ATPase
activities were measured in membrane preparations derived
from erythrocytes of untreated and lithium-treated depress¬
ive patients in order to study ATPase activities in
depression and the effects of lithium treatment.
Two major kinds of membrane preparations have been
used over the past twenty years: the resealed ghost prepar¬
ation (Hoffman, Tosteson, Whittam, I960; Hoffman, 1962;
Bodeman and Passow, 1972) and the so-called erythrocyte
•»
membrane preparation (Hanahan, 1973). The term membranes
is used throughout this thesis to refer to the latter
type of preparation. The majority of membrane preparation
methods involve hypotonic haemolysis of the cells followed
by subsequent washing of the membranes in hypotonic
buffer and by using such methods membranes free from
haemoglobin can be prepared. In the experiments to be
described a method involving hypotonic haemolysis and
subsequent washing in 10 mil fris buffer (20 mosm, ideal
osmolarity) pH 7.4 was used (Dick, Dick and Tosteson, 1969).
Membrane preparations are artifacts of their own
preparation and must be regarded as only derivatives of
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the true erythrocyte membrane (hanallan, 1973). in three
illuminating studies it has been shown that the properties
of membrane preparations depend markedly on the conditions
used during preparation (hramley, Coleman and Pinean, 1971;
Kanahan and Ekholm, 1972; II anahan, Ekholm and mildenbrandt,
1973). As discussed by Hananan (1973) this causes diff¬
iculties in comparing results from meabrane preparations
derived under different conditions, membranes prepared by
Hypotonic naemolysis possess a limiting plasma membrane
and permeability properties which vary according to the
preparative conditions (^raaley et al. t 1971). .'leasure-
ment of ATPase activity in membrane preparations requires
ATP, sodium and calcium to be present at the inner siae
of the membrane (Y/hittam and Ager, 1962; Schatzmann and
Vincenzi, 1969; rramley et aL, 1971) and because of this
ATPase estimations are particularly susceptible to vari¬
ations in the permeability of membrane preparations
(Bramley et al., 1971; Hanahan et al.t 1973). Both intact
erythrocytes and membranes prepared by centrifuging a
hypotonic haemolysate v/ithout subsequent hypotonic wash¬
ing show no ATPase activity unless broken up by freezing
and thawing. Freeze-thaw treatment and sonication also
increase ATPase activity in some membrane preparations
exposed to several hypotonic washes. Such an increase in
activity is thought to be due to increased permeability
of the preparation to ATP or to activators (nramley et al.,
1971; Hanahan et al., 1973). Cyyptic activity of enzymes
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other than ATPases have also been reported (Duchan and
Collier, 1971). by suitable manipulation of the osmol-
arity and pi; of the haemolysing buffer it is possible to
control the ATPase activity of the final membrane prepar¬
ation (Bramle.y et al., 1971; Hanahan et al., 1973). Using
hyptonic bicarbonate buffers, nramley and colleagues were
able to show minimum retention of haemoglobin in membrane
preparations when 10 - 20 nosm buffer was used. Little
non-hae i protein was lost using buffers of 20 - 00 ;aosm
but below 20 laosm there was a marked increase in the loss
of protein. This was accompanied by a loss of acetyl¬
cholinesterase and Ca + mg ATiase activity, membranes
prepared at 80 mosm buffer had low ha/k and Ca + Mg
ATPase activity but it was increased by sonication or
Triton-X-100 treatment. In contrast membranes prepared
at 10 mosm buffer had high ATPase activities but these
were not increased by disruptive treatments. Experiments
using radioactively labelled AH showed membranes prepared
with 10 mosm buffer to have a high permeability. Lramley
et al., (1971) interpreted these results as showing a
variation in the permeability of the membranes depending
on preparative conditions together with fragmentation and
inactivation of enzymes when very low (<lOmosm) osmolarity
buffers were used. Panahan et al. , (1973) showed that
using Trie buffer, ph 7.4, 20 mosm as naemolysing buffer
the resulting membranes possessed no cryptic ATPase
activity and were therefore permeable to ATP. These
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workers also investigated the effects of the pH of the
haemolysing buffer and found that using a pH 5.6 buffer
resulted in a preparation with high haemoglobin retention
together with low ATIase activities which were increased
by freeze-thaw treatment. Acetylcholinesterase activity
was little affected by buffer pH (Hanahan et al., 1973) or
by buffer osmolarity between 20 and 80 mosm (bramley et al. ,
1971). Considering acetylcholinesterase is thought to Le
situated, on the outside of the erythrocyte membrane
(Juliano, 1973) this supports the hypothesis that the
differences in ATIase activity between membranes prepared
under different conditions are due to differences in
permeability properties, banahan et al., (1973) also
reported that the chemical nature of the buffer was
immaterial in determining the membrane preperties at a
given buffer pM and osmolarity.
It is well established that the Na/K ATTase activity
present in the erythrocyte membrane is associated with
active transport of sodium and potassium (Dunham and Glynn,
1961; Skou, 1965; Whittarn and Wheeler, 1370). In addition
to this ATTase activity deperdaht on hg, stimulated by
sodium and potassium and sensitive to ouabain Dunham and
Glynn (1961) also detected an activity dependant on
magnesium only and which was insensitive to ouabain. In
addition they found calcium to cause a stimulation of t:.e
ouabain-insensitive activity. Ouch magnesium dependant
( .. ATIase) and calcium stimulated magnesium dependant
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activities (Ca + hg A.TPase) were also reported by Wins
and Schoffeniels (1966). As pointed out by Wins and
Schoffeniels the physiological function of the Mg ATl'ase
is unknown. It could possibly reflect adenyl cyclase
activity since adenyl cyclase produces pyrophosphate
which might be detected in the analysis of inorganic
phosphate. Adenyl cyclase has been reported present in
the human erythrocyte membrane (Sheppard and hurghardt,
1968; loose, R. , unpublished observations) tn.it the
activity is very low.
Nakao et al., (Nakao, Nagano, Adachi and Nakao, 1963)
were able, by potassium iodide fractionation, to obtain
two preparations from erythrocyte membranes. One possessed
Ra/K ATPase activity which was sensitive to ouabain and
the other contained an ouabain-insensitive Mg ATPase
which was not stimulated by sodium or potassium. These
workers suggested therefore that the Ra/K ATPase and Mg
ATI'ase were separate enzymes. howler and Duncan (1969)
studying the heat sensitivity of ATPases in crayfish
muscle membranes also concluded that Ra/K ATPase and Mg
ATPare v/ere separate enzymes. Recently, Drickamer (1979)
studied ATPases by studying erythrocyte membrane protein
phosphorylation in the presence of magnesium alone,
calcium and magnesium and finally sodium, potassium and
magnesium. Using gel electrophoresis he was able to
separate three different phosphorylated proteins corres¬
ponding to the different ionic conditions, he concluded
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that the three Aliases were distinct enzymes. The avail¬
able evidence suggests therefore that the hg ATPase and
a/ : ATFase are distinct enzymes.
The function of the calcium stimulated ATIase (Ga
ATPase) and Ca + Ig Aliase has been a subject of contro¬
versy and confusion. ' ins and Schoffeniels (1566)
suggested they flight be associated with actomyosin-like
protein in erythrocyte membranes (Ohnishi, 1962). In
contrast Ca ATiase has also been suggested to be involved
in the active transport of calcium out of the erythrocyte
(Schatzmann and Vincenzi, 1969). ATI lias been shown to
i
be necessary for active transport of calcium from the
erythrocyte (Schatzmann, 1966; Schatzmann and Vincenzi,
1969). In addition erythrocyte ghost ATPase activity
has been shown to be stimulated by internal, but not
external, calcium (Schatzmann and Vincenzi, 1969) ana
more recently Schatzmann (1973) has shown that the
intracellular calcium concentration for half .maximal
ftimulatlon of calcium transport to be in close agree¬
ment with the value of the dissociation constant for Ca
find the Ca ATPase. The situation was complicated however
by the finding of two Ca ATPase activities in erythrocyte
e nbranes - a high affinity and low affinity activity
(,' c" atznann and Rossi, 1371). These workers also pointed
out that the low affinity activity alone or the total
activity, but not the high affinity activity alone, could
account for active calciu,.. transport. Wolf (1972) and
- 156 -
Schatzmann (1973) failed to repeat the finding of two
separate activities and Schatzmann was of the opinion
that the occurrence of two activities was an artifact
due to exposure of the membranes to EDTA. Recently,
however, Quist and Roufougalis (1975) have found two
separate activities in membrane preparations some ox
which were exposed to EDTA and some not. Furthermore
these workers showed that on exposing the erythrocyte
membranes to low ionic strength the high affinity Ca
ATPase (or an activator) was lost from the membrane
whereas the low affinity was not. Other studies of the
relationship between calcium transport and Ca ATI ase have
used inhibitory substances such as lanthanum chloride and
ruthenium red. Using inside-out vesicular erythrocyte
/ \ "+"4* "f*
membranes Weiner and Lee (1969) showed 0.1 mM La to
completely inhibit both active transport of calcium into
the vesicles and Ca ATT'ase activity while having no effect
on the Mg ATPase or Na/K. ATPase activity. Ruthenium red
was found to specifically inhibit the Ca ATPase (Watson,
Yincenzi and Davis, 1971). Subsequent work using La+++
and ruthenium red has not been conclusive as to whether
all or part of the Ca ATPase activity is involved in
transport but this may be due to the problem of imperme¬
ability of some of the ghost preparations used (Quiet
and Roufougalis, 1973; 1975a; 1975b). In conclusion
there is considerable experimental evidence to support
the hypothesis that at least part of the Ca ATIase
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activity in the erythrocyte membrane is associated with
the active transport of calcium.
There is however the possiblity of a second Ca ATPase
enzyme. There is also evidence supporting the hypothesis
that part of the Ca ATPase activity is due to a contract¬
ile protein. Exposure of erythrocyte membranes to low
ionic strength causes a loss of protein from the membrane
(some 25'/ of total membrane protein). The major components
lost are two polypeptides called spectrin (Pare esi,
Steers, "archesi and Tillack, 1570; Juliano, 1573). In
addition such extraction procedures also cause a loss in
Ca ATPase activity from the membrane and this mas been
associated with fibrillar material (Rosenthal, Pregenow
and Moses, 1970; Avissar, be Vries, Ben-Shaul and Cohen,
1975). Ouch activity could be the high affinity Ca -'Prase
which Quist and Koufougalis (1975a) found was lost from
erythrocyte embraces on exposure to low ionic strength.
The relationship between spectrin and actomyosin-like
proteins extracted from erythrocyte membranes (Ohnishi,
1962) is uncertain but recent work has suggested actin-
like protein to be present in low ionic strength extracts
but to be a minor band separate from spectrin (filtney
and Betmere, 1975). These workers were able to show
the characteristically decorated arrow head for '.ation of
actin in the presence of heavy neromyosin. Spectrin
filaments were also seen but were not decorated or of
double helical structure. t.er workers studied erythrocyte
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membrane phosphorylation and showed that on exposure to
low strength solutions the membranes showed a decrease in
Ga + hg dependant phosphorylation in the proteins running
in the spectrin region on gel electrophoresis, (Weiderrnann
and Brdczka, 1975). They also showed Ga ATPase activity
to be present in a small fraction (10/ ) of spectrin and
they suggested Ca ATPase was not associated with spectrin.
Guidotti (1972) has reported low ionic strength exposure
to remove a myosin-like protein from erythrocyte membranes.
Despite the confusion evident from these studies, it
can be concluded that erythrocyte membranes probably
contain actin-like and myosin-like proteins which possess
Ca + Mg ATPase activity. The interaction of actin and
myosin in the intact membrane could possibly be respons¬
ible for My ATPase activity since extracted fibrillar
material possesses kg ATPase activity in the presence of
rabbit muscle actin (Avisser et al., 1975) and interaction
of muscle actin and myosin is known to give rise to Ig
ATPase activity (Bendall, 1969).
Results presented in section III showed chronic
lithium administration to rats to increase synaptic
plasma membrane Mg ATPase specific activity. In order to
investigate whether lithium administration to humane had
a similar effect on membrane Ig ATPase, Rg ATPase activity
wras studied in erythrocyte membranes prepared from
psychiatric patients receiving lithium treatment.
Previous wor-' has implicated Ra/h ATI ase activity and
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sodium transport in erythrocytes as alterin,, during the
course of depressive illness. Naylor et al., (1973)
studied Na/K ATPase in erythrocyte membranes from patients
suffering from depressive illness and showed a correlation
between amelioration of mood and increased Na/K ATPase
activity. Hokin-Neaverson et al. (1974) showed bipolar
manic depressives to have a lower ouabain-sensitive sodium
efflux from erythrocytes than control subjects. In view
of the implication of the Na/K ATPase with active sodium
transport (Whittam and '-"heeler, 1970) and in view of
Naylor's finding that araelioration of mood is correlated
with Na/K ATPase one would expect a decreased specific
activity of Na/K ATPase in erythrocyte membranes prepared
from depressive patients. This was investigated in the
present study. Experiments were also designed to examine
the effect of lithium treatment on Na/K ATPase activity
and to try and elucidate whether the reported effect of
lithium treatment on Na/K ATPase (Dick et al., 1974) was
due to an effect of the drug or a secondary effect due to
a change in the state of the patient.
lid » (1974) reported a correlation between
mood and erythrocyte membrane Na/K ATPase activity in a
single patient. Since the mature human erythrocyte carries
out no protein synthesis (Harris and Kellernever, 1970)
such a correlation must reflect in vivo activation of the
enzymes. In view of the extensive washing of the membranes
this war thought to be unlikely. Experiments were carried
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out to study ATPace activities in me libraries prepared, from
three control individuals over a period of time in order
to study the extent of variation and to investigate if
this could he accounted for methodologically. In addition,
experiments were carried out to investigate whether the
effects of lithium on erythrocyte lipases were dependant
on the production of new cells. In an attempt to relate
changes in ATPase activities caused by lithium treatment
to possible changes in ion distribution the effect of
lithium treatment on plasma and erythrocyte sodium,
potassium and magnesium concentrations was studied.
Calcium ions have heen implicated in many cellular
processes (Outhbert, 1970) and it was therefore of inter¬
est to study Ca ATFase in. the present experiments since
this may reflect the activity of the calcium pump.
The data, relating to human material, to be described
in this section, is derived from studies of ha/h, hg and
Ca ATPases in erythrocyte membranes from untreated depress¬
ive patients and both long and short term lithium treated
patients. The ion distribution data is derived from a
random selection of these same patients.
In order to connect the human erythrocyte membrane
worh with the effects of lithium treat-lent on rat synaptic
membranes an additional series of animal experiments were
performed in which the effects of chronic lithium treat¬
ment on rot erythrocyte mm brcre • u t :a and
erythrocyte ion distribution were studied.
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'ost chemicale used were Analar grade from Iritish
Drug Houses, Ltd., Poole, and may be assumed to be so
unless stated otherwise. Tris was purchased from Sigma
Chemical Co., Ltd. Animals and the administration of
lithium to them in the diet was as described in Section
III.
1. I reparation of human ery throcyte membranes.
The method of preparation used in the present series
of experiments was that of Lick et al. , (1969) with, certain
slight modifications. A diagram outlining the method is
shown in Figure 20. Elood (10 - 20 ml) was collected by
venipuncture and placed in sodium heparin tubes. After
centrifugal,ion at 1000 r for 4 minutes the plasma was
discarded and the cell pellet then washed three times in
ice-cold isotonic sodium chloride (156eM) buffered with
r rah Tris, pH 7.4. hashing was by repeated centrifugations
at 1000 ; for 4 minutes at room temperature. After one
or two washes the buffy coat was removed by aspiration
and discarded. The washed cell pellet was resuspended in
the cell wash solution to an approximate 40:'; haematocrit.
fn aliquot of the cell suspension was taken for accurate
determination of the haeraatocrit and a known volume of
the remainder haemolysed by addition of 10 mm Tris buffer,
pH 7.4 (34 ml buffer:6 ml cell suspension) and vortexed
briefly. The haemolyrate was left at 0°C for 10 - lr
minutes and then cehtrifuged at 28,000 g for 103 minutes
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PREPARATION OF HUMAN ERYTHROCYTE MEMBRANES
10-20 ml. fresh blood in sodium heparin tube
centrifuge 1000g/4 min. Room temperature
plasma erythrocyte pellet. Resuspend in 6-10 ml. cell wash*
and Centrifuge 1000g/4 min. to wash cells
Repeat 3 times and remove buffy coat.
erythrocyte pellet. Resuspend in ceil wash to give a 40% (approx.)
haematocrit. Haemolyse cells in lOmM Tris buffer - 6 mi. cell
suspension to 34 ml Tris buffer.
Leave at 0°-4°C for 10-15 min. Then centrifuge 28,000g/105 min.
at 9°-10°C. All subsequent operations at 9°-10°C.
I
Supernatant
* cellwash is 156mM NaCl+5mM
Tris buffer pH 7.4
Membrane pellet
Resuspend in lOmM




Repeat previous re suspension and centrifugal ion




A diagram illustrating the method used
of human erythrocyte membranes.
for
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using a Eeckman I.2-G5' ultracentrifuge with a swing-out
rotor. The speed of this and subsequent centrifugations
was increased from that originally used by Hick et al. in
order to achieve adequate pelleting of the membranes. in
order to obtain reproducible preparations it was also
necessary for all the post-lysis centrifugations to be
carried out between 9 and 10°C. Centrifugation at
28,000 g for 105 minutes produced a red membrane pellet.
The membranes were then washed three times by resuspension
in 10 mM Tris buffer and centrifugation at 28,000 g for
1 hour. At the end of the final centrifugation there was
a layer of fluffy, white or faintly pinkish membranes at
the bottom of the tube together with a pellet of cell
debris and haemoglobin. The membranes were dispersed by
brief vortexing and decanted into a fresh tube for storage.
The pellet of debris remained in the centrifuge tube and
it was then washed once in 10 mil Tris buffer by vortexing
and the wash added to the membranes. 10 ami Tris buffer
was added to the membranes to give a final volume equal to
the original volume of cell suspension and the membranes
were well mixed and left overnight at 4°C before assaying
for ATFase activity.
The above method produced adequate membrane prepar¬
ations which possessed ATPase activity but the pelleting
of the membranes was poor. Use of an angle-head rotor
(together with anMSE Superspeed 63 ultracentrifuge) for
all post-lysis centrifugations gave much improved pelleting
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and a much higher yield of membranes in terms of protein
but the specific activity of the ATPases in the membranes
was essentially unchanged (Table 14.). The fact that
increased yield is accompanied by no changes in specific
activity of the various ATPases indicates that the sus¬
pensions of membranes during preparation are homogenous
and therefore the efficiency of pelleting of the membranes
should not be critical in determining the ATPase activities
of the final membrane pellet. The Beckman ultracentrifuge
together with the swing-out rotor was used throughout
this study on account of it allowing a faster preparation
time.
Using the Beckman ultracentrifuge, membranes prepared
from a single sample of blood were reprodueable in their
ATPase activities as judged by enzyme activity in five
preparations made from a single sample of cell haemolysate
(Table 15.). The preparative procedure outlined above
seems therefore to give reproducible membrane preparations
from a given cell haemolysate.
2. Preparation of rat erythrocyte membranes.
Animals were anaesthetised with nembutal (70 rng/kg)
and the chest opened. 5 ml blood was removed by cardiac
puncture and placed in a sodium heparin tube. Blood from
two animals was pooled for each membrane preparation.
Membrane preparation was as described above for human
material except that an angle rotor was used together with
an USE Superspeed 65 ultracentrifuge.
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Table 14. Characteristics of human erythrocyte membrane
prepared using swing-out and angle-head rotors.
Membranes were prepared from a single haemolysate
using either a swing-out rotor (with Beckman
L2-65B ultracentrifuge) or an angle-head rotor
(with M.S.E. 65 Superspeed ultracentrifuge) for
all post-lysis centrifugations. ATPase specific
activities are expressed as nmol P./^r/mg protein.
Protein yield is expressed as mg protein/litre
cells. Values given are means - standard
deviations froin three preparations in each case..
Swing-out rotor, Angle-head rotor,
Beckman L2-65B MSE Superspeed 65
ultracentrifuge centrifuge
Na/K ATPase activity 113 - 7 132 i 23
Mg ATPase activity 303 - 19 303 - 24
Ca + Mg ATPase activity 767 - 40 688 i 84
Protein yield 3.17- 0.08 +1i—it<-\• 0. 46
- 166 -
Table 15. The reproducibility of erythrocyte membrane
ATPase specific activity in membranes prepared
from a single haemolysate. A single haeraolysate
was divided into 5 aliquots and 5 separate
membrane preparations produced (using swing-
out rotor). The mean ATPase specific activities
- standard deviations for these five preparations
are shown below. Activities are expressed as
nrnol P./hr/mg protein.
1
a/K ATi-'ase Ig ATPase Ca + >lg ATPase
activity activity activity
245 - 11 240 - 23 730 - 91
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3. Estimation of ATPase activity.
Incubation conditions.
ATPase activity was assayed by measuring the inor¬
ganic phosphate produced during incubation of the membrane
preparation with 3 mil disodium-ATi (from B.B.H. , Poole or
Eoehringer Ltd.). Incubation was for 30 minutes at 37-5°C.
The incubation conditions were based on those of Kurokawa,
et al., (1965), '• anting and Carava. , io (1963) and bins and
Schoffeniels (1966). For the estimation of i a/K ATI-ase
and 'g ATPase activities the incubation conditions were
as described in Section III, with water being used to make
up the volume of the Eg ATlase incubation medium. ATI ase
activity in the presence of Ca++ was estimated using an
assay medium containing 0.15 nE CaClc in addition to LITA,
Tris and i-igCl^ in the same concentrations as was used for
the assay of Eg ATPase activities. Reaction and enzyme
blanks were run with all assays and inorganic phosphate
liberated estimated by comparison with standard phosphate
solutions. All estimations were done in triplicate.
Enzyme activity was measured under three different
sets of ionic conditions: in the presence of magnesium as
the sole cation, in the presence of calcium and magnesium
and in the presence of sodium, potassium and magnesium.
The activity in the presence of magneshim alone was defined
as the ++dependant ATPase activity and this was insens¬
itive to the presence of ouabain. Tne difference between
activity in the presence of sodium, potassium and magnesium
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and activity in the presence of magnesium alone was
defined as the ! a/K stimulated Hg++ dependant Alb ase activ¬
ity7 and this was completely abolished by ouabain. The
activity in the presence of both calcium and magnesium
•f + 4"f
was defined as the Ca + Hg dependant ATPase activity
(Ca + ;• g ATPase) and the difference between that and the
Ag++ dependant activity was defined as the Ca++ stimulated
•f + f
dependant activity (to be hereafter referred to as
the Ca stimulated or Ca ATPase activity). During the
routine estimation of ATPases all activities were defined
in terms of differential cation activation without the use
of ouabain.
b. Estimation of inorganic phosphate.
Initially, during the development of the preparation
and assay of erythrocyte membranes, inorganic phosphate
produced during incubation with ATI was determined by the
method of hartin and Doty as described by Lindberg and
Ernster (1956). This method involves precipitation of
protein with trichloroacetic acid, reaction of the phosphate
to form a phosphomolybdate complex and then extraction of
the complex into an isobutanol-benzene mixture. An aliquot
of the complex-containiru or( anic layer is then reduced
with stannous chloride and the resulting blue colour meas¬
ured spectrophotometrically. Although this method had
proved adequate in the determination of ATPase activities
in subcellular fractions of brain it was found not to
be satisfactory for AT'J'ase assays involving erythrocyte
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membranes on account of the large variability between
replicate samples and general lack of reproducibility.
Moaersky and his colleagues (..ozersky, Pettinati
and Kolman, 1966) reported the Martin and Doty method to
have low reproducibility and low sensitivity. They pointed
out three problems associated with the method: the reduct¬
ion of the phosphomolybdate complex was not reproducible,
silicotungstic acid caused interference and the presence
of protein reduced the recovery of phosphate. In contrast
Martin and Doty (1949) added silicotungstic acid in order
to prevent protein chelating phosphate and so preventing
its reaction with molybdate. In view of these previous
studies it was possible that the poor reproducibility oi
the Martin and Doty method in the present experiments was
due to protein interference. Therefore an experiment was
carried out to investigate the effects of albumin and
silicotun^itic acid (prepared as described by Martin and
Doty, 1949) on the estimation of phosphate in a standard
KII^PO^ solution. The results are shown in Table 16. and
they show that neither the presence of protein in an amount
comparable to that in ATPase assay samples nor the use of
silicotungstic acid affected the reproducibility of the
estimation of phosphate. This suggests that protein
interference is an unlikely explanation of the poor
reproducibility of the method for phosphate esti.aation.
In the presence of albumin, addition of silicotungstic
acid increased the absorbance obtained with a iven
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Table 16. The effects of albumin and silicotungstic acid
on the estimation of inorganic phosphate by the
method of Martin and Doty. A standard phosphate
solution (KH^PO^) was assayed by the method of
Martin and Doty as described by Lindberg and
Ernster (1956), (a) in the presence and absence
of bovine serum albumin (0.1 mg/ml) and (b) in
the presence of albumin and silicotungstic acid
(1 ml, prepared as described by martin and Doty,
1949). Results are shown as absorbance readings
(standard units). Values are means - standard
deviations with the number of estimations in
parentheses. Groups were compared using a
Students 't' test, *p u.005 between groups
with and without silicotungstic acid.
Absorbance
control 0.166 - 0.007
(no albumin, (12)
no silicotungstic acid)
Albumin added 0.161 - 0.006*
(12)




phosphate standard and this may he due to the prevention
of occlusion of phosphate hy silicotungstic acid. The
effect, although statistically significant (p 0.005) is
only small (6,8% increase in mean value).
ATPase activities in erythrocyte membranes are low
compared to other tissues (Bonting and Caravaggio, 1963).
This low activity exascerbates the poor reproducibility
in the analysis method since it is necessary to attempt
to measure a small difference in absorbance between the
reaction blank and the sample with enzyme present. Thus
a standard deviation of 3 - 6/> in the measured absorbance
produced a 15 - 301' standard deviation in enzyme activity.
An alternative approach to the problem of reproducibility
was therefore to use a more sensitive method for the
analysis of inorganic phosphate rather than attempting to
improve the Martin and Doty method, nozersky et al. (1966)
reported that estimation of phosphate by measurement of
the absorbance of the unreduced, yellow phosphomolybdate
complex after extraction into isobutanol-benzene gave in<-
creased sensitivity compared to the conventional .iartin
and Doty method. Similar methods, also measuring the
formation of the unreduced phosphomolybdate compLex but
using different solvents for extraction, have been
devised (tabler and V.ollenberger, 1958; -aylor et al.,
1973) and one of these together with the method of
Lecocq and Inesi (1966) were investigated as possible
alternative methods of phosphate analysis.
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The method described by Lecocq and inesi involve::
formation of a phosphomolybdovanadate comples which is
estimated spectrophotometrically by its absorbance at
350 or 400 run. The absorption spectrum of the complex
was studied by reacting a standard phosphate solution
with the necessary reagents as described by iecocq and
Inesi (1966) and the results are snown in figure 21.
The spectrum shows a broad peak at 350 rim but at 4u0 nm
the absorbance changes rapidly with wavelength. Therefore
only the absorbance at 350 nm is suitable for spectro¬
photometry analysis. As shown in figure 22 estimation
of a standard phosphate solution by measurement of the
absorbance of the phosphomolybdovanadate complex at 350 nm
gave a doubling of sensitivity compared to the method due
to artin and Doty. however use of £towards method of
phosphate analysis (described by Naylor et al., 1973)
gave a ten-fold increase in sensitivity as shown in figure
22. This method involves extraction of the phosphomolyb-
date complex into ethyl acetate and measurement of the
absorbance at 310 nm. In principle it is comparable to
the methods of iozersky et al. (1966) and Wahler and
Wollenberger (1956). The latter used extraction into iso-
_Q
propyl acetate and were able to detect 10 mol of phosphate.
As shown in Figure 21 the absorption of the phosphomoly!-
date complex in ethyl acetate has a broad peak around
310 nm making the method perfectly adequate for spectro¬
photometry analysis. The spectrum of the phosp iomolybdate
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WAVELENGTH (NM)
Figure 21. Absorption spectra of derivatives used in the
estimation of inorganic phosphate. A standard phosphate
solution (KH^PO^) was reacted (a) as per the method of
Stoward as described by Naylor et al. (1973), (b) as per
the method of Martin and Doty as described by lindberg and
Ernster (1956) and (c) as per the method of Lecocq and Inesi
(1966). Spectra shown are for the ethyl acetate extract used
in the method of Stoward (A), the isobutanol-benzene extract
obtained by the method of Martin and Doty and used by
Mozersky et al. (1966) (B) and the reaction mixture obtained
using the procedure of lecocq and Inesi (1966) (C).
Absorbance is given in arbitary units.
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ABSORBANCE
Figure 22. Sensitivity of different methods for estimation
of inorganic phosphate. Standard curves are shown for
estimation of phosphate in a solution of KH^PO^ by (a) the
method of Stoward as described by Naylor et al. (1973),-X-,
(b) the method of Martin and Doty as described by Lindberg
and Ernster (1956), -o-, and (c) the method of lecocq and
Inesi (1966) using absorbance at 350 nm as the measure of
phosphate, Absorbance is given in standard absorbance
units. Values are means of three estimations.
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co-nplex in isobutanol-benzene also shows a :eak at 31 - -\r.
(Figure 21) and is comparable to the spectrum of the
complex extracted into ethyl acetate. The high sensitiv¬
ity in the method of Stoward .may be due to the omission
of the reduction reaction used by martin and Doty and tie
choice of solvent for extraction.
In view of the high sensitivity of Stowards nethod it
was subsequently used for all inorganic phosphate estim¬
ations. The estimation was not affected by the ionic
constituents of the incubation medium and using the method
for ATPase estim. tions ATPase activity was shown to be
linear with respect to time (over 1 hour) and amount of
membrane material added (0.02 - 0.16 mg protein). The
only problem encountered was that occasionally a batch
of ATP could not be used on account of a high blank value.
The details of the method of phosphate analysis are
given below:
Reasents:
Perchloric acid-tungstosilicic acid reagent (PATSA):
48.5 - 50 ml perchloric acid (Analar, 72k) was added to
300 ml water, 40 g dodecatungstosilicic acid (Analar, from
B.D.H., ) added, dissolved and the solution made up to
500 ml.
klolybdate reagent:
14.5 g sodium molybdate dihydrate and 131.3 ' sodium
chloride were dissolved in 1 litre of water.
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Standard phosphate solution:
4 63.6 :ng H2P04/10G al. This was diluted by between 1/60
and 1/600 and 2.6 ml taken for analysis. This gave
standards of between 16.6 and 166 nrnol.
Iroced are:
The ATIase reaction was stopped by placing the tubes
in ice and the tubes left in ice for 6 - 10 minutes, iia.ch
tube was subsequently reacted in turn. 0.5 ml PA 'ISA and
then 1.5 ml raolybdate reagent were added and the sample
vortexed briefly. 4 ml etftyl acetate was added, the mixture
vortexed for 30 seconds and the tubes then returned to ice.
After separation of the two layers, a 1 ml aliquot of the
upper organic layer was placed in a clean tube. whilst
sampling the upper layer care was taken not to disturb
the precipitate of protein at the interface between the
layers otherwise the aliquots of the organic layer became
turbid and it was not possible to measure the optical
density accurately. The absorbance at 310 nrn was measured
in the aliquots of the upper layer and the amount of phos¬
phate in the original samples calculated by comparison of
the optical densities with those from standard phosphate
solutions. Standards were run with each assay,
c.byresslon of results.
■lost ATPase activities are given as specific activities
in terms of nanomoles of inorganic phosphate liberated per
hour per milligram of protein (nmol ih/hr/mg protein),
aemstocrits of each; cell suspension were measured prior
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to haemolysis so that results could also be expressed as
nmol 1,/hr/litre of original cells if required.
Protein was measured by the method of Lowry et al.,
(1951) as given in Appendix 2. Haematocrits were measured
using an ESS microhaematocrit centrifuge. Samples were
centrifuged at 16,000 g for 5 minutes.
4. Estimation of haemoglobin.
Haemoglobin was estimated in a certain number of
preparations. The method of analysis used was that
described by roderaann and Passow (1972).
Samples, standards (bovine haemoglobin, Sigma Chem¬
ical Go.) and blanks were diluted 1+4 with glacial
acetic acid and left at room temperature for 19 minutes.
The absorbance of the solutions was then measured at 400 nm.
5. Standard ATiase.
In certain experiments a standard ATiase preparation
was assayed in addition to the membrane preparations. A
brain microsomal Na/K ATiase preparation (Sigma Chemical
Co.) was used. The purchased preparation was dissolved
in water and aliquots placed in separate tubes. The sol¬
utions were then freeze-dried overnight and stored at
-20°C. Hnen required, tubes were thawed and incubation
medium added.
6. Estimation of lithium in membrane preparations.
Attempts were made to estimate the concentrations of
lithium in membranes prepared from people receiving lithium
treatment. Such preparations were stored at -20 C until
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analysed.
Lithium was estimated by atomic absorption spectro¬
photometry using both flame and flameless techniques.
Lerkin-Elmer 360 atomic absorptiometer was used throughout,
together with a HGA-74 heated graphite furnace for the
flameless technique. For estimation by standard flame
methods the nerabranes were not diluted and they were com¬
pared to standards of lithium chloride in deionized
distilled water. The method of analysis using the graphite
furnace was that described in section ill. 30 ^ul of mem¬
brane suspension v/as injected into the furnace and com¬
pared with 30 ^ul aliquots of standards. Standards consisted
of membrane preparations from people not receiving lithium
treatment with known amounts of lithium chloride (Laker
Chemical Co. Ltd.) added.
'-easurement of • las..,a and intracellular erythrocyte xon
concentrations.
The procedure adopted for separation of plasma and
subsequent washing of the cell pellet followed methods
used by Smith and Samuel (1970) and Glen and uellinger
(1973).
measurement of ion concentrations in erythrocytes
separated from plasma, but not washed ,is subject to error
due to plasma contamination (Leilin, Knight, Munro-Paure
and Anderson, 1966). Cuch error is particularly evident
in the case of sodium because the erythrocyte contains
11 til - ' -■ ~ - ' 1 " en' : tion.
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I-lasma contamination of erythrocytes separated by cenxri-
fugation has been termed 'trapped plasma'. The problem
of trapped plasma may be overcome either by estimating
the plasma contamination or by washing the cells in suit¬
able ion-free solutions (Beilin et al., 1966).
Glen and Bellinger (1973) used ^Cr-EDTA in order to
measure the extent of plasma trapping. Isotope was added
to whole blood and the plasma and erythrocytes separated
31
and ' Cr estimated in both. The contamination of the
51
erythrocytes with plasma as judged by the amount of ' Cr
in the erythrocyte pellet was less than 17'. however in
51
the present work Cr-EDTA was found unsatisfactory for
the estimation of trapped plasma for two reasons, firstly
sodium content of erythrocytes was more consistent when
uncorrected. Secondly in some cases the sodium content
corrected for trapped plasma (beilin et al., 1966} had a
negative value. Similar problems have been found previously
(Loose, R., personal communication). The negative sodium
content found when using trapped plasma corrections
51
suggested that tnere was some binding of ' Cr to erythro¬
cytes. This was investigated in two ways.
51
firstly the Cr content of rat erythrocytes was
studied as a function of the number of washes in isotonic
choline chloride to which the erythrocytes had been exposed.
1 g samples of erythrocyte pellets v/ere counted using a
Gamma , uard y-ray spectrometer set specifically for "~Cr.
*1
All sa piles were counted for 20 minutes. ' Cr-..- ITA (from
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the Radiochemical Centre, Amersham) was added to pooled
rat blood so as to give approximately 2 uCi/ml blood.
After mixing, aliquots were washed in isosmotic (260 mosm)
choline chloride by mixing and centrifugation as described
below. As shown in Figure 23 it was not possible to
51
remove all the ' Cr from the erythrocytes suggesting some
binding did occur. The curve shown in the figure also
suggests that two washes is sufficient to remove all the
51
Cr present due to plasma contamination of the erythrocyte
pellet.
A second experiment was performed in which aliquots
of rat erythrocytes (separated from plasma but not washed)
were suspended in a solution of isosmotic choline chloride
containing approximately 5 JuCi/ml of ^Cr-KDTA and then
51
separated by centrifugation as described below. Cr war
estimated in 1 ml aliquots of suspension fluid before
erythrocytes were added and after they had been removed
by centrifugation. The results (Table 17.) show a 1.1,
tr "i
reduction (p<0.025) in the Cr concentration of the sus¬
pension fluid after contact with erythrocytes. This
51
suggests rat erythrocytes bind isotopic chromium. Cr,
as free chromium ions, is used to ta, erythrocytes (harris
and Kellermayer, 1370) and it is possible that free Cr
in the isotope preparation used could account for the
51 51
apparent binding of ' Cr-KDTA to erythrocytes. The ' Cr-
EDTA preparation is only 99, complexed when prepared (The
Radiochemical Centre, personal communication) and this
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51 _•»
Cr content (c.p.m./q x IO )
8
—i 1 r 1 1 1 i 1 i
2 4 6 8 10
No.otvoshes
51
Figure 23. Cr content of rat erythrocytes as a function
51
of number of washes in 260 mosm choline chloride. Cr-EDTA
was added to rat blood (2 ^juCi/ml blood) and the erythrocytes
separated by centrifugation to 16,000 g. Erythrocytes were
subsequently washed in 260 mosra choline chloride as described
in the text. Aliquots of erythrocytes were taken for estim-
51 51
ation of Cr. The figure shows Cr content of erythrocytes
(expressed as C.P.M./kg erythrocytes, all counts corrected
for background) after various numbers of washes. Results
are from a single experiment.
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Table 17. Concentration of "'"L Cr-EDTA in 260 mosm choline
chloride before and after contact with rat
erythrocytes. Cr-EDTA (5 yaCi/ml) was added
to 260 mosm choline chloride and 1 ml aliquots
51
taken for Cr estimation. Rat erythrocytes
were added to the remaining solution (1 ml
erythrocytes/4 ml choline chloride), mixed and
erythrocytes removed immediately by centrifug¬
al ion (the solutions were brought momentarily
up to 16,000 g). 1 ml aliquots of the choline
51
chloride solution were taken for " Cr estimation.
51
Results show the Cr concentration in the
choline chloride as C.P.M./ml (corrected for
"f*
background). Values are means - standard
deviations with number of estimations in
parentheses. Groups were compared using a




Original choline 16625 -^206
chloride solution (5)
Choline chloride after 15344 - 610
contact with rat (5)
erythrocytes
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could er. a : Is reduced during l torage. The results of
51
taese experiments su, rest the Cr-LDTA preparation used
by Glen and Bellinger (1973) is not satisfactory for
estimation of trapped plasma in the case of the rat and
they put doubt on its value for use with human material.
Further experiments studied the effect of successive
washing of rat erythrocytes on their sodium content
(Figure 24). hashing of erythrocytes and estimation of
sodium was as described below. The results show two or
three washes to cause a drastic reduction in sodium content
51
concomittant with the reduction in Cr labelling (Figure
23). This reduction in sodium content probably represents
the removal of plasma contamination. The small, steady
loss of sodium with subsequent successive washes is prob¬
ably due to leakage of sodium from the erythrocytes.
eau e and Ortis (1971) showed sodium to leal-: out from
rat erythrocytes suspended in sodium-free solution. If
leakage is the correct explanation of this slow loss of
sodium, extrapolation of the sodium content back to 'zero
wash* (see Figure 24) should allow estimation of the true
intracellular sodium concentration of the rat erythrocyte.
This was found to have a value of 2.7 mraol/kg wet cells
which compares well with the value of 4.4 mil reported by
eau'e and Ortis (1971). It is evident from these results
that three washes in sodiu:n-free solution is sufficient to
reduce trapped plasma to negligable proportions. Beilin




""I I I I I I I-
2 4 6 8
No. of washes
Figure 24. Sodium concentration in rat erythrocytes after
washes in 260 mosm choline chloride. Rat erythrocytes
were washed and sodium estimated in them as described in
the text. The figure shows mean values from three
experiments and these experimental values are described
by the solid curve shown. Extrapolation of the sodium
concentration to 'zero-wash' is also shown ( ).
Sodium ccrcentration(rnmd./kg)
20
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centrifugal force (approximately 20,000 g) reduced trapped
plasma to a small constant value and secondly that the
washing of erythrocytes did away with the need for estim¬
ating trapped plasma. In the present experiments which
used a centrifugal force of 16,000 g and three washes of
erythrocytes it was not necessary tnerefore to routinely
estimate trapped plasma.
The procedure for preparation of plasma and of cell
haemolysate was as follows: g - 10 ml fresh blood.was
placed in a heparinised tube (approximately 200 units
mucous heparin) and centrifuged by bringing momentarily
up to 16,000 g. This and all subsequent centrifugatioris
were done at 10°C using an MSB Mistral 2L centrifuge
fitted wit; a high speed angle-head. After aspirating off
the plasma, the cell pellet was resuspended in 263 nosia
sucrose (human material) or 260 mosm choline chloride
(rat material) and the centrifugation repeated. After
three such washes the buffy coat and top layer of qells
was removed from the cell pellet. A weighed aliquot of
erythrocytes was then haemolysed in a weighed quantity
of deionized. water (1 ml cells:10 ml water), haemolysate
and plasma, samples were stored at -20°C until analysis.
Analysis of Na, Mg and Li was by atomic absorption
sue ctropho tometry u sis a Perl in-Ll.mer 36-) atomic absor..—
tiometer set at the following wavelengths: lithium (670 nm),
sodium (589 nm), potassium (766 ma) and magnesium (2c5 nm).
All samples and standards v ore diluted 1:3 for socM
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potassium and magnesium analysis and 1:10 for litnium
analysis. Lanthanum chloride (0.1/ w/v) in deionized
water was used for all dilutions. Standards consisted of
the respective metallic chlorides dissolved in deionized
water. Ion concentrations were expressed per litre for
plasma and per kilogram of wet cells for the erythrocytes.
In the case of the animal work, the rats were anaes¬
thetised with nembutal (70 mg/kg) and 6 ml blood removed
by cardiac puncture.
8. Information regarding patients studied,
a. General:All blood samples were taken between 9 and
10.30 a.m. and were delivered to the laboratory within
45 minutes. Patients took only a light breakfast on the
morning of sampling but otherwise tnere was no dietary
control. Those patients on lithium took no medication on
the morning of sampling. The small group of untreated
epileptics studied were outpatients at the Northern
General Hospital, Edinburgh. The patients in the ill,
untreated depressed group were all inpatients at the
Metabolic Ward, Craig House, Royal Edinburgh Hospital
while of the lithium treated group some were inpatients
in the same ward but the majority were outpatients.
besides the group of epileptic patients, all the
patients studied were suffering or had suffered from some
kind of depressive illness. Two major types of patients
were studied: a group of patients who were ill and on no
drug treatment (except sodium amytal as a night sedative)
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and a group of patients who had received lithium treatment.
In addition some of the untreated group were re-examined
after a period of receiving lithium therapy.
t>. Diagnosis; Patients were diagnosed by two independant
psychiatrists, the referring clinical psychiatrist and a
research psychiatrist. Criteria for the diagnosis of
depression were those recommended by the 8.R.C. Clinical
Psychiatry Committee (1965) and the criteria for the
diagnosis of mania were those described by Feighner,
Robins, Guze, Woodruff, Winokur and iunoz (1972). Uni¬
polar and bipolar depressives were diagnosed using the
criteria discussed by Perris (1966). Patients receiving
lithium treatment were assessed as to whether they were
ill or recovered.
RESULTS.
1 • Variation in erythrocyte membrane Aihrase activities in
specific individuals.
An experiment was performed to investigate the vari¬
ation in ATPase activities of membranes prepared from three
individuals on several occasions over a period of weeks.
Three healthy males aged 24 (J.H. ), 28 (A.C.) and 32 (A.V.)
were studied. Blood samples were taken between 9 and 10 a.in.
once a week for five weeks. Each week, aliquots of a stand¬
ard ATFase preparation were assayed along with the membrane
preparations.
Haematocrits were measured at the cell suspension
stage of each membrane preparation and ATPase activities
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were expressed both as nmol P./hr/litre of cells and
nrnol P;/hr/mg protein. Haemoglobin and total protein
were estimated in each preparation and protein yield per
litre of original cells calculated. The results for each
individual are shown in Figures 25, 26 and 27.
The results show a large variation in the ATPase
activity of consecutive membrane preparations from a
given individual. There was however little variation in
the activity of the standard ATPase preparation. It is
unlikely therefore that the variation in the membrane
ATPase activities was due to methodological error in the
ATPase assay itself.
As shown in Figure 28 the enzyme activities expressed
in terms of protein are significantly correlated (r = 0.833,
p<0.00l) with activities expressed per litre of cells. It
is unlikely therefore that the variation in activity was
due to variation in the protein composition of the pre¬
paration. This is further substantiated by the lack of
correlation between either protein yield or membrane
haemoglobin content and enzyme activity (Figures 25, 26
and 27). Variation in enzyme activity, if caused by
variation in preparative techniques, must therefore be due
to qualitatively different preparations. There is no
consistent pattern in the variation of enzyme activity
between the three individuals studied and this also
suggests that there was no consistent methodological
error.
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ATPase specific activity (5 of activity at week 1) (Each p„ameter as r of value at Week x)
0 20 40 60 80 100 120 Haematocrit Protein yield Haemoglobin
content
1 i 1 1 1 1 »
MSBBEBMSMSm Week 1 100 100 100
Week 2 87 121 107
{/////////////////\ i X Week 3 67 82 59
J////////\ x Week 4 72 83 82
J////////////////////\' Week 5 74 120 62
—X— standard ATPase £3 Mg ATPase
□ Na/K ATPase 0 Ca + Mg ATPase
Figure 25. Characteristics of erythrocyte membranes prepared
from a single subject on five separate occasions. Results
given are for subject J.H. (mal^ 24). Specific activities
of membrane ATPases, activity of a standard ATPase preparation,
protein yield and haemoglobin content of the membranes and
haematocrit of cell suspensions used for preparation of
membranes are shown for each preparation. All parameters
are expressed as a percentage of the value for the preparation
at week 1. All parameters were measured in duplicate or ■
triplicate and results shown are mean values.
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ATPase specific activity (ft of activity at week 1)






(Each parameter as Ct of value at Week 1)
Haematocrit Protein yield Haemoglobin
content
7///////////////////////rm Week 1 100 100 100
Week 2 99 128 97
Week 3 80 113 83
Week 4 78 122 93
Week 5 90 109 47
— X standard ATPase
□ Na/K ATPase
0 Mi; ATPase
m Ca + Mg ATPase
Figure 26. Characteristics of erythrocyte membranes prepared
from a single subject on five separate occasions. Results
given are for subject A.C. (male, 28). Specific activities
of membrane ATPases, activity of a standard ATPase prepar¬
ation, protein yield and haemoglobin content of the membranes
and haematocrit of cell suspensions used for preparation of
membranes are shown for each preparation. All parameters
are expressed as a percentage of the value for the prepar¬
ation at week 1. All parameters were measured in duplicate
or triplicate and results shown are mean values.
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ATPase specific activity (% of activity at weejt 1)
0 20 40 60 80 100 120
1 i I I i i i
(Each parameter as % of value at Week 1)
Haematocrit Protein yield Haemoglobin
content
v nn i'/un / // i // / rrm Week 1 100 100 100
zzzzzzzzzzzzz Week 2 92 94 69
V////////////////1 Week 3 71 92 60
>/////////////n//////7jm X Week 4 75 86 96




Ca + Mg ATPase
Figure 27. Characteristics of erythrocyte membranes prepared
from a single subject on five separate occasions. Results
given are for subject A.V. (male, 32). Specific activities
of membrane ATPases, activity of a standard ATPase prepar¬
ation, protein yield and haemoglobin content of the membranes
and haematocrit of cell suspensions used for preparation of
membranes are shown for each preparation. All parameters
are expressed as a percentage of the value for the prepar¬
ation at week 1. All parameters were measured in duplicate





































ATPase activity (nmol P / hr/litre cells) cfs % of
activity at week I
Figure 28. Correlation between erythrocyte membrane ATPase
activity related to membrane protein and activity related
to volume of cells from which membranes were prepared.
Results are shown for membranes prepared from three control
subjects (J.H., A.C. and A.V.) on five occasions. Activities
were calculated both as nmol i'p/hr/mg protein and nmol Pp/
hr/l cells and then expressed as percentages of the
activities (per mg protein and per 1 cells) of the membranes
prepared at week 1. The figure shows the relationship
between the activity per mg protein as a percentage of
the value at week 1 and the activity per 1 cells as a
percentage of the value at week 1. There was a significant
correlation (r = 0.833, p<0.00l) between the two expressions
of enzyme activities.
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There was only one step in the membrane preparation
which was variable from week to week and that was the
haemolysis stage. The cell suspension was haemolysed at
a constant ratio of cell suspension to haemolysing buffer
but the haematocrit of the cell suspension varied and so
the ratio of volume of cells to volume of haemolysing
buffer also varied from week to week. Inspection of
Figures 25 - 27 shows no consistent pattern between the
haematocrit of the cell suspension before haemolysis and
the various ATPase activities in the membrane preparations.
There was no correlation between enzyme activity and
haematocrit value. It is unlikely therefore that vari¬
ations in the cell:buffer ratio caused the variation in
ATPase activity.
2. Age and Sex effects.
Table 18 shows the age and sex composition of the
various groups of patients studied. There was no sig¬
nificant difference between the age composition of the
various groups of depressive patients or the controls.
The epileptic group however consisted of considerably
younger people. Only the unipolar untreated group was
unbalanced in terms of sex composition. Comparison of
male and female control subjects showed no significant
difference in ATPase activities between the sexes but
there was a trend towards high Ca ATPase and Ca + hg
ATFase activity in males and high ha/h ATPase in females
(Table 19). None of the ATPase activities were correlated
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Table 18. Age and sex composition of the groups of
subjects used in the study of human erythro¬
cyte membrane ATPase activities. Ages are
given as mean values - standard deviations
with number of subjects in parentheses.
Numbers of males and females in each group
are given.




















7 male, 9 female
1 male, 8 female
3 male, 6 female47 - 17
(9)
94 - 11 3 male, 2 female
(10)
6 male, 8 female
2 male, 4 female
4 male, 6 female
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Table 19. Specific activities of ATPases in erythrocyte
membranes prepared from male and female control
subjects. Results are expressed as nmol Im/hr/
mg protein and grouped according to sex of
subject. Values given are means - standard
deviations with number of subjects in
parentheses.
Male subjects Female subjects
ha/K ATPase activity 286 - 67 377 - 151
(4) (6)
Mg ATPase activity 376 - 61 323 -156
(4) (6)
Ca + Mg ATPase activity 1104 - 136 809 4 331
(4) (6)
Ca ATPase activity 728 - 84 487 - 264
(4) (6)
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with age. It is unlikely therefore that age or sex
factors contributed to differences in ATPase activities
between the groups. They may however have increased the
variance of the parameters studied and so where possible
groups have been compared on an age and sex matched basis.
3. ATPase activities in erythrocyte membranes from ill,
untreated depressive and untreated epileptic patients.
Results given in Table 20 are a comparison of the
ATPase activities in membranes prepared from a group of
controls and activities in groups of ill, untreated,
depressive patients. All patients were depressed at the
date of sampling. Regardless of diagnosis the ill, un¬
treated patients showed a reduced ba/K ATPase activity
compared to controls (p<0.05). Comparison of controls
with an age and sex matched group of these patients
(Table 21.) also showed a reduced ba/X ATPase activity in
the ill, depressed patient group (p<0.025).
On dividing the group of patients into bipolar and
unipolar groups (Table 20.) the unipolar . roup show3 a
marked reduction in Na/X ATPase compared to controls
(p<0.005) whilst the bipolar group showed only a slight
reduction in i.a/h ATPase activity with respect to controls,
hg dependant, Ca + Mg dependant and Ca. stimulated ATPase
activities were not significantly altered in ill patients
as compared to controls.
A small group of untreated epileptics were also stud¬
ied and these showed a ha/K ATPase activity very similar
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Table 20. Specific activities of Aliases in erythrocyte
membranes prepared from blood of ill, untreated
depressive patients and from control subjects.
Results are shown for all ill untreated patients
regardless of diagnosis and the same patients
divided into unipolar and bipolar depressive
groups according to diagnosis. Specific
activities are expressed as nmol P^/hr/mg
protein. Values given are means - standard
deviations with number of subjects in parentheses.
Groups were compared using a students 't* test,


































156 - 94** 263 - 145
(9) (12)
256 i 135 294 - 80
(9) (12)
819 - 303 937 - 255
(7) (12)
576 - 203 643 - 211
(7) (12)






























































































































to that of controls (Table 22.).
4. The effects of long-term lithium administration on
ATPase activities in erythrocyte membranes from depressive
-patients.
The first part of this study consisted of a comparison
between a group of untreated, depressed patients and a
group of patients (including some ill and some recovered)
who had received lithium treatment for at least one year.
The two groups were age and sex matched. The results
(Table 23.) show both an increased Na/K ATlase activity
and an increased Mg dependant ATPase activity in the
lithium-treated group (p<0.025, p<0.05 respectively).
There was no difference in the Ga + Mg ATPase or Ca ATlase
activities between the two groups.
Subsequent to this initial study further patients
were investigated and the results of the total study are
shown in Table 24. The groups were not age and. sex
matched but the composition in terms of age and sex v/as
not significantly different. Comparison of untreated
patients with the total group of all lithium treated
patients showed a barely significant (p<0.1) increase in
"f*
Kg ATPase activity. Such an increase wras also seen in
the lithium-failed group. The Mg ATPase specific activity
of the lithium-recovered group was greater than that of
the untreated group but the difference was not statistic¬
ally significant. There was also a decreased Ca ATPase
activity in the lithium recovered and total lithium
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Table 22. Na/K ATFase specific activity in erythrocyte
membranes prepared from blood of a group of
untreated epileptic patients and from a group
of control subjects. Results are expressed as
nraol F^/hr/mg protein. Values given are means
- standard deviations with the number of patients
in parentheses.
ba/K ATPase activity
controls 342 - 132
(10)
+
epileptic patients 309 - 137
(6)




















































































Table 24. Specific activities of ATPases in erythrocyte
membranes prepared from blood of a group of ill,
untreated depressive patients and a group of
patients who had received lithium treatment for
at least 1 year. The lithium-treated group was
also divided into those patients who had
recovered and those who were ill (lithium-failed).
Values given are means - standard deviations
with the number of subjects in parentheses.
Groups were compared using a Students 't* test,









Na/E ATPase 217 ± 137 223 - 91 248 i 95 179 -
activity (21) (14) (9) (3)
Mg ATPase 279 - 107 350 - 113* 331 - 130 364 -
activity (21) (14) (9) (5)
Ca + . g ATPase 894 - 280 841 - 281 766 - 298 975 -
activity (19) (14) (9) (5)
0a, ATPase 618 i 211 490 - 190* 437 - 189** 585 1
activity (19) (14) (9) (5)
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groups (p<(3.P5'# p<0.1 respectively) but no change in the
Ca + .\f: ATP as e activity, hone of the groups showed
significant differences in ha/h ATPase activity when
compared to controls. However there were trends towards
an increased Na/h ATPase activity in the lithium-recovered
group and a trend towards a decreased activity in the
lithium-failed group. The lithium failed group showed a
.ligher :g ATI ase and Ca + Ac ATPase activity than the
recovered group but these differences were not statistic¬
ally significant.
A study was also carried out in which samples were
taken from certain of the patients while ill and untreated
and from the same patients after they had received lithium
treatment for between 9 months and 1 year. All these
patients except one had recovered and had had no episode
of illness since starting lithium. The results from this
experiment are shown in Table 25. and they show an
increased activity of all the ATPase activities measured
after lithium treatment.
• 'j-'be effects of short-term lithium treatment on AT., ase
activities .in erythrocyte membranes from depressive
oatlents.
ATPase activities were measured in .membranes prepared
from blood of a group of the depressed patients while ill
and untreated and asain after 2-4 weeks of receiving
lithium therapy. The results are shown in Ta le 26. They
. low an increased ATPase specific activity < .. )










































































































































































after lithium treatment but there was no difference in the
activities of the other Aliases. Two of the patients
studied had also received electroconvulsive shock treat¬
ment during the period between sampling.
Estimation of lithium in erythrocyte membranes.
It was important to investigate the possibility that
the observed differences in ATIase activities in membranes
from people receiving lithium were due to activation of
the enzymes by lithium present in the membranes.
Membranes from six lithium-treated patients were
analysed for lithium by both flame and flameless atomic
absorption spectrophotometry. No lithium could be detected
by either method despite a detection limit of 1 nmol.
Therefore it is possible to state with some confidence
that there is no lithium present in the membrane prepar¬
ations from lithium-treated patients.
7. The effects of long-term lithium treatment on plasma
and erythrocyte ion concentrations.
Plasma and erythrocyte ion concentrations were
measured in a group of ill, untreated patients and a
group of patients who had received lithium treatment for
at least 1 year. The results are shown in Table 27. The
only significant difference between the two groups is the
increased intracellular sodium in erythrocytes from
lithium-treated patients (p<3.05).
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Table 27. Plasma and erythrocyte ion concentrations for a
group of ill, untreated depressive patients and
a group of patients who had received lithium
treatment for at least one year. Plasma ion
concentrations are expressed as an, erythrocyte
ion concentrations as mmol/kg wet cells. Values
given are means - standard deviations, with the
number of subjects in parentheses, oroups were
compared using a Students 't' test, *p 0.05.
untreated lithium-treated
patients patients
PIasma magnesium 0.81 - 0.11 0.82 - 0.07
concentration (13) (13)
Plasma sodium 134.2 - 10.4 137.5 - 9.5
concentration (13) (13)
Plasma potassium 4.36 - 0.73 4.36 - 0.46
concentration (13) (13)
Plasma, lithium 0.83 - 0.18
concentration (13)
Erythrocyte magnesium 2.11 - 0.34 2.17 - 0.23
concentration (13) (12)
Erythrocyte sodium 7.64 - 1.66 * 8.80 - 0.86*
concentration (13) (12)
Erythrocyte potassium 93.8 i 6.5 92.1 — 9.0
concentration (13) (12)
'Ery thro cy te 1 ithiuoi — 0.39 - 0.13
concentration (12)
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6. The effects of chronic lithium administration to rats
on erythrocyte membrane ATj ase activities and ion concen¬
trations in erythrocytes and rlasma.
ATiases were Measured in erythrocyte membranes pre¬
pared from control rats and from rats given lithium
chloride in their diet for 3 weeks (60 mmol LiCl/kg food).
Plasma lithium concentrations at the time of blood sampl¬
ing were between 0.48 and 0.63 mm. No effect of lithium
on the ATiases was evident (Table 28.).
In a separate experiment administration of lithium
chloride in the diet (100 mmol LiCl/kg food) caused a
reduction in intracellular erythrocyte magnesium concen¬
tration (p<0.0l). The lithium-treated group also showed
an increase in plasma magnesium but this effect was not
statistically significant. There was no effect of lithium
on plasma or erythrocyte sodium concentration. .These
results are shown in Table 29.
klbCliOslOu.
The specific activities of the ATiases in membranes
prepared from human erythrocytes were of similar order to
those described by Lick et al., (1974) and Feig and
Guidotti (1974). In view of the studies of hanahan em al.
(1973) and Lramley et al. (1971) trie preparative procedure
used in the present experiments (20 mosm haemolysing
buffer, p} 7.4) would be expected to mroduce membranes
exhibiting their total ATIase capacity with no cryptic
activity.
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Table 28. The effect of chronic lithiuu administration on
rat erythrocyte membrane ATPase specific
activities. Rats were given lithium chloride
in the diet (60 mmol LiGl/kg food) for 3 weeks.
Activities are expressed as nmol lv/hr/mg
protein. Values given are means ~ standard
deviations, number of animals in parentheses.
controls lithium-treated
Na/K ATPase 371 - 163 408 - 192
activity (4) (4)
Mg ATPase 497 - 82 333 - 131
activity (4) (4)
Ca + Mg ATPase 1009 - 143 992 - 73
activity (4) (4)
Ca ATPase 512 - 199 460 - 90
activity (4) (4)
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Table 29. The effect of chronic lithium administration on
rat erythrocyte and plasma ion concentrations.
Rats were given lithium chloride in the diet
(100 minol LiCl/kg food) for 1, 2 and 3 weeks.
Plasma ion concentrations are expressed as an,
erythrocyte ion concentrations as mmol/kg wet
cells. Values given are means - standard
deviations with toe number of animals in
parentheses. Groups were compared using a
Students ' t' test, *p 0.01 compared to contols.
controls lithium-treated
Length of
lithium - 1 week 2 weeks 3 weeks
treatment
Plasma - 0.Q3 -0.19 0.79 -0.25 1.13-^0.22
lithium (6) (6) (6)
concentration
Erythrocyte - 1.00-0.09 1.20-0.16 1.29-0.21
lithium (3) (5) (6)
concentration
Plasma 141.2 - 4.4 138 - 4.4 144.5 - 4.5 142.8 - 3.3
sodium (17) (6) (6) (6)
concentration
Erythrocyte 2.33 - 0.37 2.12 - 0.1b 2.32 - 0.23 2.28 - 0.28
sodium (17) (5) (6) (6)
concentration
Plasma 0.91 - 0.11 1.01 ± 0.09 1.02 ± 0.17 0.99 4 0.12
magnesium (17) (o) (6) (6)
concentration
Erythrocyte 1.64 - 0.17 1.31 - 0.12;' 1.62 - u.17 1.31 - 0.15*
magnesium (17) (5) (6) (6)
concentration
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There was considerable variation in ATlase activities
in erythrocyte membranes prepared from a single control
subject on successive occasions. Such variation was found
in all three ATlase activities studied and in all three
individual subjects. There was no consistent pattern of
variation either between the various enzymes or between
the three individuals and this suggests that the variation
in activity was not due to any consistent methodolo{ ical
error. A standard ATPase was assayed together with the
membrane preparations and this showed little variation in
enzyme activity so providing evidence that the variation
in membrane ATlase activities was not due to methodolog¬
ical error in the ATPase assay. The variation in activity
must therefore have been due either to in vivo variation,
to variation in the sample of blood cells taken or to
variation produced during preparation of the membranes.
Sampling variation could have occured if successive
samples contained different populations of erythrocytes
in respect to cell age. Hanahan (1973) has pointed out
that the age distribution of erythrocytes could be a
cause of variation in membrane preparations. Cohen et al.
(Cohen, Ekholm, Luthra ana lianahan, 1373) were unable to
show any consistent relationship between erythrocyte cell
age as judged bj cell density and ATPase activities in
freeze-thawed cells. Other workers have shown Oa ATlase
activity in membrane preparations to depend on cell age
and in addition p /Thar e was found to be increased in
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jeople with high (10 - ) reticulocyte counts (Feig and
Guidotti, 1974). However the number of cells present in
each blood sample is so large that it is unlikely that
wee ly samples contained different populations of cells.
Variation in specific enzyme activity could have
arisen from variation in the enzyme, protein or haemo¬
globin content of the membranes, lianahan et al. (1972)
showed that under preparative conditions Similar to those
used in these experiments, Ag ATPase and Ga ATrase activity-
was lost during prepax-ation but there was no loss of ha/n
ATiase activity. Variation in such loss of activity
could lead to variation in enzyme activity in the final
preparation. On a given day membrane preparations from a
single haemolysate were reproducible in terms of rotein
yield and ATiase activities. Thus the pelleting of the
membranes would seem to be reproducible during a given
preparation. In addition, when the yield of membranes was
drastically increased by usin£;; an angle rotor during
preparation the specific activities of the ATI ases were
unchanged. There would therefore not seem to be any
heterogeneity in the membrane suspensions during prepar¬
ation. When ATPase activities in membranes from three
individuals were studied over several weeks there was a
marked correlation between the ATPase activities expressed
per litre of original cells and ATPase activities expressed
per milligram of protein. This correlation between activ¬
ity. referred to the original cellular material and activity
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referred to the final preparation indicates that the
variation in ATPase activities within the individuals was
not due either to variation in the quantitative yield of
membranes in terms of protein or to variation in the
yield of enzyme in the membranes. This is supported by the
lack of consistent pattern between either protein yield
or membrane haemoglobin content with ATPase activities in
successive preparations. The variation in ATPas e spec¬
ific activity cannot be explained therefore by variation
in haemoglobin or total protein content of the membranes,
variation in the recovery of enzyme activity in the
Membranes or by heterogeneity of the membrane suspensions
together with variation in the efficiency of centrifug¬
al ion. The quantitative aspects of the preparation are
reproducible. Variation could have occured in the qualit¬
ative nature of the preparation - for example in the
degree of crypticity of the enzymes involved. Enzyme
crypticity, however, is an unlikely explanation in view of
the lack of pattern between variation in the three Aliases
studied.
The only step in the preparation which varied from
week to week was the haemolysis stage. Variation in cell
to haemolysing buffer ratio was a possible cause of alter¬
ations in the membrane properties which might be reflected
in altered ATPase activities, it would be interesting to
study membranes prepared from a single blood sample using
cell suspensions of different haematocrits. Such an
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experiment would be informative on whether variation in
cell suspension haematocrit could have been a possible
source of the observed variation in membrane ATPase
activities, however, such a source of variation is
unlikely since there was no consistent pattern between
the haemolysis conditions as judged by the haematocrit of
the cell suspension to be lysed and the final membrane
ATPase activities.
In conclusion, no methodological or preparative
rationale can be given to explain the variation in ATPase
activities found within individuals. It is also unlikely
that the variation was due to differences in the populat¬
ions of erythrocytes samples. Therefore one must consider
the possibility that the variation reflects alterations
of activity, in vivo.
The nature human erythrocyte synthesises no protein
(Harris and Kellermeyer, 1970) and so a changed amount of
enzyme measured in a red cell population can only occur in
association with new cells. As the life of the mature
human erythrocyte is approximately 120 days (Harris and
Kellermeyer, 1970) the changes in ATPase activities found
over periods of two or three weeks could not have been
due to different amounts of enzyme present in cells sampled.
Thus the changes in activity must have been due to alter¬
ations in the activation and inhibition of enzyme in vivo.
It would seem unlikely that the membrane preparation, after
extensive washing, could reflect in vivo activation.
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However, the results of experiments in which patients
were studied after only 2-4 weeks of litnium treatment
showed an increased erythrocyte membrane Kg ATPase activity
after this period. Sue], an effect could not have been clue
to new enzyme and it further suggests that erythrocyte
membrane ATPase activities may reflect in vivo activation
of these enzymes.
measurement of ATPase activities in erythrocyte
membranes from depressed patients showed no difference in
Ig ATPase and Ca ATPase specific activities compared to a
group of controls. However groups of depressive patients
of mixed diagnosis (both unipolar and bipolar) showed a
significantly decreased ha/K ATPase specific activity
compared to controls, both .matched and unmatched with
regard to age and sex. Separation of patients into uni¬
polar and bipolar groups showed a decreased specific
activity of Na/K ATPase in the unipolar group compared to
controls but only a slight, non-significant difference
between the bipolar group and controls. This is in con¬
trast to the work of hokin-Keaverson et al. (1974) who
found decreased erythrocyte sodium efflux in bipolar,
manic patients. The reason for the difference between
unipolar and bipolar patients is unclear but it may be
related to severity of symptoms, however, this remains
to be investigated.
Investigation of a small .roup of untreated epileptics
showed no difference in ha/Y ATPase specific activity
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compared to controls. These patients were outpatients and
so do not act as hospitalisation controls, uowever the
results suggest that the changes in ha/a ATPase activity
seen in depressives is not a general effect associated
with central nervous system dysfunction.
The possibility that the decreased ha/.. ATI ase spec¬
ific activity found in aepressives was due to some effect
of hospitalisation cannot be unequivocally ruled out.
However Maylor et al. (1973) showed that in hospitalised
depressive patients amelioration of mood was associated
with increased erythrocyte membrane ha/K ATPase activity.
This showed that recovery from depression was associated
with increased Na/I ATPase activity despite the patients
being hospitalised both when ill and recovered so suggest¬
ing a relationship between enzyme activity and clinical
state. Hokin-Neaverson et al. (1974) found a group of
bipolar patients, including both inpatients and outpatients
to have reduced sodium efflux. These studies make it
unlikely that the observed decreased specific activity of
erythrocyte membrane .a/ ATPase in depressed patients
was due to hospitalisation.
It cannot be decided fro.; the present experiments
whether the decreased specific activity of ha/} ATIase is
due to a reduced amount of enzyme* to changes in activation
or to inhibition of the enzyme. The results of Maylor
et al. (1973) showed a change in erythrocyte membrane
Ma/? ATP ase over a 42 day period and this period is long
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enou, for the change to he accounted for in terras of
new cells. results discussed earlier, however, suggest
erythrocyte membrane AT. ase activities may reflect in vivo
activation and inhibition.
f further question posed by the present woric is
whether the reduced specific activity of Na/K ATIase in
depressive patients is the result of metabolic disturb¬
ances due to depression or an event in the aetiology of
depression itself. The present results do not allow
this question to be answered.
Comparison of untreated depressive patients with
patients who had received lithium treatment for at least
one year showed the lithium-treated group had a signifi¬
cantly higher erythrocyte membrane Na/K ATPase specific
activity. Similarly, patients studied both untreated and
after 9-12 months lithium treatment showed increased
Na/K ATPase specific activity after lithium treatment.
No lithium could be detected in membranes prepared from
erythrocytes of lithium-treated patients and therefore it
is unlikely that the increased ATPase activity was due to
in vitro activation by lithium present in the membrane
preparations. The increased Na/K 'ATPase specific activity
in erythrocyte membranes following lithium treatment
confirms the findings of nick et al. (1974). These workers
were unable to determine whether this effect was due to
tie drug itself or due to a change in clinical state of
the patient. In the present work it was possible to
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examine this question. Splitting the group of lithium-
treated patients into those who had recovered and were
well and those who were ill despite receiving lithium
showed a trend towards increased membrane Na/K ATPase in
the recovered group compared to untreated patients whereas
the lithium-failed group showed a trend towards decreased
membrane Na/K ATPase activity. These results suggest
therefore that lithium treatment only causes an increase
in a/ AT] ase activity when it is associated with recovery
of the patients. This is supported by the finding that
amelioration in mood is correlated with increased 9a/K
ATPase activity (haylor et al., 1973). Lithium itself
would seem therefore not to cause any change in erythrocyte
membrane wa/K ATPase specific activity.
Lithium-treated patients showed an increased intra¬
cellular erythrocyte sodium concentration compared to
untreated patients. The majority of these patients had
recovered so it was not possible to separate drug and
recovery effects in this case, erythrocyte sodium concen¬
tration has been shown to decrease on recovery from
depressive illness (Naylor et al., 1971; Laylor et al.,
1973). Recovery from depression during lithium treatment
has been found to be associated with an increase in
erythrocyte sodium concentration (.iendels et al., 1971;
, .endels and Frazer, 1974) although this increase has not
been confirmed by a third study (^endels et al.. 1972).
It may be that the increase in sodium concentration found
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during recovery on lithium is an effect of lithium rather
than an effect due to change in clinical state. It is
anomalous that in the present work the increased erythro¬
cyte sodium concentration was associated with increased
a/ . ATPase specific activity in the erythrocyte membrane.
Previously Naylor et al. (1973) showed increased ha/K
ATPase activity to "be associated with decreased erythrocyte
sodium concentration. It is possible the anomaly in the
present work was caused by patients receiving lithium
treatment. Perhaps lithium prevented an increased activity
in the sodium pump being reflected in a decreased intra¬
cellular sodium concentration. It is possible lithium
increased the intracellular sodium concentration by
competing with sodium for the extrusion mechanism so
inhibiting sodium efflux (see Section II of this thesis).
In view of the association of ba/h ATPase activity
with the sodium pump (Whittarn and Wheeler, 1970) the changes
in Na/K ATPase activity observed in depression would be
expected to be reflected by changes in the active trans¬
port of sodium and potassium. The present results provide
evidence therefore that there is decreased active sodium
efflux in depressive patients. Earlier workers showed
decreased sodium efflux from erythrocytes of bipolar,
manic patients compared to controls (.iiokin-i eaverson et al. .
1974). It is probable therefore that both depressive and
manic phases of affective disorders are associated with
decreased sodium transport.
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Both short-term (2-4 weeks) and long-term (9 - 12
months) lithium treatment caused an increased specific
activity of erythrocyte membrane Mg ATPase. This effect
is seen with short-term treatment where recovery was at
the most only partial and with long-term treatment
regardless of clinical state and this suggests the increased
activity is due to an action of lithium and not due to a
change in clinical state of the patients.
it lias been reported that people with high reticulo¬
cyte counts (10 - 30 ) have an increased specific activity
of erythrocyte membrane mg ATI ase compared to control
subjects (Peig and Guidotti, 1974). It was possible
therefore that the effect of lithium treatment observed
in the present work was due to an effect on erythrocyte
production. This is unlikely however since lithium
treated patients have reticulocyte counts within the
normal range (Lille, Jensen, Jenson and Poulsen, 1975).
The increase in erythrocyte membrane mg ATIase
activity observed after only 2-4 weeks of lithium treat-
ant suggests that the effect of lithium on specific
enzyme activity is not dependant on the production of new
cells and thus is not dependant on synthesis of more
enzyme. The effect of lithium is most likely due to
activation by some unknown factor. Examination of erythro¬
cyte membranes from lithium-treated patients failed to
detect any lithium in the preparations. Lin, sch and hartin
(1976) failed to detect lithium in the plasma membranes of
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erythrocytes from lithium-treated patients but the sens¬
itivity of their technique was' such that it was equivocable
whether there was any lithium present. The high sens¬
itivity of the present analytical method used to detect
lithium allows the unequivocable statement that there was
no significant amount of lithium present in the erythro¬
cyte membrane preparations. Therefore increased ATPase
activity in erythrocyte membranes from lithium-treated
patients was not due to lithium present in the membranes.
Other workers have shown that erythrocytes from
lithium-treated patients possess decreased choline trans¬
port compared to control subjects and that this decreased
transport is evident both when the cells have been extens¬
ively washed and in ghosts when both intracellular and
extracellular lithium has been removed (Lee, Lingsch,
Lyle and martin, 1974; Lingsch and lartin, 1976). Results
from a patient who had stopped receiving lithium showed
a slow increase in erythrocyte choline transport after
termination of lithium treatment, consistent with an
increase associated with new erythrocytes. This was
interpreted as lithium affecting choline transport via a
mechanism which could operate only in the developing
erythrocyte and not by activation such as suggested to
explain its effect on Mg ATPase specific activity.
The physiological significance of the increased Xg
ATPase activity as a result of lithium treatment is uncert¬
ain as the function of t: is enzy le in the erythrocyte is
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unknown. One night speculate however that the enzyme
affected is associated with actomyosin-like protein in
the membranes.
Lithium treatment had no consistent effect on Ca
ATPase activity. This activity is thought to reflect, in
part at least, the active calcium transport system and
the present results suggest therefore that chronic admin¬
istration of lithium does not affect the active transport
of calcium. This is of some interest since calcium is of
such importance to many aspects of cell function (Cuthbert,
1970).
There have been several conflicting reports concerning
the effects of lithium administration to humans on plasma
magnesium concentrations. Lithium has been reported to
increase (i ielsen, 1964a; Bunney, Goodwin, Lavis and
Eawcett, 1968; Aronoff, Evans and Lurell, 1971) decrease
(Frizel, Coppen and marks, 196* ) and have no effect upon
(Eurrner, eltzer, Schriener and ieigelson, 1979) plasma
magnesium. The present results show no effect of lithium
on plasma magnesium. Length of time receiving, lithium or
diagnosis cannot explain these discrepencies when all
tnese studies are compared. Lunner et al. (1975) claimed
that previous workers* results showing increased plasma
magnesium were due to the short length of time of lithium
administration but careful consideration of the literature
does not support this view.
In agreement with previous workers (hielsen, 1964a;
- 223 -
limner et al., 1973) the present results show no effect
of lithium treatment on human ery tlirocyte magnesium
concentrations. Administration of lithium to rats
caused a trend towards reduced erythrocyte magnesium
concentrations in support of the findings of Haavaldsen
and Ingvaldsen (1973). Lithium also raised plasma magnes¬
ium in rats as previously shown by other workers (hielsen,
1 ;G4b; Andreoli, Villani and rrambilla, 1 72; lirch and
Jenner, 1973; I aavaldsen and Ingvaldsen, 1973) . As
discussed by hullin (1975) the mechanism involved in
lithium's action on magnesium metabolism is unknown,
however the evidence for decreased erythrocyte magnesium
and increased plasma magnesium suggests the possibility
of ionic displacement.
The lack of effect of lithium treatment on human
erythrocyte and plasma magnesium concentrations compared
to its effect of increasing erythrocyte membrane hg ATPase
activity suggests there is no relationship between
magnesium concentrations and Mg ATPase activity. This is
supported by the results from the animal work in which
3 week treatment with lithium affected magnesium aistril-
ution but not (although, this was using a lower dose) the
Mg ATPase. It has been suggested that lithium might exert
its action on magnesium dependant enzymes through its
effects on magnesium distribution (Glen, 1976). This does
not seem to be the case for the Mg ATPase of the erythro¬
cyte membrane. The mechanism by which this enzyme is
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affected "by lithium remains to he investigated. Likewise
t e reason for the lack of effect of lithium on rat erythro¬
cyte membrane kg ATTase also remains to be investigated.
The difference in lithium distribution between plasma and
erythrocyte in the two species could perhaps explain the
difference in the effects of lithium. Alternatively, the
difference could be in the nature of the erythrocyte
membrane preparations.
The experiments described in this section nave led
to the following conclusions:
1. There is considerable variation in erythrocyte membrane
AT:ase activities when a single person is sampled over
successive weeks, no methodological rationale was found
to explain this, so suggesting the possibility that tre
enzyme activities reflected in vivo variation.
2. repressive patients had a lower erytnrocyte membrane
ha/' ATI ase specific activity compared to controls. This
was particularly evident in unipolar- patients.
3. Lithium-treated patients possessed an increased
erythrocyte membrane ha/K ATPase activity compared to ill,
untreated patients. This however was probably due to
change in illness state and not to lithium itself.
4. Lithium-treated patients showed an increased erythrocyte
sodium concentration compared to untreated patients.
5. ; ithium itself caused an increase in erythrocyte mem¬
brane kg ATIase activity and this was not dependant on
the production of new erythrocytes. The change did not
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seen related to lithium effects on magnesium distribution.
6. Lithium administration for 3 weeks had no effect on
rat erythrocyte membrane ATPases.
7. Lithium increased rat plasma magnesium concentration
and tended to decrease rat erythrocyte magnesium concen¬






Results presented in section V showed erythrocyte
membrane Na/K ATPase activity to be reduced in depressive
patients and this was particularly evident in unipolar
patients. Na/K ATPase activity was not significantly
reduced in a group of bipolar patients. It was argued that
these effects were unlikely to be due to an effect of
hospitalisation and it was concluded that depression was
associated with a reduction in Na/K ATPase activity. A
reduced Na/K ATPase activity in depression has been post¬
ulated previously (Naylor et al., 1973) but the present
results provide the first direct evidence for such a
hypothesis. In view of the association between active
sodium transport and Na/K ATPase activity (Whittaia and
Wheeler, 1970), a reduction in Na/K ATPase activity would
be expected to result in a reduction in active sodium
transport. This would possibly give rise to further
changes in sodium metabolism. If the observed reduction
in Na/K ATPase activity in erythrocytes occured in all
cells of the body during depression such a change in enzyme
function could explain the previouslyr reported changes in
sodium metabolism including reduced sodium transport out
of saliva, reduced sodium transport into lumbar cerebro¬
spinal fluid and increased residual non-oxchangeable sodium
(Coppen, 1967; Glen et al., 196b; Carroll, 1972). It is
possible that the previously observed abnormalities in
sodium metabolism during depression are all the result of
a single cause, namely a reduction in Na/K ATPase activity
associated with the sodium-pump. Mendels and colleagues
(Mendels and Frazer, 1974; Schless et al., 1975) have
suggested there is a defect in erythrocyte membrane cation
transport in depression such that it causes an increase in
the intracellular erythrocyte lithium concentration.
Lithium transport in the erythrocyte is not thought to
involve the sodium-pump ( aizels, 1968; Mendels and Frazer,
1974; Haas, Schooler and Tosteson, 1975; Duhm, Eisenried,
Becker and Greil, 1976) and therefore changes in sodium-
pump activity are unlikely to directly affect the intra¬
cellular lithium concentration. I owever there is evidence
that the erythrocyte intracellular sodium concentration
influences the intracellular concentration of lithium.
Duhm et al. (lj76) found the ratio of intracellular to
extracellular lithium concentrations to be proportional
to the ratio of sodium concentrations. In addition, the
ratio of intracellular to extracellular lithium concen¬
trations has been shown to be related to the intracellular
sodium concentration (Mendels and Frazer, 1974). Thus it
is possible that an increase in erythrocyte intracellular
sodium concentration could lead to an increase in erythrocyte
intracellular lithium concentration. Thus if a reduction
in Na/K ATPase activity was associated with a reduction in
active sodium efflux and an increase in intracellular sodium
concentration, a reduction in ia/i ATPase activity in depress¬
ion could explain the increased intracellular lithium concen¬
tration reported in depressive patients ( endels and Frazer,
1973, 1974; Lyttkens et al., 1973) and therefore the erythro¬
cyte membrane cation transport defect postulated "by k.endels
and Eraser (1974) could he a reduction in Na/K ATPase
activity. As yet however there is no consistent evidence
for an increased intracellular sodium concentration in
depression. In summary, it is possible to embrace the
majority of reported changes in sodium and lithium metab¬
olism in depression in one hypothesis by postulating a
reduction in membrane Na/K ATI ase activity in depressive
patients.
It cannot be determined from the present results
whether the reduction in Na/K ATPase activity was due to
a reduction in the amo\mt of catalytic protein or a change
in the state of activation of the enzyme. Enzyme activity
was measured in an extensively washed preparation and this
would suggest activation effects to be an unlikely explan¬
ation. However for reasons discussed in section V the
possibility of the Na/K ATPase activity reflecting changes
in activation of the enzyme must be considered. Dick et al.
(1974) have postulated a correlation between mood and
erythrocyte membrane Ka/K ATPase activity in a single
subject over a period of weeks. In view of the lifespan of
the human erythrocyte (Harris and Kellermeyer, 1970) such
an effect would most probably reflect changes in activation
of the enzyme. If the results do reflect changes in
activation of the enzyme, the nature of the activators and
inhibitors involved remains obscure. 3-5-cyclic adenosine-
- 230 -
monophosphate, thyroid lormones and adrenocorticosteroids
have all been shown to have effects on ha/K ATIase activity
(Edelman, 1973; Schwartz, Lindenmeyer and Allen, 1973) and
various endocrine changes have been reported in depression
(Coppen, 1967). However a link between changes in ATPase
activity in depression and hormonal influences is purely
speculative.
The finding that there is reduced i-ia/h Allase activity
in depression is in contradiction to the results of haylor
and colleagues who failed to show any difference in erythro¬
cyte active sodium transport between depressed patients
and controls (Naylor et al., 1970b). However these authors
only studied four control subjects and so they may have
obtained a false impression of the control population.
Other workers found erythrocyte active sodium transport to
be reduced in a group of manic-depressive patients during
the manic phase of illness and on the basis of these
results suggested there to be a genetic abnormality in
active sodium transport in manic-depressive illness (Hokin-
heaverson et al. , 1974). The present work was unable to
support such a. hypothesis since bipolar (manic-depressive)
patients did not show a significant reduction in erythrocyte
membrane Na/K ATPase activity compared to controls. It
would be useful to study more bipolar' patients and in
particular patients in the manic phase of illness in order
to see if there is a difference between unipolar and bi¬
polar patients.
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Several workers have suggested there to be a genetic
abnormality in cation t ansport in depression (hokin-
fteaverson et al.t 1974; hendels and Frazer, 1974) and others
suggested an abnormality in sodium transport to be important
in the aetiology of depression (Coppen, 1967; Baer et al.,
1970c; Singh, 1970). The present work suggests that a
reduced Na/K ATPase activity could be the abnormality
involved but there is no evidence concerning whether the
change in activity is genetically derived and whether the
change is an event in the aetiology of depression of the
result of metabolic and hormonal disturbances occuring in
depression. It remains to be seen whether a reduction in
Na/K ATPase activity and active sodium transport is an
important event in depression. Despite its importance
being equivocable, the reduction in Na/K ATPase activity in
depression suggests this enzyme as a possible site of action
of lithium salts.
Lithium has been reported to affect a large number of
biochemical processes and it is difficult to decide which,
if any, are of relevance to its therapeutic action. One
important criterion is the concentration of lithium employed.
When used therapeutically concentrations of 0.6 - 1.6 nh
are achieved in plasma (Schou and haastrup, 1967; Schou,
1976). This plasma concentration is accompanied by con¬
centrations of approximately 0.2 mm in lumbar cerebrospinal
fluid (Appendix I). There is thought to be little or no
restriction on ion movement between C.5.F. and brain
extracellular fluid (Davson, 1967) and results presented
in section II together with findings of Proclcop and marcus
(1972) show lithium can diffuse out of the U.P.P.-containing
spaces into "brain. It is likely therefore that in patients
receiving lithium treatment the brain extracellular fluid
lithium concentration is similar to that in C.S.I'., that
is approximately 0.2 rnJ-I. In rats the erythrocyte:plasma
ratio of lithium concentrations is approximately 1.3
(section V). this value is in good agreement with rat
cerebral slices tissue:medium ratio for lithium (1.29 -
1.66, V'raae, hillman and hound, 1976). This suggests the
intracellular:extracellular lithium concentration ratio
in the brain is similar to the erythrocyte:plasma ratio.
If this is the case, taking the erythrocyte:plasma lithium
ratio in the human as 0.5 (section V) and the brain extra¬
cellular lithium concentration as 0.2 mh one would predict
an intracellular lithium concentration of approximately
0.1 nik in the brain of patients receiving lithium therapy.
These calculations suggest that only effects of lithium
found with concentrations of 0.1 - 1.0 a: can be of any
relevance to the therapeutic actions of tne drug. A second
criterion, important in chronic treatment experiments, is
tl e state of the animals. If the animals are particularly
stressed or they show signs of toxicity then it is possible
that changes found during lithium treatment are not relevant
to the theraxieutic action of lithium but to its toxic effects
or to general stress of the animals. -Daily intraperitoneal
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injection of lithium chloride is both stressful and unpleas¬
ant to the animals. In addition it leads to high, toxic
concentrations of lithium in the body (Morrison et al.t
1971; Schou, 1976). Diet administration, although resulting
in reduced gain in "body weight, is probably a better method
of lithium administration since the lithium concentrations
are lower and more stable (Morrison et al.. 1971; Schou,
1976) and the animals are less stressed.
Using therapeutically relevant concentrations (0.6 -
1.2 mU), lithium was found to have significant effects on
sodium transport from blood to C.3.P. (section II). These
results were interpreted as showing a stimulation of the
sodium-pump by lithium applied to the potassium sensitive
side of the system and an inhibition when applied to the
sodium-sensitive side. Previous work has shown lithium to
stimulate Na/K ATPase activity and sodium transport when
presented to the potassium sensitive side of the system
in a variety of tissues hut these effects were obtained
with high concentrations of lithium and mostly either in
the absence of potassium or in the presence of a low (2 uM)
potassium concentration (Whittan and Ager, 1964; Glen et al..
1972; Tobin et al., 1974; Ploeger, 1974a; Robinson, 1973).
The present results suggest therapeutically relevant con¬
centrations of lithium to have an effect at physiological
concentrations of potassium, lithium might stimulate
sodium transport from the potassium sensitive side of the
system through an action on the potassium transporting
site (Whittam and Ager, 1964), the external sodium allo-
steric site (Cavieres and Ellory, 1974) or a combination
of both (Robinson, 1975). The present results do not
distinguish between such possibilities, however it is
possible to glean a little information on the nature of
the effect. Since the removal of lithium from ventricular
perfusion fluid is probably by diffusion (irockop and
harcus, 1972; this thesis, section li) it is unlikely that
lithium was actively transported across the choroid plexuses
in the present experiments. Thus the effect of lithium on
stimulating sodium transport across the choroid plexus was
not dependant on lithium itself being transported by the
sodium-pump. It has been suggested that lithium inhibits
the sodium-pump when present intracellularly (1'loeger,
1974b) and the present results support this hypothesis and
suggest such an effect could occur at therapeutic concen¬
trations of lithium. Overall the results suggest that
both the stimulatory and inhibitory effects of lithium on
the sodium-pump could occur when lithium is given clinically.
These studies provide experimental evidence to support the
basic premise of the hypothesis forwarded by Glen and
heading (1975) to explain the action of lithium: that
lithium stimulates the sodium-pump at the potassium sensit¬
ive Biae and inhibits it at the sodium sensitive side.
..owever other premises of tneir hypothesis, such as the
intracellular sodium concentration in depression and mania,
have yet to be supported by experimental evidence.
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The hypothesis that the orientation of the sodium-
pump will determine the effect of lithium upon it and
that lithium will stimulate at the potassium sensitive
side and inhibit at the sodium sensitive side may explain
and be compatible with some of the previous contradictory
reports of the effects of lithium on the sodium-pump.
Dloeger's finding (1974b) that lithium given during a
potassium free pre-incubation period inhibited the sodium-
pump may be due to lithium acting at the intracellular site
of the pump rather than at the extracellular site as he
suggested. There are several repiorts of lithium inhibit¬
ing sodium transport across epithelial tissue (Zerahn, 1955;
fiber abd Curran, 1370; herrera Egea and herrera, 1971;
Leblanc, 1972; Dolman and Edmonds, 1576). The exact
mechanism of sodium transport across epithelia is equivoc-
able (Koeford-Johnsen and Ussing, 1950; Finn, 1976) and
this makes interpretation of the effect of lithium difficult.
In some cases lithium has been shown to inhibit the satur¬
able component of transport across epithelia (Biber and
Curran, 1970; Leblanc, 1972) and. it is possible this effect
reflects an inhibition of the sodium-pump by lithium inter¬
acting: with the sodium sensitive side of a pump system.
Lithium has been reported to reduce the potential difference
and short circuit current across the isolated frog skin and
also to reduce the ouabain-sensitive oxygen consumption
(Candia and Chiarandini, 1373). The authors of this report
suggested on the basis of these results that the effects
of lithium on epithelial sodium transport might he due, in
part, to an inhibition of the sodium-pump. The picture is
complicated since lithium has been shown to have inhibitory
effects when presented from both sides of the colonic
epithelium (Dolman and Edmonds, 1976). Further clarific¬
ation of lithium's effect in these systems awaits a clearer
understanding of epithelial sodium transport. Low concen¬
trations of lithium presented in vitro to the optimally
stimulated Na/K ATPase have been shown to have no effect
on activity in some cases (Ploeger, 1974a; this thesis,
section III), however these results were obtained using
nerve homogenates and synaptic plasma membranes and both
such preparations would have lost the orientation of the
Na/K ATPase in that lithium would have been able to inter¬
act with both sides of the system simultaneously. Opposing
stimulation and inhibition may explain the lack of effect
actually observed. As discussed in section V an intra¬
cellular inhibitory effect of lithium on the sodium-pump
can explain the anomaly that lithium-treated patients
were found to have an increased erythrocyte sodium concen¬
tration and an increased erythrocyte membrane Na/K ATPase
activity.
The hypothesis that lithium has opposite effects on
the sodium-pump depending on the side of the system with
which it interacts suggests that when lithium is given
chronically its distribution inside and outside cells will
determine the net effect on the sodium-pump. Results
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presented in sections III and V examined the effect of
chronic lithium administration on erythrocyte membrane
and synaptic plasma membrane Na/K ATIase activity. Lithium-
treated patients were shown to have an increased Na/K
ATPase specific activity compared with untreated patients
but as discussed in section V this was probably due to the
recovery of the lithium-treated group rather than an effect
of lithium itself on the enzyme. The animal experiments
investigated the effect of lithium on synaptic plasma
membrane Na/K ATPase activity but failed to find an effect.
The present results therefore do not provide any evidence
for chronic lithium treatment causing any change in Na/K
ATPase activity. Although the chronic treatment experi¬
ments were unlikely to have shown any direct effects of
lithium on ATPase activities, such effects would have been
expected to lead to homeostatic changes in activation or
amount of enzyme present and such changes would have been
detected. Maybe the distribution of lithium during chronic
administration is such that there is no net effect on the
sodium-pump. Such a suggestion however needs verification
by experiment.
The observation that chronic lithium administratis
to rats did not affect the Na/K ATPase activity in the
synaptic plasma membrane is in contrast to the findings of
reading et al. (1973) and in disagreement with the finding
of reduced, vagal nerve homogenate ha,/ _ ATPase after chronic
lithiu administration (i-loeger, 1974a). One explanation
- 238 -
of this difference is t lat in the present work lithium was
administered in the diet as opposed to intraperitoneal
injection as used by the previous workers mentioned above.
Intraperitoneal administration would be expected to lead
to peaks of high lithium concentration in plasma and tissues
whereas diet administration would be expected to lead to
stable lithium concentrations (Morrison et al., 1971;
Sciiou, 1976). It may be that the reduced Ma/K ATPase
activity reported by the previous workers was due to very
high, toxic concentrations of lithium in the body. It is
possible that only high, toxic lithium concentrations lead
to chronic changes in ha/ ATP ase activity. If this is the
case then the reduction in fta/K ATPase observed by some
workers may be related to toxic effects of lithium rather
than its therapeutic action. Alternatively different
modes of administration might lead to different pharmaco¬
kinetics and distribution of lithium. The results presented
in sections III and ¥ contrast with those of Boardman et al.
(1975) who found lithium to cause an increase in fta/K ATPase
activity and ouabain-binding in EeLa cells. These workers
Interpreted their results as showing lithium to interact
with the nechanism of protein synthesis to increase ba/K
ATPase production. However the concentrations of lithium
used were higher than tsose found in the therapeutic sit¬
uation.
In conclusion, tne situation with regards to the
implication of the sodium-pump in the therapeutic action of
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lithium is confused. The results presented in this thesis,
found with lithium concentrations and administration similar
to the therapeutic situation, suggest that although lithium
acutely affects the sodium-pump lithium given over long
periods to patients does not. The results provide no
evidence to suggest that chronic lithium administration
itself affects ha/K ATPase activity.
In contrast the results provide considerable evidence
to suggest that chronic lithium administration to patients
changes the specific activity of Mg ATPase enzymes, both
long and short-term lithium administration to patients was
found to increase the erythrocyte membrane Mg ATPase specific
activity. In addition lithium.administration to rats led
to an increase in synaptic plasma membrane and mitochondrial
Mg ATPase specific activity. These results suggest that
changes in Mg ATPase enzymes might occur in the brain of
patients receiving lithium. The effects in brain v/ere
found using diet administration of lithium and may therefore
be of clinical relevance since the lithium concentrations
in the tissues are probably of a similar magnitude to those
found in the therapeutic situation.
Lithium administration to rats failed to produce any
change in erythrocyte membrane Mg ATPase activity. The
reason for the species difference between man. and the rat
in the effect of lithium on Mg ATPase is unknown. One
possibility is the difference in erythrocyte:plasma lithium
ratio. It is of interest to note that chronic lithium
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administration has been shown to inhibit erythrocyte
choline transport in man but does not have such an effect
in the rat (Lee et al., 1974; Lingsch and Martin, 1976).
It would be of interest to know the reasons for the diff¬
erent behaviour of rat and human erythrocytes.
Lithium treatment for 2-4 weeks produced an increase
in human erythrocyte rig ATPase activity. In view of the
lifespan of the erythrocyte and its inability to synthesise
protein for most of its life (barris and Kellermeyer, 1970)
this effect probably reflects in vivo activation of the
enzyme. The nature of the activator is unknown.
Lithium in vitro had no effect on synaptic plasma
membrane or mitochondrial Fig ATPase (section III). A
similar lack of effect of lithium in vitro has been reported
for Mg ATPase in other tissues (Gupta and Crollini, 1979).
Such results do not support the hypothesis that lithium
exerts its effects by means of competition with magnesium
for magnesium-dependant enzymes (Birch, 1973> 1974).
The function of the : :g ATPase activity found in
erythrocyte and synaptic plasma membranes is unknown and
therefore the physiological significance of the cnanges
in these activities following administration of lithium
is obscure. However it is possible to speculate: chronic
lithium administration to rats for three weeks gave rise
to an increase in cerebral cortex synaptic plasma membrane
Mg ATPase specific activity (section III) and to changes
in dopamine metabolism in the striatum (section IV). One
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nay postulate that there is significance in the fact that
these events occurred after the same regimen of lithium
treatment. Evidence has "been presented earlier in this
thesis that suggests there is an actomyosin-like protein
in erythrocyte membranes and in synaptosomal material
which possesses %g AT' ase activity. It is possible that
lithium treatment increased the activity of such kg ATPase
activities and that this led to an increased release of
neurotransmitter. Such a hypothesis is highly speculative.
Until the subcellular distribution of actin-like nd myosin-
like proteins is well established it must remain equivocable
whether or not the synaptic membrane fraction studied was
associated with actomyosin-like protein Mg ATPase activity.
There is little evidence for chronic lithium treatment
increasing the release of neurotransmitter. The available
evidence concerning amine metabolism following lithium
treatment is contradictory (Shaw, 1975) although there is
some consistent evidence of increased noradrenaline uptame
and increased intraneuronal metabolism. The latter would
suggest a possible decrease in release, la vitro, lit ilium
ircreases the resting release of acetylcholine and inhibits
the stimulated release (Vizi, 1975). In order to test
the hypothesis that lithium treatment increases release of
neurotransmitter through an effect on synaptic plasma
Kg ATPase activity it is necessary to establish that an
increase in release occurs after the regimen of lithium
treatment which caused an increase in synaptic plasma
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membrane Tig ATPase activity and in the same brain area.
In conclusion, this thesis lias presented an argument
and evidence to suggest that there is a reduction in Na/K
ATPase activity in depression. Evidence was presented to
suggest lithium can stimulate the sodium-pump when presented
to the potassium sensitive side of the system and inhibit
it when presented to the sodium sensitive side. Experiments
failed to provide evidence for chronic lithium administration
affecting Na/K ATPase. It was suggested that when given
therapeutically lithium has no long-term effect on la/h
ATPase activity. Results presented suggest therapeutic
lithium treatment may increase the specific activities of
certain Kg ATPases in the brain. The physiological signif¬
icance of such changes are un mown but it is speculated
they could be related to the release of neurotransmitter.
Whether or not the changes described are of relevance to




Lithium concentration in human lumbar cerebrospinal fluid.
Lithium was measured in lumbar C.S.I, samples from
5 depressive patients who had received lithium treatment
for at least 6 weeks. Following lumbar puncture, C.S.F.
samples were stored at -20°C before analysis. Lithium was
estimated by atomic absorption spectrophotometry at 670 nin
using an SP 90 Lye Unicam atomic absorptiometer. Samples
were compared with standards of aqueous lithium carbonate.
The lithium concentration in the samples was 0.21
- 0.04 (Mean value - standard deviation).
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/ ■'}' ;L'IX 2.
Method of estimation of protein.
Total protein was estimated throughout the work
described in this thesis by the method of Lowry et al.
(1951) following the procedure outlined below:
Reagents: A) 29' (w/v) ha^GO^ in 0.1 M ftaOH.
1) i: (w/v) CuS04.5h20.
C) 2? (w/v) sodium potassium tartrate.
D) 50 parts of A added to 1 part E and
1 part C.
E) Eolin-Ciocalateau reagent (B.D.K., Poole)
diluted 1+1.5 with water.
P) Bovine serum albumin (Sigma Ltd.) as
standard. 15 - 75 jug in 0.3 ml.
Procedure: 3 ml solution G was added to 0.3 ml of
samples, standards and blanks (water). After mixing, tlxe
solutions were left at room temperature for 15 minutes.
0.3 ml solution D was then added to each tube and the
solutions mixed by vortexing. After standing at room
temperature for 30 minutes, the absorbance of the solutions
was measured at 750 nm. Protein content of samples was
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